GB2475435A - Producing a product using shuttle vectors containing essential chloroplast genes - Google Patents
Producing a product using shuttle vectors containing essential chloroplast genes Download PDFInfo
- Publication number
- GB2475435A GB2475435A GB1100928A GB201100928A GB2475435A GB 2475435 A GB2475435 A GB 2475435A GB 1100928 A GB1100928 A GB 1100928A GB 201100928 A GB201100928 A GB 201100928A GB 2475435 A GB2475435 A GB 2475435A
- Authority
- GB
- United Kingdom
- Prior art keywords
- yeast
- dna
- vector
- vectors
- chloroplast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108700031407 Chloroplast Genes Proteins 0.000 title claims abstract description 44
- 239000013605 shuttle vector Substances 0.000 title abstract description 19
- 239000013598 vector Substances 0.000 claims abstract description 444
- 238000000034 method Methods 0.000 claims abstract description 238
- 210000003763 chloroplast Anatomy 0.000 claims abstract description 215
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 182
- 239000003550 marker Substances 0.000 claims abstract description 98
- 150000003505 terpenes Chemical class 0.000 claims abstract description 73
- 102000004190 Enzymes Human genes 0.000 claims abstract description 68
- 108090000790 Enzymes Proteins 0.000 claims abstract description 68
- 230000000243 photosynthetic effect Effects 0.000 claims abstract description 60
- 238000002744 homologous recombination Methods 0.000 claims abstract description 48
- 230000006801 homologous recombination Effects 0.000 claims abstract description 48
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 40
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 40
- 239000002157 polynucleotide Substances 0.000 claims abstract description 40
- 230000010076 replication Effects 0.000 claims abstract description 35
- 235000007586 terpenes Nutrition 0.000 claims abstract description 25
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 21
- 239000000194 fatty acid Substances 0.000 claims abstract description 21
- 229930195729 fatty acid Natural products 0.000 claims abstract description 21
- 210000002230 centromere Anatomy 0.000 claims abstract description 16
- 230000029553 photosynthesis Effects 0.000 claims abstract description 15
- 238000010672 photosynthesis Methods 0.000 claims abstract description 15
- 230000000593 degrading effect Effects 0.000 claims abstract description 14
- 239000002028 Biomass Substances 0.000 claims abstract description 11
- 241001464430 Cyanobacterium Species 0.000 claims abstract 2
- 108020004414 DNA Proteins 0.000 claims description 405
- 238000004519 manufacturing process Methods 0.000 claims description 52
- 241000894006 Bacteria Species 0.000 claims description 44
- 230000006798 recombination Effects 0.000 claims description 31
- 238000005215 recombination Methods 0.000 claims description 30
- 108020004998 Chloroplast DNA Proteins 0.000 claims description 22
- 101150050575 URA3 gene Proteins 0.000 claims description 14
- 230000003362 replicative effect Effects 0.000 claims description 11
- 241000206602 Eukaryota Species 0.000 claims description 3
- 230000004543 DNA replication Effects 0.000 claims 7
- 108020000946 Bacterial DNA Proteins 0.000 claims 3
- 241001560459 Dunaliella sp. Species 0.000 claims 1
- 241000168525 Haematococcus Species 0.000 claims 1
- 241000195663 Scenedesmus Species 0.000 claims 1
- 125000005313 fatty acid group Chemical group 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 139
- 230000001580 bacterial effect Effects 0.000 abstract description 56
- 241000195493 Cryptophyta Species 0.000 abstract description 52
- 150000004665 fatty acids Chemical class 0.000 abstract description 20
- 238000010230 functional analysis Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 224
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 157
- 150000007523 nucleic acids Chemical class 0.000 description 109
- 102000039446 nucleic acids Human genes 0.000 description 107
- 108020004707 nucleic acids Proteins 0.000 description 107
- 239000000047 product Substances 0.000 description 106
- 230000014509 gene expression Effects 0.000 description 86
- 229940088598 enzyme Drugs 0.000 description 66
- 241000196324 Embryophyta Species 0.000 description 56
- 230000037361 pathway Effects 0.000 description 47
- 230000009466 transformation Effects 0.000 description 45
- 238000012986 modification Methods 0.000 description 41
- 230000004048 modification Effects 0.000 description 41
- 230000035772 mutation Effects 0.000 description 38
- 241001474374 Blennius Species 0.000 description 34
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 33
- 239000012634 fragment Substances 0.000 description 31
- 239000013612 plasmid Substances 0.000 description 31
- 238000012217 deletion Methods 0.000 description 29
- 230000037430 deletion Effects 0.000 description 29
- 230000001131 transforming effect Effects 0.000 description 27
- 230000002792 vascular Effects 0.000 description 27
- 238000010367 cloning Methods 0.000 description 26
- 238000011049 filling Methods 0.000 description 26
- 230000008707 rearrangement Effects 0.000 description 26
- 230000006870 function Effects 0.000 description 25
- 241000828585 Gari Species 0.000 description 24
- 210000003463 organelle Anatomy 0.000 description 24
- 238000007792 addition Methods 0.000 description 23
- 230000003115 biocidal effect Effects 0.000 description 23
- 108091028043 Nucleic acid sequence Proteins 0.000 description 20
- 230000010354 integration Effects 0.000 description 20
- 229930195733 hydrocarbon Natural products 0.000 description 19
- 150000002430 hydrocarbons Chemical class 0.000 description 19
- 239000002773 nucleotide Substances 0.000 description 19
- 125000003729 nucleotide group Chemical group 0.000 description 19
- 229930027917 kanamycin Natural products 0.000 description 18
- 229960000318 kanamycin Drugs 0.000 description 18
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 18
- 229930182823 kanamycin A Natural products 0.000 description 18
- 239000002609 medium Substances 0.000 description 18
- 230000001105 regulatory effect Effects 0.000 description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 17
- 229910052799 carbon Inorganic materials 0.000 description 17
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 16
- 239000002585 base Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 239000002245 particle Substances 0.000 description 16
- 210000005253 yeast cell Anatomy 0.000 description 16
- 229920001817 Agar Polymers 0.000 description 15
- 239000008272 agar Substances 0.000 description 15
- 238000010353 genetic engineering Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 108020004705 Codon Proteins 0.000 description 14
- 230000012010 growth Effects 0.000 description 14
- 102100023072 Neurolysin, mitochondrial Human genes 0.000 description 13
- 238000001727 in vivo Methods 0.000 description 13
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 12
- 108700039887 Essential Genes Proteins 0.000 description 12
- 239000003242 anti bacterial agent Substances 0.000 description 12
- 239000000446 fuel Substances 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 12
- 239000004215 Carbon black (E152) Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 11
- 229940071257 lithium acetate Drugs 0.000 description 11
- 229920001184 polypeptide Polymers 0.000 description 11
- 102000004196 processed proteins & peptides Human genes 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 229910052717 sulfur Inorganic materials 0.000 description 11
- 210000002706 plastid Anatomy 0.000 description 10
- 101710165761 (2E,6E)-farnesyl diphosphate synthase Proteins 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 101710156207 Farnesyl diphosphate synthase Proteins 0.000 description 9
- 102100035111 Farnesyl pyrophosphate synthase Human genes 0.000 description 9
- 101710125754 Farnesyl pyrophosphate synthase Proteins 0.000 description 9
- 101710089428 Farnesyl pyrophosphate synthase erg20 Proteins 0.000 description 9
- 101710150389 Probable farnesyl diphosphate synthase Proteins 0.000 description 9
- 239000002243 precursor Substances 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 230000008685 targeting Effects 0.000 description 9
- -1 y-terpinene synthase Proteins 0.000 description 9
- 108020005345 3' Untranslated Regions Proteins 0.000 description 8
- 101150096273 ADE2 gene Proteins 0.000 description 8
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000006166 lysate Substances 0.000 description 8
- 238000000844 transformation Methods 0.000 description 8
- 108020003589 5' Untranslated Regions Proteins 0.000 description 7
- 108700010070 Codon Usage Proteins 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 101150075980 psbA gene Proteins 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 101150009006 HIS3 gene Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000000137 annealing Methods 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000009630 liquid culture Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 230000006641 stabilisation Effects 0.000 description 6
- 238000011105 stabilization Methods 0.000 description 6
- 229960005322 streptomycin Drugs 0.000 description 6
- 108091035539 telomere Proteins 0.000 description 6
- 102000055501 telomere Human genes 0.000 description 6
- 244000105624 Arachis hypogaea Species 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 5
- 241000219823 Medicago Species 0.000 description 5
- 108091093105 Nuclear DNA Proteins 0.000 description 5
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 5
- 244000062793 Sorghum vulgare Species 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000037353 metabolic pathway Effects 0.000 description 5
- 210000001938 protoplast Anatomy 0.000 description 5
- 229960000268 spectinomycin Drugs 0.000 description 5
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 5
- 210000003411 telomere Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 102000005575 Cellulases Human genes 0.000 description 4
- 108010084185 Cellulases Proteins 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000588722 Escherichia Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 4
- 239000004098 Tetracycline Substances 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 241000209149 Zea Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 4
- 230000001851 biosynthetic effect Effects 0.000 description 4
- 229930002875 chlorophyll Natural products 0.000 description 4
- 235000019804 chlorophyll Nutrition 0.000 description 4
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 244000013123 dwarf bean Species 0.000 description 4
- 238000001976 enzyme digestion Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 229960002180 tetracycline Drugs 0.000 description 4
- 229930101283 tetracycline Natural products 0.000 description 4
- 235000019364 tetracycline Nutrition 0.000 description 4
- 150000003522 tetracyclines Chemical class 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000045232 Canavalia ensiformis Species 0.000 description 3
- 235000009467 Carica papaya Nutrition 0.000 description 3
- 240000006432 Carica papaya Species 0.000 description 3
- 241001147674 Chlorarachniophyceae Species 0.000 description 3
- 241000218631 Coniferophyta Species 0.000 description 3
- 244000241257 Cucumis melo Species 0.000 description 3
- 240000001980 Cucurbita pepo Species 0.000 description 3
- 241000192700 Cyanobacteria Species 0.000 description 3
- 102000004594 DNA Polymerase I Human genes 0.000 description 3
- 108010017826 DNA Polymerase I Proteins 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- 101100463822 Emericella nidulans phacB gene Proteins 0.000 description 3
- 241000195623 Euglenida Species 0.000 description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
- 229930182566 Gentamicin Natural products 0.000 description 3
- 244000299507 Gossypium hirsutum Species 0.000 description 3
- 241000206759 Haptophyceae Species 0.000 description 3
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- 241000219739 Lens Species 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 3
- 229930193140 Neomycin Natural products 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 238000010222 PCR analysis Methods 0.000 description 3
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000008577 Pinus radiata Nutrition 0.000 description 3
- 241000218621 Pinus radiata Species 0.000 description 3
- 241000206572 Rhodophyta Species 0.000 description 3
- 108010022394 Threonine synthase Proteins 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000008238 biochemical pathway Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 102000004419 dihydrofolate reductase Human genes 0.000 description 3
- 235000005489 dwarf bean Nutrition 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002363 herbicidal effect Effects 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Natural products CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 238000012269 metabolic engineering Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229960000485 methotrexate Drugs 0.000 description 3
- 229960004927 neomycin Drugs 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 101710195549 (S)-beta-macrocarpene synthase Proteins 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- SEHFUALWMUWDKS-UHFFFAOYSA-N 5-fluoroorotic acid Chemical compound OC(=O)C=1NC(=O)NC(=O)C=1F SEHFUALWMUWDKS-UHFFFAOYSA-N 0.000 description 2
- 241000218642 Abies Species 0.000 description 2
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 2
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 2
- 235000003911 Arachis Nutrition 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 108010018763 Biotin carboxylase Proteins 0.000 description 2
- 235000011331 Brassica Nutrition 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 240000008100 Brassica rapa Species 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241001674345 Callitropsis nootkatensis Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000010523 Cicer arietinum Nutrition 0.000 description 2
- 244000045195 Cicer arietinum Species 0.000 description 2
- 240000006740 Cichorium endivia Species 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 2
- 240000006497 Dianthus caryophyllus Species 0.000 description 2
- 244000078127 Eleusine coracana Species 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 241000144833 Halomonas salina Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 235000005206 Hibiscus Nutrition 0.000 description 2
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 2
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 244000267823 Hydrangea macrophylla Species 0.000 description 2
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 2
- 241000227653 Lycopersicon Species 0.000 description 2
- 241000208467 Macadamia Species 0.000 description 2
- 108020005196 Mitochondrial DNA Proteins 0.000 description 2
- 101100264174 Mus musculus Xiap gene Proteins 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 241000234479 Narcissus Species 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 240000007377 Petunia x hybrida Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 2
- 241000218606 Pinus contorta Species 0.000 description 2
- 235000013267 Pinus ponderosa Nutrition 0.000 description 2
- 235000010582 Pisum sativum Nutrition 0.000 description 2
- 240000004713 Pisum sativum Species 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 241000219000 Populus Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000001416 Pseudotsuga menziesii Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241000208422 Rhododendron Species 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 244000082988 Secale cereale Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 241000223892 Tetrahymena Species 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 102000005488 Thioesterase Human genes 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 241000592342 Tracheophyta Species 0.000 description 2
- 241000219793 Trifolium Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 240000003021 Tsuga heterophylla Species 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 235000010749 Vicia faba Nutrition 0.000 description 2
- 240000006677 Vicia faba Species 0.000 description 2
- 235000002098 Vicia faba var. major Nutrition 0.000 description 2
- 241000219977 Vigna Species 0.000 description 2
- 240000004922 Vigna radiata Species 0.000 description 2
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 2
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 2
- 235000010726 Vigna sinensis Nutrition 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 101150043989 alpA gene Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001195 anabolic effect Effects 0.000 description 2
- 210000004507 artificial chromosome Anatomy 0.000 description 2
- 239000010426 asphalt Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000003733 chicria Nutrition 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000004136 fatty acid synthesis Effects 0.000 description 2
- ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 description 2
- 229960000961 floxuridine Drugs 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000003502 gasoline Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 239000003350 kerosene Substances 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000010687 lubricating oil Substances 0.000 description 2
- 101150109301 lys2 gene Proteins 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 230000002101 lytic effect Effects 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 125000001477 organic nitrogen group Chemical group 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000003348 petrochemical agent Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000003209 petroleum derivative Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 101150010007 psbD gene Proteins 0.000 description 2
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 101150074945 rbcL gene Proteins 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 229940016590 sarkosyl Drugs 0.000 description 2
- 108700004121 sarkosyl Proteins 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 239000011269 tar Substances 0.000 description 2
- 108020002982 thioesterase Proteins 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 108010082737 zymolyase Proteins 0.000 description 2
- BQOFWKZOCNGFEC-BDAKNGLRSA-N (+)-Delta3-carene Chemical compound C1C(C)=CC[C@H]2C(C)(C)[C@@H]12 BQOFWKZOCNGFEC-BDAKNGLRSA-N 0.000 description 1
- 108030001864 (+)-bornyl diphosphate synthases Proteins 0.000 description 1
- 229930006713 (+)-car-3-ene Natural products 0.000 description 1
- BBPXZLJCPUPNGH-CMKODMSKSA-N (-)-Abietadiene Chemical compound CC1(C)CCC[C@]2(C)[C@@H](CCC(C(C)C)=C3)C3=CC[C@H]21 BBPXZLJCPUPNGH-CMKODMSKSA-N 0.000 description 1
- FAMPSKZZVDUYOS-HRGUGZIWSA-N (1E,4E,8E)-alpha-humulene Chemical compound C\C1=C/CC(C)(C)\C=C\C\C(C)=C\CC1 FAMPSKZZVDUYOS-HRGUGZIWSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- XBGUIVFBMBVUEG-PFONDFGASA-N (E)-gamma-bisabolene Chemical compound CC(C)=CCC\C(C)=C1/CCC(C)=CC1 XBGUIVFBMBVUEG-PFONDFGASA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- ONVABDHFQKWOSV-UHFFFAOYSA-N 16-Phyllocladene Natural products C1CC(C2)C(=C)CC32CCC2C(C)(C)CCCC2(C)C31 ONVABDHFQKWOSV-UHFFFAOYSA-N 0.000 description 1
- QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 1
- 101710186512 3-ketoacyl-CoA thiolase Proteins 0.000 description 1
- 108010014293 5-epi-aristolochene synthase Proteins 0.000 description 1
- JCAIWDXKLCEQEO-PGHZQYBFSA-N 5beta,9alpha,10alpha-labda-8(20),13-dien-15-yl diphosphate Chemical compound CC1(C)CCC[C@@]2(C)[C@H](CCC(/C)=C/COP(O)(=O)OP(O)(O)=O)C(=C)CC[C@@H]21 JCAIWDXKLCEQEO-PGHZQYBFSA-N 0.000 description 1
- 108010000951 8-epicedrol synthase Proteins 0.000 description 1
- 235000004507 Abies alba Nutrition 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 244000283070 Abies balsamea Species 0.000 description 1
- 244000178606 Abies grandis Species 0.000 description 1
- 235000017894 Abies grandis Nutrition 0.000 description 1
- 235000004710 Abies lasiocarpa Nutrition 0.000 description 1
- BBPXZLJCPUPNGH-UHFFFAOYSA-N Abietadien Natural products CC1(C)CCCC2(C)C(CCC(C(C)C)=C3)C3=CCC21 BBPXZLJCPUPNGH-UHFFFAOYSA-N 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 240000007241 Agrostis stolonifera Species 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000219318 Amaranthus Species 0.000 description 1
- 235000004047 Amorpha fruticosa Nutrition 0.000 description 1
- 240000002066 Amorpha fruticosa Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 235000001271 Anacardium Nutrition 0.000 description 1
- 241000693997 Anacardium Species 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000218156 Aquilegia Species 0.000 description 1
- 101000906787 Arabidopsis thaliana 1,8-cineole synthase 1, chloroplastic Proteins 0.000 description 1
- 101000906782 Arabidopsis thaliana 1,8-cineole synthase 2, chloroplastic Proteins 0.000 description 1
- 101100163849 Arabidopsis thaliana ARS1 gene Proteins 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 101001065065 Aspergillus awamori Feruloyl esterase A Proteins 0.000 description 1
- 241001463143 Auca Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000218993 Begonia Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 108030000358 Botryococcene synthases Proteins 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 241001301148 Brassica rapa subsp. oleifera Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000220243 Brassica sp. Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 101100307034 Caenorhabditis elegans rps-12 gene Proteins 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 241000219312 Chenopodium Species 0.000 description 1
- 241000195585 Chlamydomonas Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 241001633993 Cineraria Species 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 108030003505 Cis-muuroladiene synthases Proteins 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 101710118490 Copalyl diphosphate synthase Proteins 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 241000522193 Coronilla Species 0.000 description 1
- 235000004035 Cryptotaenia japonica Nutrition 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 description 1
- 240000002495 Cucumis melo var. inodorus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- 241000612153 Cyclamen Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 240000004585 Dactylis glomerata Species 0.000 description 1
- 235000012040 Dahlia pinnata Nutrition 0.000 description 1
- 244000033273 Dahlia variabilis Species 0.000 description 1
- 241000208296 Datura Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 241000202296 Delphinium Species 0.000 description 1
- BQOFWKZOCNGFEC-UHFFFAOYSA-N Delta3-Carene Natural products C1C(C)=CCC2C(C)(C)C12 BQOFWKZOCNGFEC-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 235000014466 Douglas bleu Nutrition 0.000 description 1
- 235000007349 Eleusine coracana Nutrition 0.000 description 1
- 235000013499 Eleusine coracana subsp coracana Nutrition 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000237537 Ensis Species 0.000 description 1
- 108030004983 Epi-cedrol synthases Proteins 0.000 description 1
- XVULBTBTFGYVRC-UHFFFAOYSA-N Episclareol Natural products CC1(C)CCCC2(C)C(CCC(O)(C)C=C)C(C)(O)CCC21 XVULBTBTFGYVRC-UHFFFAOYSA-N 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 240000002395 Euphorbia pulcherrima Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 241000234643 Festuca arundinacea Species 0.000 description 1
- 241000218218 Ficus <angiosperm> Species 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000204888 Geobacter sp. Species 0.000 description 1
- 241000735332 Gerbera Species 0.000 description 1
- 108030004951 Germacrene-A synthases Proteins 0.000 description 1
- 241000245654 Gladiolus Species 0.000 description 1
- 240000005322 Gloxinia perennis Species 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 240000000047 Gossypium barbadense Species 0.000 description 1
- 235000009429 Gossypium barbadense Nutrition 0.000 description 1
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 241001495448 Impatiens <genus> Species 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 235000021506 Ipomoea Nutrition 0.000 description 1
- 241000207783 Ipomoea Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 101710183158 Isopimaradiene synthase Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 101150007280 LEU2 gene Proteins 0.000 description 1
- 241000208822 Lactuca Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000219729 Lathyrus Species 0.000 description 1
- 241000209499 Lemna Species 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108010054320 Lignin peroxidase Proteins 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 240000004296 Lolium perenne Species 0.000 description 1
- 108030004940 Longifolene synthases Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000002262 Lycopersicon Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 108010059896 Manganese peroxidase Proteins 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 1
- 101150037717 Mavs gene Proteins 0.000 description 1
- 235000009072 Mesembryanthemum Nutrition 0.000 description 1
- 241000219480 Mesembryanthemum Species 0.000 description 1
- 101001014220 Monascus pilosus Dehydrogenase mokE Proteins 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 101100059658 Mus musculus Cetn4 gene Proteins 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 101000997933 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) (2E,6E)-farnesyl diphosphate synthase Proteins 0.000 description 1
- 101001015102 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Dimethylallyltranstransferase Proteins 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 101000894711 Origanum vulgare Bicyclo-germacrene synthase Proteins 0.000 description 1
- 241000566145 Otus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000001591 Pachyrhizus erosus Nutrition 0.000 description 1
- 244000215747 Pachyrhizus erosus Species 0.000 description 1
- 235000018669 Pachyrhizus tuberosus Nutrition 0.000 description 1
- 235000007199 Panicum miliaceum Nutrition 0.000 description 1
- 240000008114 Panicum miliaceum Species 0.000 description 1
- 241000208181 Pelargonium Species 0.000 description 1
- 101000573542 Penicillium citrinum Compactin nonaketide synthase, enoyl reductase component Proteins 0.000 description 1
- 244000115721 Pennisetum typhoides Species 0.000 description 1
- 235000007195 Pennisetum typhoides Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000218196 Persea Species 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- 241000222385 Phanerochaete Species 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 1
- LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 description 1
- 108010035235 Phleomycins Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102100035362 Phosphomannomutase 2 Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
- 108010081996 Photosystem I Protein Complex Proteins 0.000 description 1
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 241000218595 Picea sitchensis Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000008593 Pinus contorta Nutrition 0.000 description 1
- 241001236219 Pinus echinata Species 0.000 description 1
- 235000005018 Pinus echinata Nutrition 0.000 description 1
- 235000011334 Pinus elliottii Nutrition 0.000 description 1
- 241000142776 Pinus elliottii Species 0.000 description 1
- 244000019397 Pinus jeffreyi Species 0.000 description 1
- 235000017339 Pinus palustris Nutrition 0.000 description 1
- 241000555277 Pinus ponderosa Species 0.000 description 1
- 235000013269 Pinus ponderosa var ponderosa Nutrition 0.000 description 1
- 235000013268 Pinus ponderosa var scopulorum Nutrition 0.000 description 1
- 235000008566 Pinus taeda Nutrition 0.000 description 1
- 241000218679 Pinus taeda Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000985694 Polypodiopsida Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 235000000497 Primula Nutrition 0.000 description 1
- 241000245063 Primula Species 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 description 1
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 241000220299 Prunus Species 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 241001290151 Prunus avium subsp. avium Species 0.000 description 1
- 235000006029 Prunus persica var nucipersica Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000017714 Prunus persica var. nucipersica Species 0.000 description 1
- 108091008109 Pseudogenes Proteins 0.000 description 1
- 102000057361 Pseudogenes Human genes 0.000 description 1
- 235000008572 Pseudotsuga menziesii Nutrition 0.000 description 1
- 235000005386 Pseudotsuga menziesii var menziesii Nutrition 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 108010018903 S-linalool synthase Proteins 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241001591024 Samea Species 0.000 description 1
- 101100097319 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ala1 gene Proteins 0.000 description 1
- 244000297627 Senna alata Species 0.000 description 1
- 241001138418 Sequoia sempervirens Species 0.000 description 1
- 235000005775 Setaria Nutrition 0.000 description 1
- 241000232088 Setaria <nematode> Species 0.000 description 1
- 235000008515 Setaria glauca Nutrition 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241001112810 Streptocarpus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 108030000407 Syn-copalyl-diphosphate synthases Proteins 0.000 description 1
- 241000192707 Synechococcus Species 0.000 description 1
- 241000192584 Synechocystis Species 0.000 description 1
- 101150006914 TRP1 gene Proteins 0.000 description 1
- 235000012308 Tagetes Nutrition 0.000 description 1
- 241000736851 Tagetes Species 0.000 description 1
- FRJSECSOXKQMOD-HQRMLTQVSA-N Taxa-4(5),11(12)-diene Chemical compound C1C[C@]2(C)CCC=C(C)[C@H]2C[C@@H]2CCC(C)=C1C2(C)C FRJSECSOXKQMOD-HQRMLTQVSA-N 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 108030004268 Terpinolene synthases Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000218638 Thuja plicata Species 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 102000007641 Trefoil Factors Human genes 0.000 description 1
- 235000015724 Trifolium pratense Nutrition 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
- 235000008554 Tsuga heterophylla Nutrition 0.000 description 1
- 241000722921 Tulipa gesneriana Species 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 244000301083 Ustilago maydis Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 108030003566 Valencene synthases Proteins 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- 108010053355 Vetispiradiene synthase Proteins 0.000 description 1
- 241000219873 Vicia Species 0.000 description 1
- 235000002096 Vicia faba var. equina Nutrition 0.000 description 1
- 240000002895 Vicia hirsuta Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 241000863480 Vinca Species 0.000 description 1
- 241000405217 Viola <butterfly> Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 108700040099 Xylose isomerases Proteins 0.000 description 1
- 101000720152 Zea mays Acyclic sesquiterpene synthase Proteins 0.000 description 1
- 240000003307 Zinnia violacea Species 0.000 description 1
- 241000588901 Zymomonas Species 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 101150067314 aadA gene Proteins 0.000 description 1
- 229930014549 abietadiene Natural products 0.000 description 1
- 108010093941 acetylxylan esterase Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- HMTAHNDPLDKYJT-CBBWQLFWSA-N amorpha-4,11-diene Chemical compound C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(C)=C)[C@H]21 HMTAHNDPLDKYJT-CBBWQLFWSA-N 0.000 description 1
- HMTAHNDPLDKYJT-UHFFFAOYSA-N amorphadiene Natural products C1=C(C)CCC2C(C)CCC(C(C)=C)C21 HMTAHNDPLDKYJT-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- NERNKRPBSOBEHC-UHFFFAOYSA-N anti-copalol Natural products CC1(C)CCCC2(C)C(CCC(C)=CCO)C(=C)CCC21 NERNKRPBSOBEHC-UHFFFAOYSA-N 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 235000000183 arugula Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 1
- 230000010310 bacterial transformation Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000000081 body of the sternum Anatomy 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- OSQPUMRCKZAIOZ-UHFFFAOYSA-N carbon dioxide;ethanol Chemical compound CCO.O=C=O OSQPUMRCKZAIOZ-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- 108010073469 casbene synthetase Proteins 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 108010080434 cephalosporin-C deacetylase Proteins 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 229930186364 cyclamen Natural products 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- ONVABDHFQKWOSV-HPUSYDDDSA-N ent-kaur-16-ene Chemical compound C1C[C@H](C2)C(=C)C[C@@]32CC[C@@H]2C(C)(C)CCC[C@@]2(C)[C@@H]31 ONVABDHFQKWOSV-HPUSYDDDSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 108010038658 exo-1,4-beta-D-xylosidase Proteins 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 230000002573 hemicellulolytic effect Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 101150113423 hisD gene Proteins 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229930190166 impatien Natural products 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 108010090785 inulinase Proteins 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 108010091662 levopimaradiene synthase Proteins 0.000 description 1
- 230000001533 ligninolytic effect Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 125000000396 limonene group Chemical group 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000003915 liquefied petroleum gas Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 235000014684 lodgepole pine Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000005739 manihot Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 238000003068 pathway analysis Methods 0.000 description 1
- 230000002351 pectolytic effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- MFZOSKPPVCIFMT-UHFFFAOYSA-N pinazepam Chemical compound C12=CC(Cl)=CC=C2N(CC#C)C(=O)CN=C1C1=CC=CC=C1 MFZOSKPPVCIFMT-UHFFFAOYSA-N 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 101150058614 psbH gene Proteins 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000003499 redwood Nutrition 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000000673 shore pine Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000012536 storage buffer Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 108010087432 terpene synthase Proteins 0.000 description 1
- 150000003535 tetraterpenes Chemical class 0.000 description 1
- 235000009657 tetraterpenes Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N zingiberene Chemical compound CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/68—Stabilisation of the vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The functional analysis of genes frequently requires the manipulation of large genomic regions. A yeast-bacteria shuttle vector is described that can be used to clone large regions of DNA by homologous recombination. A method of producing a product is provided, comprising obtaining a plurality of vectors collectively providing all chloroplast genes necessary for photosynthesis, each vector having two homologous recombination regions, one vector having a homologous polynucleotide of interest, one vector having a yeast replication element, one having a bacterial replication element, and one having a yeast stability element/selection marker and not having the yeast replication element; assembling the vectors into an assembled genome by introducing into yeast, selecting for assembly using the stability element/selection marker, introducing the assembled chloroplast genome into a photosynthetic host organism and expressing the homologous polynucleotide to produce the product of interest. The product may be a terpene, terpenoid, fatty acid or biomass degrading enzyme. The host may be an algae or cyanobacterium. The bacterial replication element may be a P1 or F factor replication element. The yeast replication element may be a yeast centromere or autonomous replication sequence. The yeast selection marker may be URA3 and an additional marker.
Description
SYSTEM FOR CAPTURING AND MODIFYING LARGE PIECES OF GENOMIC DNA AND CONSTRUCTING
ORGANISMS WITH SYNTHETIC CHLOROPLASTS
CROSS-REFERENCE
10001] This application claims priority to and benefit of U.S. Provisional Application No. 60/978,024 (filed October 5, 2007), which application is incorporated herein by reference.
BACKGROUND OF THE INVENTION
[0002] For the thnctional analysis of many genes, investigators need to isolate and manipulate large DNA fragments. The advent of genomics and the study of genomic regions of DNA have generated a need for vectors capable of canying large DNA regions.
[0003] In general, two types of yeast vector systems are presently available. The first type of vector is one capable of transferring small insert DNA between yeast and bacteria. A second twe of vector is a fragmenting vector which creates interstitial or terminal deletions in yeast artificial chromosomes (YACs). The small insert shuffle vectors are able to recombine with and recover homologous sequences. They are centromere-based and replicate stably and autonomously in yeast, but also contain a high-copy origin of replication for maintenance as bacterial plasmids. However, these vectors are limited by their small insert capacity. The second type of vector (also known as fragmenting vectors) has recombinogenic sequences, but is unable to transfer the recovered insert DNA to bacteria for large preparations of DNA.
[0004] Researchers use fragmentation techniques to narrow down the region of interest in YACs. However, isolating sufficient quantities of YAC DNA from agarose gels for microinjection or electroporation remains cumbersome. Purification remains a problem when the YAC comigrates with an endogenous chromosome. In addition, YACs may be chimeric or contain additional DNA regions that are not required for the particular functional study.
[0005] Types of vectors available for cloning large fragments in bacteria are cosmids, PIs and bacterial artificial chromosomes (BAC5). These vectors are limited to bacteria and cannot be shuttled to yeast for modification by homologous recombination. Bacterial vectors are also limited in their use for transforming plants and algae. For example, though chloroplasts are thought to originate from the endosymbiosis of photosynthetic bacteria into eukaryotic hosts translation of chloroplasts in more complex. Adding to the complexity of genetically engineering plants and algae is the presence of multiple chloroplasts with multiple copies of the chloroplast genome. Thus, there exists a need for developing a method to express proteins from large fragments of DNA in the chloroplasts of plants and algae
SUMMARY OF THE INVENTION
[0006] The present invention relates to compositions and methods of isolating, characterizing, and/or modifying large DNA, including entire genomes of bacteria and chloroplasts. The compositions include shuttle vectors into which target DNA may be inserted. The methods include modifting or manipulating target DNA by removing, adding or rearranging portions and introducing the modified DNA into a host.
[0007] One aspect of the present invention provides an isolated vector comprising a yeast element, a bacterial origin of replication, and at least 20 kh genomic DNA. In some vectors, the yeast element is a yeast centromere, a yeast autonomous replicating sequence, yeast auxotrophic marker, or a combination thereof The DNA may be from a non-vascular photosynthetic organism, for example a macroalgae, microalgae, Ch. vulgaris, C. reinhardiii, D. sauna, S. quadricanda or H. pluvalis. In some embodiments, the genomic DNA is modified, for example by insertion of a heterologous or homologous polynucleotide, deletion of one or more nucleic acid bases, mutation of one or more nucleic acid bases, rearrangement of one or more polynucleotides, or a combination thereof In some instances, the modification is synthetic. Vectors of the present invention, when transformed into a host cell, may result in production of a product not naturally produced by the host cell.
Some examples of such products include biomass-degrading enzymes, a fatty acids, terpenes or terpenoids. In some host cells, expression of the vector results in an increase production of a product naturally produced by said host cell, for example, a biomass-degrading enzynie, a terpene or a terpenoid. The vectors of the present invention may ffirther comprise one or more selection markers, for example, a yeast marker, a yeast antibiotic resistance marker, a yeast auxotrophic marker, a bacterial marker, a bacterial antibiotic resistance marker, a bacterial auxotrophic marker, an algae marker, an algae antibiotic resistance marker, an algae auxotrophic marker, or a combination thereof. Vectors of the present invention may also contain cliloroplast genornic DNA which comprises 1)1-200 genes; 2) all essential chloroplast genes;andlor 3) 30-400 kh.
10008] Also described herein is a host cell comprising the vectors described herein. Exemplary host cells may be naturally non-photosynthetic or photosynthetic and include, for example, Saccharomyces cerevisiae, Escherichia co/i, macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sauna, S. quadricanda or H. p/uva/is.
10009] In another aspect of the invention, a method for producing a vector is provided where tile method involves inserting targeting DNA into a vector -where the vector comprises a yeast centromere, a yeast autonomous replicating sequence, and a bacterial origin of replication, transforming an organism with the vector and capturing a portion of a chloroplast genome, thus producing a vector with a portion of a chloroplast genome. In some instances, the targeting DNA is chloroplast genomic DNA. This method may be used to capture a portion of a genome which is 10-400 kb in length. In some instances, the capturing step occurs by recombination. The captured portion of a chloroplast genome maybe co-transformed into an organism with a vector, thus the recombination step may occur in vivo. Organisms used to practice methods disclosed herein may be eukaryotic and/or photosynthetic. In some instances, the organism is a non-vascular photosynthetic organism, for example a macroalgae, microalgae, Ch. vu/garis, C. rein/ian/i/i, D.sa/ina, S. quadricanda or H. pluva/is. Organisms used to practice methods disclosed herein may also he non-photosynthetic, for example yeast. In some instances, a non-photosynthetic organism may contain exogenous chloroplast DNA. In some embodiments, an additional step of modifying a portion of a chloroplast genome is utilized. A modification may he achieved through homologous recombination. Such recombination may occur in an organism, for example a eukaryotic and/or photosynthetic organism. In some instances, the organism is a non-vascular photosmthetic organism, for example a macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sauna, s. quadricanda or H. p/uva/is. In other instances, the organism may be non-photosynthetic, for example a yeast. In embodiments with a modification step, the step may comprise addition of a polucleotide, deletion of one or more nucleic acid bases, mutation of one or more nucleic acid bases, rearrangement or a polynucleotide, or combination thereof [0010] Further disclosed herein is an isolated vector comprising essential chloroplast genes, a selectable marker and a manipulation in one or more nucleic acids in the vector. In some instances, essential chloroplast genes are cloned from a non-vascular photoshynthetic organism such as macroalgae, microalgae, Ch. vu/garis, C. reinhardtü, D. sauna, S. quadricanda or H. p/uvalis. Essential chloroplast genes for use in the vectors described herein may be synthetic. Tile vectors described herein may farther comprise an expression cassette, which may further comprise a region for integration into target DNA, for example organelle DNA. The vectors described herein may also contain one or more selection markers, for example, an auxotrophic marker, an antibiotic resistance marker, a chloroplast marker, or combinations thereof In some instances, the essential chioroplast genes are those required for chloroplast ifinction, photosynthesis, carbon fixation, production of one or more hydrocarbons, or a combination thereof Essential chloroplast genes may comprise up to 200 genes and/or consist of up to 400 kb. In some of the vectors described herein a manipulation in one or more nucleic acids is an addition, deletion, mutation, or rearrangement. In some instances, expression of the vector in a host cell produces a product not naturally produced by said host cell. In other instances, expression of a vector of the present invention results in an increase production of a product naturally produced by said host cell. Examples of such products are biomass degrading enzymes, fatty acids, terpenes or terpenoids.
[0011] As described herein, one aspect of the present invention is an isolated chloroplast comprising a vector of the present invention. In another aspect, a host ccii comprising a vector of the present invention is provided. Host cells useful in tile present invention maybe naturally non-photosynthetic or naturally photosynthetic. Examples of organisms useful for the present invention include Sacc/iaromyces cerevisiae, Esc/ierichia co/i, macroalgae, microalgae, Ch. vu/garis, C. rein/ian/ill, D. sal/na, S. quadricanda or H p/malls.
10012] In another aspect of the present invention, a method for transforming a cell or organism is provided where the method comprises inserting into said cell or organism a vector comprising all essential chioroplast genes and optionally one or more genes not naturally occuning in said cell or organism. In some embodiments, the method flirther comprises the step of eliminating substantially all chloroplast genomes in said cell or organism. A cell or organism usetlil for this method may be photosynthetic, non-photosynthetic and/or eukaryotic. A cell or organism useful for this method may be non-vascular. In some instances, the vector for use in this method may also comprise an expression cassette and the expression cassette may he capable of integrating into non-nuclear DNA. In one embodiment the one or more genes not naturally occurring in the cell or organism is a gene in the isoprenoid pathway, MVA pathway, or MEP pathway. In another embodiment, the essential chioroplast genes are those that are required for chloroplast function, photosynthesis, carbon fixation, production of one or more hydrocarbons, or a combination thereof [00131 Further provided herein is a method for modifying an organism comprising the steps of transforming the organism with a vector comprising one or more polrnucleotides sufficient to perform chloroplast function. In some instances, a vector useful for this method further comprises a sequence for production or secretion of a compound from said organism. In some instances, the compound is an isoprenoid. In other instances, the vector comprises all essential chloroplast genes. In still other instances, the essential chloroplast genes are rearranged or mutated. An organism useful for some embodiments comprises essentially no chloroplast genome prior to transformation.
[0014] Yet another method provided herein is a method for making a product from an organism comprising the step of transforming said organism with a vector comprising at least 20kb of genomic DNA and one or more of the following: (i) a gene not naturally occurring in said organism; (ii) a deletion in a gene naturally occurring in said organism; (iii) a rearrangement of genes naturally occurring in said organism; and (iv) a mutation in a gene naturally occurring in said organism. In some instances, the organism is naturally photosynthetic. In other instances, the additional genes encode enzymes in the isoprenoid pathway, LvIVA pathway, or MEP pathway. In still another embodiment, the present disclosure provides a method for transforming a cell or organism comprising inserting into said cell or organism a chloroplast and a vector comprising all essential chioroplast genes.
10015] The present disclosure also provides a method of producing an artificial chloroplast genome comprising the steps of (a) providing a vector comprising one or more essential chloroplast genes; (b) adding to said vector a DNA fragment; (c) transforming a cell or organism with tile vector produced by step (h); and (d) determining whether chloroplast frmnction exists with said added DNA fragment. In some instances, the added DNA fragments comprises one or more coding regions for an enzyme in the isoprenoid, MVA or MEP pathway.
[0016] The present disclosure also provides a shuttle vector comprising a chioroplast genome. A genome maybe modified.
Also provided herein is a vector comprising an isolated, functional chloroplast genome. A chloroplast genome useful in such a vector maybe modified.
[0017] Further provided herein is a method of producing an artificial chloroplast genome comprising the steps of (a) providing a vector comprising all essential chloroplast genes; and (b) removing, adding, mntating, or rearranging DNA from the chloroplast genome. Snch a method may further comprise the steps of transforming a redacted genome into a host organism; and (d) determining chloroplast function in the host organism. In some instances, steps (F), (c), and (d) are repeated. In still other instances, the chloroplast genome is from an organism selected from the gronp consisting of macroalgae, microalgae, Ch. vulgaris, C. reinhardili, D. sal/na, S. quadricanda or H. pluvalis. In other instances, the host organism is selected from the group consisting of macroalgae, microalgae, Ch. vulgaris, C. reinhardtii, D. sal/na, S. quadricanda or H. pluvalis. For some embodiments, the method may further comprise the step of removing redundant DNA from a chloroplast genome. In other embodiments, the vector comprises all or substantially all of a chloroplast genome. A chloroplast genome useful in the present invention may be cloned from a photosynthetic organism or may be a synthetic chloroplast genome. In some instances, the vector further comprises a gene not natnrally occurring in the host organism, for example a gene from the isoprenoid pathway, IY1VA pathway, or MEP pathway.
[0018] Yet another method provided herein is a method of producing an artificial chloroplast genome comprising the steps of (a) providing a vector comprising an entire chloroplast genome; (b) deleting a portion of said entire chloroplast genome; and (c) determining whether chloroplast function exists withont said deleted portion. In another aspect of the present invention, a composition comprising an isolated and functional chloroplast genome is provided. In some instances, a composition comprises a modification to said chloroplast genome.
10019] Further provided herein is an cx vivo vector comprising a nucleic acid comprising at least about 10% of a chloroplast genome and a manipulation in one or more nucleic acids in the vector. In some instances, the nucleic acid is cloned from a non-vascular photosynthetic organism, for example a macroalgae, microalgae, Ch. vulgaris, C. reinhardtii, D. sal/na, S. quadricanda orH. pluvalis. In some instances, the nucleic acid is synthetic. A vector of the present invention may further comprise an expression cassette and an expression cassette may further comprise a region for integration into target DNA. In some instances, the target DNA is organelle DNA. A vector useful in the present invention may further comprise one or more selection markers, for example an auxotrophic marker, an antibiotic resistance marker, a chloroplast marker, or combinations thereof In some embodiments, a manipulation in one or more nucleic acids in a vector may be an addition, deletion, mutation, or rearrangement. Expression of the vector may result in production of a product not naturally produced by a host cell and/or an increase production of a product naturally produced by a host cell. Examples of some products of the present invention include a terpene, terpenoid, fatty acid, or hiomass degrading enzyme.
[0020] Also provided herein is an cx vivo vector comprising a nucleic acid comprising at least abont 20 kilobases of a chloroplast genome and a manipulation in one or more nucleic acids in said vector. In some instances, the nucleic acid is cloned from a non-vascular photosynthetic organism, for example a macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sal/na, S. quadricanda orH. pluvalis. In some instances, the nucleic acid is synthetic. A vector of the present invention may further comprise an expression cassette and an expression cassette may further comprise a region for integration into target DNA. In some instances, the target DNA is organelle DNA. A vector useful in the present invention may further comprise one or more selection markers, for example an auxotrophic marker, an antibiotic resistance marker, a chloroplast marker, or combinations thereof In some embodiments, a manipulation in one or more nucleic acids in a vector may be an addition, deletion, mutation, or rearrangement. Expression of the vector may result in production of a product not naturally produced by a host cell and/or an increase production of a product naturally produced by a host cell. Examples of some products of tile present invention include a terpene, terpenoid, fatty acid, or hiomass degrading enzyme.
[0021] Further provided herein is a method of producing a vector containing a reconstructed genome, comprising: introducing two or more vectors into a host cell, wherein the vectors comprise fragments of a genome, recombining the vectors into a single vector comprising at least about 90% of a genome, thereby producing a vector containing a reconstructed genome. In some instances, the host ccii is eukaryotic, for example, S. cerevisiae. In other instances, the genome is an organelle genome. The organelle may he a chloroplast, for example a chloroplast from an alga, particularly a microalga such as Ch. vulgaris, C. reinhardtii, D. salina, S. quadricanda or H. pluvalis. In some instances, the two or more vectors comprise a selectable marker. In other instances, at least one of said fragments is synthetic. In still other instances, a further step comprising modifting a portion of the genome is useful in this method. Such a modification may comprise an addition, deletion, mutation, or rearrangement. In other embodiments, the modification is the addition of an exogenous nucleic acid which results in the production or increased production of a terpene, terpenoid, fatty acid or biomass degrading enzynie.
INCORPORATION BY REFERENCE
[0022] All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individuat publication or patent application was specifically and individually indicated to be incorporated by reference.
BRIEF DESCRIPTION OF THE DRAWINGS
10023] The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which: 10024] In the figures, the following abbreviations are used: H153: yeast H153 gene; TRPJ: yeast TRPJ gene; URA3: yeast URA3 gene; ADE2: yeast ADE2 gene; LYS2: yeast LYS2 gene; TEL: yeast telomere; CEN: yeast centromere; ARS: autonomously replicating sequences, yeast origin of replication; 5FOA: 5-fluoroorotic acid; Kan: kanamycin resistance gene; P1 plasmid rep: P1 plasmid replicon; p1 lytic rep: p1 lytic replicon.
[0025] Figure 1 provides a general description of a hybrid vector of the present invention. A) Vector schematic. B) DNA shuttling between organisms.
[0026] Figure 2 is a schematic showing construction of a hybrid vector.
[0027] Figure 3 is a schematic showing sites of integration in chloroplast genome DNA. Circled numbers indicate target sites for modification. The box indicates the site targeted by the hkrid gap-filling vector 10028] Figure 4 is a schematic of selectable markers for modification and/or stabilization.
10029] Figure 5 is a schematic for introduction of hybrid vector into chioroplast genome DNA.
10030] Figure 6 is PCR data showing integration of hybrid vector (and stabilization vector) in algae.
10031] Figure 7 shows analysis of captured DNA. A) Restriction digest with EcoRI ofisolated vectors containing chloroplast(L, ladder; C, parent hybrid vector; 1, Clone 1; and 2; Clone 2). B) Restriction digest with EcoRI of isolates of Clone 1 that were passaged through yeast (L, ladder; C,; 1, Clone 1; and A-M; yeast isolates). C) Southern analysis of Clones 1 and 2 digested with EcoRI and probed with radioactive Hint/rn-digested total DNA from C. reinharcltii.
[0032] Figure 8 is a schematic showing architecture of isolated cx vivo vectors containing chioroplast genome DNA.
[0033] Figure 9 shows growth of parent and transformed algae cells under various selection conditions.
[0034] Figure 10 is a schematic of restriction analysis for manipulation vectors. A) Schematic of vector architecture. B) Analysis of modified vector by restriction analysis with EcoRI [0035] Figure 11 shows modification of a chloroplast genome to produce a biomass-degrading enzyme. A) PCR screen of isolated transformants. B) Endoxylanase activity from isolated transformants.
10036] Figure 12 shows a PCR screen of isolated transformants modified to produce isoprenoids with tile FPP synthase expression cassette targeted to site 3 (A) or site 4 (B).
10037] Figure 13 is a schematic showing capture of a partial chloroplast genome using recombination in yeast.
10038] Figure 14 is a schematic showing capture of an entire chloroplast genome using recombination in yeast.
10039] Figure 15 is a schematic showing reassembly of an entire chloroplast genome using recombination in yeast.
DETAILED DESCRIPTION OF THE INVENTION
[0040] While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be emp toyed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
10041] Technical and scientific terms used herein have the meanings commonly understood by one of ordinary skill in the art to which the instant invention pertains, unless otherwise defined. Reference is made herein to various materials and methodologies known to those of skill in the art. Standard reference works setting forth the general principles of recombinant DNA technology include Sambrook et al., "Molecular Cloning: A Laboratory Manual", 2d ed., Cold Spring Harbor Laboratory Press, Plainview, N.Y., 1989; Kaufman et al., eds., "Handbook of Molecular and Cellular Methods in Biology and Medicine", CRC Press, Boca Raton, 1995; and McPherson, ed., "Directed Mutagenesis: A Practical Approach", IRL Press, Oxford, 1991. Standard reference literature teaching general methodologies and principles of yeast genetics useftil for selected aspects of the invention include: Sherman et al. "Laboratory Course Manual Methods in Yeast Genetics", Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., 1986 and Guthrie et al., "Guide to Yeast Genetics and Molecular Biology", Academic, New York, 1991.
[0042] Any suitable materials and/or methods known to those of skill can be utilized in canying out the instant invention.
Materials and/or methods for practicing the instant invention are described. Materials, reagents and the like to which reference is made in the following description and examples are obtainable from commercial sources, unless otherwise noted.
This invention teaches methods and describes tools for capturing and modifying large pieces of DNA. It is especially useful for modifying genomic DNA, including tile whole genome of an organism or organelle, or a part thereof Novel prophetic uses of the invention are also described. The invention relates to the manipulation and delivery of large nucleic acids. The invention further relates to recombinational cloning vectors and systems and to methods of using the same.
10043] Contemporary methods for genetically engineering genomes (e.g., chloroplast genornes) are time intensive (> 1 month) and allow for only a limited number of manipulations at a time. If multiple modifications to a target genome are desired, the process must be iterated, ftirther increasing the time required to generate a desired strain. Because metabolic engineering and/or smthetic biology require numerous modifications to a genome, these technologies are not amenable to rapid introduction of modifications to a genome. Thus, a new technology that allows for multiple modification of the chloroplast genorne in a short amount of time will enable tile application of metabolic engineering and/or synthetic biology to chloroplast genornes. The disclosure herein describes such technology.
[0044] The instant invention provides a versatile, recombinational approach to the capture, cloning, and manipulation of large nucleic acids from target cells and organdIes (e.g., chloroplasts). One aspect of the present invention provides a recombinational cloning system. More specifically, the invention provides vectors, which in some embodiments, rely on homologous recombination technologies to mediate the isolation and manipulation of large nucleic acid segments. Another aspect of the present invention provides methods for using such recombinational cloning vectors to clone, to manipulate and to deliver large nucleic acids to target cells andlor organdIes such as chloroplasts.
10045] In one preferred embodiment, homologous recombination is performed in vitro. In a particularly preferred embodiment of the invention, homologous recombination is performed in vivo. In a more preferred embodiment, homologous recombination occurs in an algae cell. In another more preferred embodiment, homologous recombination occurs in a yeast cell. In one preferred embodiment, homologous recombination occurs in Saccharomyces cerevisiae or Saccharomyces pombe. In yeast, the combination of efficient recombination processes and the availability of numerous selectable markers provides for rapid and complex engineering of target DNA sequences. Once all of the modifications are made to an cx vivo vector containing chloroplast genome DNA, the entire vector can be introduced into a chloroplast in a single transformation step. Thus, employing yeast technology will enable the application of metabolic engineering and/or synthetic biology to chloroplast genomes. One aspect of the present invention provides an isolated vector comprising a yeast element, a bacterial origin of replication, and at least 20 kh genomic DNA. In some vectors, the yeast element is a yeast centromere, a yeast autonomous replicating sequence, or a combination thereof. The DNA may be from a non-vascular photosynthetic organism, for example a macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sauna, S. quadricanda or H pluva/is. In some embodiments, the genomic DNA is modified, for example by insertion of a heterologous or homologous polynucleotide, deletion of one or more nucleic acid bases, mutation of one or more nucleic acid bases, rearrangement of one or more polynucleotides, or a combination thereof In some instances, the modification is synthetic. Vectors of the present invention, when transformed into a host cell, may result in production of a product not naturally produced by the host cell. Some examples of such products include biomass-degrading enzymes, a fatty acids, terpenes or terpenoids. In some host cells, expression of the vector results in an increase production of a product naturally produced by said host cell, for example, a hiomass-degrading enzyme, a terpene or a terpenoid. The vectors of the present invention may further comprise one or more selection markers, for example, a yeast marker, a yeast antibiotic resistance marker, a bacterial marker, a bacterial antibiotic resistance marker, an algae marker, an algae antibiotic resistance marker or a combination thereof. Vectors of the present invention may also contain chioroplast genomic DNA which comprises 1) 1 -200 genes; 2) all essential chloroplast genes;andlor 3)30-400 kb.
10046] Also described herein is a host cell comprising the vectors described herein. Exemplary host cells may be naturally non-photosmthetic or photosynthetic and include, for example, Saccharomyces cerevisiae, Escherichia co/i, macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sauna, S. quadricanda or H. p/uva/is.
[0047] In another aspect of the invention, a method for producing a vector is provided where the method involves inserting targeting DNA into a vector -where the vector comprises a yeast centromere, a yeast autonomous replicating sequence, and a bacterial origin of replication, transforming an organism with the vector and capturing a portion of a chloroplast genome, thus producing a vector with a portion of a chloroplast genome. In some instances, the targeting DNA is chloroplast genomic DNA. This method may be used to capture a portion of a genome which is 10-400 kb in length. In some instances, the capturing step occurs by recombination. The captured portion of a chioroplast genome may he co-transformed into an organism with a vector, thus tile recombination step may occur in vivo. Organisms used to practice methods disclosed herein may be eukaryotic and/or photosynthetic. In some instances, the organism is a non-vascular photosynthetic organism, for example a macroalgae, microalgae, Ch. vulgaris, C. reinhardlil, D. sauna, S. quadricanda or H. pluvalis. Organisms used to practice methods disclosed herein may also be non-photosynthetic, for example yeast. In some instances, a non-photosynthetic organism may contain exogenous chloroplast DNA. In some embodiments, an additional step of modifying a portion of a chloroplast genome is utilized. A modification may he achieved through homologous recombination. Such recombination may occur in an organism, for example a eukaryotic and/or photosmthetic organism. In some instances, the organism is a non-vascular photosmthetic organism, for example a macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sauna, s. quadricanda or H. p/zlva/is. In other instances, the organism may be non-photosthetic, for example a yeast. In embodiments with a modification step, the step may comprise addition of a polmucleotide, deletion of one or more nucleic acid bases, mutation of one or more nucleic acid bases, rearrangement or a polynucleotide, or combination thereof [0048] Further disclosed herein is an isolated vector comprising essential chloroplast genes, a selectable marker and a manipulation in one or more nucleic acids in the vector. In some instances, essential chloroplast genes are cloned from a non-vascular photoshynthetic organism such as macroalgae, microalgae, Ch. vu/garis, C. reinhardtü, D. sauna, S. quadricanda or H. pluva/is. Essential chloroplast genes for use in the vectors described herein may he synthetic. The vectors described herein may further comprise an expression cassette, which may further comprise a region for integration into target DNA, for example organelle DNA. The vectors described herein may also contain one or more selection markers, for example, an auxotrophic marker, an antibiotic resistance marker, a chloroplast marker, or combinations thereof In some instances, the essential chloroplast genes are those required for chloroplast ffinction, photosynthesis, carbon fixation, production of one or more hydrocarbons, or a combination thereof Essential chloroplast genes may comprise up to 200 genes and/or consist of up to 400 kb. In some of the vectors described herein a manipulation in one or more nucleic acids is an addition, deletion, mutation, or rearrangement. In some instances, expression of the vector in a host cell produces a product not naturally produced by said host cell. In other instances, expression of a vector of the present invention results in an increase production of a product naturally produced by said host cell. Examples of such products are biomass degrading enzymes, fatty acids, terpenes or terpenoids.
[0049] As described herein, one aspect of the present invention is an isolated chloroplast comprising a vector of the present invention. In another aspect, a host cell comprising a vector of the present invention is provided. Host cells useful in the present invention may be naturally non-photosynthetic or naturally photosynthetic. Examples of organisms useful for the present invention include Saccharornvces cerevisiae, Escherichia co/i, macroalgae, microalgae, Ch. vu/garis, C. rein hardtii, D. sal/na, S. quadricanda or H. p/ma/is.
10050] In another aspect of the present invention, a method for transforming a cell or organism is provided where the method comprises inserting into said cell or organism a vector comprising all essential chloroplast genes and optionally one or more genes not naturally occurring in said cell or organism. In some embodiments, the method further comprises the step of eliminating substantially all chloroplast genomes in said cell or organism. A cell or organism usefUl for this method may he photosynthetic, non-photosynthetic and/or eukaryotic. A cell or organism useful for this method may be non-vascular. In some instances, the vector for use in this method may also comprise an expression cassette and the expression cassette may he capable of integrating into non-nuclear DNA. In one embodiment the one or more genes not naturally occurring in the cell or organism is a gene in the isoprenoid pathway, MVA pathway, or MEP pathway. In another embodiment, the essential chloroplast genes are those that are required for chloroplast function, photosynthesis, carbon fixation, production of one or more hydrocarbons, or a combination thereof.
10051] Further provided herein is a method for modifying an organism comprising the steps of transforming the organism with a vector comprising one or more polynucleotides sufficient to perform chloroplast function. In some instances, a vector useful for this method further comprises a sequence for production or secretion of a compound from said organism. In some instances, the compound is an isoprenoid. In other instances, the vector comprises all essential chloroplast genes. In still other instances, the essential chloroplast genes are rearranged or mutated. An organism useful for some embodiments comprises essentially no chloroplast genome prior to transformation.
[0052] Yet another method provided herein is a method for making a product from an organism comprising the step of transforming said organism with a vector comprising at least 20 kb of genomic DNA and one or more of the following: (i) a gene not naturally occurring in said organism; (ii) a deletion in a gene naturally occurring in said organism; Oii) a rearrangement of genes naturally occurring in said organism; and (iv) a mutation in a gene naturally occurring in said organism. In some instances, tile organism is naturally photosynthetic. In other instances, tile additional genes encode enzymes in the isoprenoid pathway, LvIVA pathway, or MEP pathway. In still another embodiment, the present disclosure provides a method for transforming a cell or organism comprising inserting into said cell or organism a chioroplast and a vector comprising all essential chloroplast genes.
10053] The present disclosure also provides a method of producing an artificial chloroplast genome comprising the steps ofi (a) providing a vector comprising one or more essential chloroplast genes; (b) adding to said vector a DNA fragment; (c) transforming a cell or organism with the vector produced by step (b); and (d) determining whether chloroplast ftinction exists with said added DNA fragment. In some instances, the added DNA fragments comprises one or more coding regions for an enzyme in the isoprenoid, MVA or MEP pathway.
[0054] The present disclosure also provides a shuttle vector comprising a chioroplast genome. A genome may be modified.
Also provided herein is a vector comprising an isolated, ftinctional chloroplast genome. A chloroplast genome useful in such a vector may be modified.
[0055] Further provided herein is a method of producing an artificial chloroplast genome comprising the steps of: (a) providing a vector comprising alt essential chloroplast genes; and (b) removing, adding, mutating, or rearranging DNA from the chloroplast genome. Such a method may thrther comprise the steps of transforming a redacted genome into a host organism; and (d) determining chioroplast function in the host organism. In some instances, steps (h), (c), and (d) are repeated. In still other instances, the chioroplast genome is from an organism selected from the group consisting of: macroalgae, microalgae, Ch. vulgaris, C. reinhardtii, D. sauna, S. quadricanda or H pluvalis. In other instances, the host organism is selected from the group consisting of: macroalgae, microalgae, C/i. vu/garis, C. reinhardtii, D. sauna, s.
quadricanda or H. pluva/is. For some embodiments, the method may ifirther comprise the step of removing redundant DNA from a chloroplast genome. In other embodiments, the vector comprises all or substantially all of a chloroplast genome. A chloroplast genorne useful in the present invention may be cloned from a photosynthetic organism or may be a synthetic chioroplast genome. In some instances, the vector ftirther comprises a gene not naturally occurring in the host organism, for example a gene from the isoprenoid pathway, MYA pathway, or MEP pathway.
[0056] Yet another method provided herein is a method of producing an artificial chloroplast genome comprising the steps of: (a) providing a vector comprising an entire chloroplast genome; (b) deleting a portion of said entire chloroplast genome; and (c) determining whether chloroptast function exists without said deleted portion. In another aspect of the present invention, a composition comprising an isolated and functional chtoroptast genome is provided. In some instances, a composition comprises a modification to said chloroplast genome.
10057] Further provided herein is an cx vivo vector comprising a nucleic acid comprising at least about 10% of a chloroplast genome and a manipulation in one or more nucleic acids in the vector. In some instances, the nucleic acid is cloned from a non-vascular photosynthetic organism, for example a macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sal/na, S. quadricanda orH. plum/is. In some instances, the nucleic acid is synthetic. A vector of the present invention may further comprise an expression cassette and an expression cassette may further comprise a region for integration into target DNA. In some instances, the target DNA is organelle DNA. A vector useftil in the present invention may further comprise one or more selection markers, for example an auxotrophic marker, an antibiotic resistance marker, a chloroplast marker, or combinations thereof In some embodiments, a manipulation in one or more nucleic acids in a vector may be an addition, deletion, mutation, or rearrangement. Expression of the vector may result in production of a product not naturally produced by a host cell and/or an increase production of a product naturally produced by a host celL Examples of some products of tile present invention include a terpene, terpenoid, fatty acid, or hiomass degrading enzyme.
10058] Also provided herein is an cx vivo vector comprising a nucleic acid comprising at least about 20 kilobases of a chloroplast genome and a manipulation in one or more nucleic acids in said vector. In some instances, the nucleic acid is cloned from a non-vascular photosynthetic organism, for example a macroalgae, microalgae, Ch. vulgaris, C. reinhardtii, D. sal/na, S. quadricanda orH. pluvalis. In some instances, the nucleic acid is synthetic. A vector of the present invention may further comprise an expression cassette and an expression cassette may further comprise a region for integration into target DNA. In some instances, the target DNA is organelle DNA. A vector useftil in the present invention may ftirther comprise one or more selection markers, for example an auxotrophic marker, an antibiotic resistance marker, a chloroplast marker, or combinations thereof In some embodiments, a manipulation in one or more nucleic acids in a vector may be an addition, deletion, mutation, or rearrangement. Expression of the vector may result in production of a product not naturally produced by a host cell and/or an increase production of a product naturally produced by a host cell. Examples of some products of the present invention include a terpene, terpenoid, fatty acid, or hiomass degrading enzyme.
[0059] Further provided herein is a method of producing a vector containing a reconstructed genome, comprising: introducing two or more vectors into a host cell, wherein the vectors comprise fiagments of a genome, recombining the vectors into a single vector compri sing at least abont 90% of a genome, thereby producing a vector containing a reconstructed genome. In some instances, the host cell is eukaryotic, for example, S. cerevisiae. In other instances, tile genome is an organelle genome. The organelle may be a chloroplast, for example a chloroplast from an alga, particularly a microalga such as Ch. vu/garis, C. reinhardtii, D. sauna, s. quadricanda or H. pluva/is. In some instances, the two or more vectors comprise a selectable marker. In other instances, at least one of said fragments is synthetic. In still other instances, a further step comprising modifiying a portion of the genome is useful in this method. Such a modification may comprise an addition, deletion, mutation, or rearrangement. In other embodiments, the modification is the addition of an exogenous nucleic acid which results in the production or increased production of a terpene, terpenoid, fatty acid or biomass degrading enzyme.
[0060] Lar2e DNA Clonin2 and Content [0061] An advantage of this invention is that it provides for the cloning, manipulation, and delivery of a vector containing chloroplast genorne DNA consisting of up to all chloroplast genes (or sequences). The chloroplast genome DNA contained in the vector can be obtained by recombination of a hybrid cloning vector with one contiguous fragment of DNA or by recombination of two or more contiguous fragments of DNA.
10062] The methods and compositions of the present invention may include captured andlor modified large pieces of DNA may comprise DNA from an organelle, such as mitochondrial DNA or plastid DNA (e.g., chloroplast DNA). The captured and/or modified large pieces of DNA may also comprise the entirety of an organelle's genome, e.g., a chloroplast genome. In other embodiments, the captured and/or modified large pieces of DNA comprise a portion of a chloroplast genome. A chloroplast genome may originate from any vascular or non-vascular plant, including algae, bryophytes (e.g., mosses, ferns), gymnosperms (e.g., conifers), and angiosperms (e.g., flowering plants-trees, grasses, herbs, shrubs). A chloroplast genome, or essential portions thereof, may comprise synthetic DNA, rearranged DNA, deletions, additions, and/or mutations. A chloroplast genorne, or portions thereof, may comprise a one or more deletions, additions, niutations, and/or rearrangements.
The deletions, additions, mutations, and/or rearrangements may be naturally found in an organism, for example a naturally occurring mutation, or may not be naturally found in nature. The chloroplast or plastid genornes of a number of organisms are widely available, for example, at the public database from the NCBI Organelle Genomes section available at http://www.ncbi.nlm.nih.gov/genomes/static/euko.htmL 10063] The target DNA sequence described herein may comprise at least 1, 2, 3, 4, or 5 deletions, additions, mutations, and/or rearrangements as compared to a control sequence (naturally occurring sequence). In some embodiments, the mutations may be ifinctional or nonfunctional. For example, a functional mutation may have an effect on a cellular function when the mutation is present in a host cell as compared to a control cell without the mutation. A non-ifinctional mutation may be silent in ifinction, for example, there is no discernable difference in phenotype of a host cell without the mutation as compared to a cell with the mutation.
100641 Captured and/or modified large pieces of DNA (e.g., target DNA), may comprise a minimal or minimized chloroplast genorne (e.g., the minimum number of genes and/or DNA fragment, required for chloroplast functionality). The captured and/or modified DNA may comprise the essential chloroplast genes, it may comprise a portion or all, or substantially all of the essential chloroplast genes. An essential gene may be a gene that is essential for one or more metabolic processes or biochemical pathways. An essential gene may be a gene required for chloroplast function, such as photosynthesis, carbon fixation, or hydrocarbon production. An essential gene may also he a gene that is essential for gene expression, such as transcription, translation, or other process(es) that affect gene expression. The essential genes may comprise mutations or rearrangements. Essential genes may also comprise a minimally flinctional set of genes to perform a function. For example, a particular function (e.g., photosynthesis) may be performed inefficiently by a set of genes/gene products, however, this set would still comprise essential genes because the function is still performed.
10065] Modified DNA may comprise at least 5, 10, 15, 20, 25, 30, 40, or 50 essential genes. In some embodiments, the DNA may comprise essential chloroplast genomic sequence of tip to 150kb in length. The DNA may comprise essential chioroplast genes as well as non-essential chloroplast gene sequences. The DNA may be single stranded or double stranded, linear or circular, relaxed or supercoiled. The DNA may also be in the form of an expression cassette. For example, an expression cassette may comprise an essential gene to be expressed in a host cell. The expression cassette may comprise one or more essential genes as well as DNA sequences that promote the expression of the essential genes. The expression cassette may also comprise a region for integration into target DNA of a host. The expression cassette may also comprise one or more essential genes and one or more genes not naturally occurring in a host cell comprising the expression cassette.
One of ordinary skill in tile arts will easily ascertain various combinations of the aforementioned aspects of the expression cassettes.
10066] In other instances, captured andlor modified pieces of DNA may comprise the entire genome of a plastid or organelle. For example, about 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% of a plastid genome, or more. In one embodiment the captured and/or modified large pieces of DNA may comprise 10-100%, 20-100%, 30-100%, 40-100%, 50-100%, 60-100%, 70-100%, 80-100%, or 90-100% of the entire genome of a plastid or cell.
[0067] In still other instances, the captured and/or modified large pieces of DNA may comprise about 10kb, 11 kb, 12 kh, 13kb, l4kb,lskb,l6kb, 17kb, l8kb,l9kb,2Okb,2lkh,22kb,23kb,24kb,25kh,26kb,27kb,28kb,29kb,3Okh, 31 kb, 32kb, 33kb, 34kb, 35kb, 36kb, 37kb, 38kb, 39kb, 40kb, 41 kb, 42kb, 43kb, 44kb, 45kb, 46kb, 47kb, 48kb, 49kb, 50kb, 51 kb, 52kb, 53 kb, 54kb, 55 kb, 56kb, 57kb, 58kb, 59kb, 60kb, 61 kh, 62kb, 63 kb, 64kb, 65 kh, 66kb, 67 kh, 68 kh, 69kb, 70 kb, 71 kb, 72 kh, 73 kb, 74 kb, 75 kb, 76 kh, 77 kh, 78 kb, 79kb, 80 kh, 81 kh, 82 kb, 83 kb, 84kb, 85kb, 86kb,87kb,88kb,89kh,9Okh,91 kb,92kb,93kb,94kh,95kb,96kb,97kb,98kh,99kh, 100kb, 101 kb, 102 kb,lO3kb,lO4kb,lOSkb,lO6kh,lO7kb,lO8kb,lO9kb,llOkh,lllkb,ll2kb,ll3kb, ll4kh,llSkb,ll6kb,ll7kb, 118kb, 119kb, 120kb, 121 kb,122kb, 123 kb, 124kb, 125kb, 126kb, 127kb, 128kb, 129kb, 130kb, 131 kb, 132kb, 133 kh, 134kb, 135kb, 136kb, 137kb, 138kb, 139kb, 140kb, 141 kb, 142kb, 143kb, 144kb, 145kb, 146kb, 147kb, 148kb, 149 kb, 150 kb, 151 kb, 152 kb, 153 kb, 154 kb, 155 kb, 156 kb, 157 kb, 158 kb, 159 kb, 160 kb, 161 kb, 162 kb, 163 kb, 164 kb,165kb,166kb,167kb,l6Skb,169kb,l7Okb,l7lkb,172kb,173kb,174kb,175kb, 176kb,177kb,l7Skb,179kh, kb, 181 kb, 182 kb, 183 kh, 184 kb, 185 kb, 186 kb, 187 kb, 188 kb, 189 kb, 190 kb, 191 kb, 192 kb, 193 kb, 194 kb, 195 kb, 196 kb, 197 kb, 198 kb, 199 kb, 200 kb, 201 kb, 202 kb, 203 kb, 204 kb, 205 kb, 206 kh, 207 kb, 208 kb, 209 kb, 210 kh, 211 kb, 212 kb, 213 kb, 214 kh, 215 kb, 216 kb, 217 kb, 218 kb, 219 kb, 220 kb, 221 kb, 222 kb, 223 kb, 224 kb, 225 kh, 226 kb, 227 kb, 228 kb, 229 kh, 230 kb, 231 kb, 232 kb, 233 kh, 234 kb, 235 kb, 236 kb, 237 kh, 238 kb, 239 kb, 240 kb, 241 kh, 242 kb, 243 kb, 244 kh, 245 kh, 246 kb, 247 kb, 248 kh, 249 kb, 50 kb, 51 kb, 252 kh, 253 kh, 254 kb, 255 kb, 256 kh, 257 kb, 258 kb, 259 kh, 260 kh, 261 kb, 262 kb, 263 kh, 264 kh, 265 kb, 266 kb, 267 kh, 268 kh, 269 kb, 270 kb, 271 kh, 272 kh, 273 kh, 274 kh, 275 kb, 276 kb, 277 kh, 278 kb, 279 kb, 280 kh, 281 kh, 282 kb, 283 kb, 284 kh, 285 kh, 286 kb, 287 kb, 288 kh, 289 kh, 290 kb, 291 kb, 292 kh, 293 kb, 294 kb, 295 kb, 296 kh, 297 kb, 298 kb, 299 kb, 300 kh, 301 kb, 302 kb, 303 kb, 304kb, 305 kb, 306 kb, 307 kb, 308 kb, 309kb, 310kb, 311kb, 312 kb, 313 kb, 314kb, 315 kh, 316kb, 317kb, 318 kb, 319 kh, 320 kb, 321 kb, 322 kb, 323 kh, 324 kb, 325 kb, 326 kb, 327 kh, 328 kb, 329 kb, 330 kb, 331 kb, 332 kb, 333 kb, 334 kb, 335 kb, 336 kb, 337 kb, 338 kb, 339 kb, 340 kb, 341 kb, 342 kb, 343 kb, 344 kb, 345 kb, 346 kh, 347 kb, 348 kb, 349 kb, 350 kb, 351 kb, 352 kb, 353 kb, 354 kb, 355 kb, 356 kb, 357 kb, 358 kb, 359 kb, 360 kb, 361 kb, 362 kb, 363 kb, 364 kb, 365 kb, 366 kb, 367 kb, 368 kb, 369 kb, 370 kb, 371 kb, 372 kb, 373 kb, 374 kb, 375 kb, 376 kb, 377 kb, 378 kb, 379 kb, 380 kb, 381 kb, 382 kb, 383 kb, 384 kb, 385 kb, 386 kb, 387 kb, 388 kb, 389 kb, 390 kb, 391 kb, 392 kb, 393 kb, 394 kb, 395 kb, 396 kb, 397 kb, 398 kb, 399 kb, 400 kb or more genomic (e.g., nuclear or organelle) DNA. In some embodiments the captured and or modified large pieces of DNA may comprise about 10-400 kh, 50-350 kb, 100-300 kb, 100-200 kb, 200-300 kb, 150-200 kh, 200-250 kb genomic DNA [0068] In still other instances, the captured and or modified large pieces of DNA may comprise about 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30,31,32,33,34,35, 36, 37, 38, 39, 40,41,42,43,44,45,46,47,48,49,50,51,52,53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121,122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140,141,142,143,144,145,146,147,148,149,150,151,152,153,154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182,1 83, 184, 185, 186, 187, 188, 189, 190,191,192,193,194,195,196,197,198, 199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 50, 51, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300 or more open reading frames, partial open reading frames, pseudogenes and/or repeating sequences.
[0069] The present invention also provides vectors comprising a cassette-able cliloroplast genome or portion thereof (e.g., a removable DNA fragment comprising a chioroplast genome or functional portion thereof). A vector of the present invention may comprise functional chloroplast units (e.g., a unit essential for metabolic processes, photosynthesis, gene expression, photosystem I, photosystem II). Vectors of the present invention may comprise a transplantable chloroplast genome or portion thereof Additionally, the vectors of the present invention may comprise a transferable chloroplast genome or portion thereof In other embodiments, the vectors comprise: 1) one or more large pieces of modified DNA; 2) all genes necessary to cany out photosynthesis; 3) all genes required for chloroplast survival and/or function; 4) essential chloroplast genes; and/or 5) sufficient naturally occurring or modified chioroplast genes to perform one or more chioroplast functions, such as photosynthesis. A vector may comprise a portion, substantially all, or all of the essential chloroplast genes. A vector may comprise at least 5, 10, 15, 20, 25, 30, 40, 50, 60, 70, 80, 90, 100 or more essential genes.
[0070] A vector may comprise chloroplast DNA of 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, 250kb or more in length. A vector may comprise essential chloroplast genes as well as non-essential chloroplast gene sequences. A vector may comprise one or more, or all, essential chloroplast genes and/or one or more genes not naturally occurring in a host cell comprising a vector. In some embodiments, a vector may comprise chioroplast genes and genes not naturally occurring in the chioroplast. A vector may comprise one or more essential chloroplast genes and/or one or more DNA seqnences or genes involved in chloroplast flinction, photosynthesis, carbon fixation, and/or hydrocarbon production. For example, a vector may comprise a seqnence required for photosynthesis and a sequence involved in the isoprenoid prodnction, MVA, and/or MEP pathways, snch as a DNA seqnence encoding a terpene synthase, or other polypeptide that prodnces a hydrocarbon, such as a terpene or isoprenoid. The invention further provides methods for cloning, manipulating and delivering a large target nucleic acid to a cell or particle, such as, for example, yeasts or bacteria. Certain embodiments of this method make use of a hybrid yeast-bacteria cloning system (See, e.g., U.S. Patent Nos. 5,866,404 and 7,083,971 and Hokanson et al., (2003) Human Gene Ther.: 14: 329-339). The vectors herein (e.g., cloning system) is comprised of a shuttle vector that contains elements for function and replication in both yeast and bacteria, allowing it to stably ftinction and replicate in either organism. This composition of functional and replicative elements yields a hybrid system which enjoys the benefits of both genetic engineering systems. The genetics of yeast (e.g., S. eerevisiae) are well understood and a powertlil assortment of molecular biology tools exists for genetic engineering in yeast.
[00711 In another aspect the invention produces a gap-filled vector by homologous recombination among the two arms and the target nucleic acid. In still another embodiment, at least one arm further comprises an origin of replication. In another embodiment of the invention, each arm fiuther comprises a rare restriction endonuclease recognition site. Homologous recombination may be performed in vitro or in vivo, for example, in a fungal cell (e.g., S. eerevisiae, Sz. pombe or U mayc/is). The invention also provides a eukaryotic host cell harboring the recombinational cloning system or vector according to the invention, for example, in a fungal cell (e.g., S. eerevisiae, Sz. pombe or U maydis).
[0072] A gap-filled linear vector may be converted to a circular vector in vitro (e.g. using T4 ligase) or in vivo, for example, in a bacterium. The circular vectors of interest can be amplified, purified, cut and used to recover sufficient amounts of DNA to be introduced either directly into a cell or into a suitable delivery system for subsequent delivery to a target cell. The methodology offers great versatility to clone and to modify any large bacterial or non-bacterial genome, and easily facilitate the use thereof as recombinational vectors. Direct delivery of a gap-filled vector into a cell may be performed by methods well known in the field such as, for example, calcium phosphate transformation methodologies or electroporation (see Sambrook et al., supra).
[0073] Accordingly, the invention provides a method for producing a recombinant delivery unit including the steps of: (a) producing a gap-filled vector containing a target sequence; (b) optionally circularizing the gap-filled vector segments of the invention; (c) propagating the vector; and (d) introducing the gap-filled vector in a delivery unit.
[0074] Bacterial systems are useful for amplifying and purifying DNA, and for functionally testing the genetic modifications and their effect on pathways. One embodiment of the present invention provides cloning system will aid in the cloning and modifying of any large genome and easily facilitate the cloning and introduction of pathways. With the ability to deliver whole pathways, certain embodiments of the present invention allow for a system biological approach to problem solving.
[0075] In general, target DNA (e.g., genomic DNA) may he captured by creating sites allowing for homologous recombination in the vector. For example, such sites maybe created by, but not limited to, gap-repair cloning, wherein a gap is created in the vector, usually by restrictive enzyme digestion prior to transformation into the yeast. When the target DNA is mixed with the vector, the target DNA is recombined into the vector. This operation is called "gap filling." This recombination can occur in bacteria, yeast, the original host organism, another organism, or in vitro. In some embodiments, recombination is performed in yeast because of the high rate of homologous recombination. Once captured, the target DNA can he modified in many ways including adding, altering, or removing DNA sequences. In some embodiments, the target DNA is genomic DNA. In other embodiments, the target DNA is organelle (e.g., mitochondria or chloroplast) DNA.
10076] In some embodiments, target DNA is modified by adding, altering or removing genes, coding sequences, partial coding sequences, regulatory elements, positive andlor negative selection markers, recombination sites, restriction sites, and/or codon bias sites. For example, the target DNA sequence may be codon biased for expression in the organism being transformed. The skilled artisan is well aware of the "codon-bias" exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Without being bound by theory, by using a host cell's preferred codons, the rate of translation may be greater. Therefore, when synthesizing a gene for improved expression in a host cell, it may be desirable to design the gene such that its frequency of codon usage approaches the frequency of preferred codon usage of the host celL The codons of the present invention may be AlT rich, for example, AlT rich in the third nucleotide position of the codons.
Typically, the AlT rich codon bias is used for algae. In some embodiments, at least 50% of the third nucleotide position of tile codons are A or T. In other embodiments, at least 60%, 70%, 80%, 90%, or 99% of the third nucleotide position of the codons are A or T. (see also U.S. Publication No. 2004/0014174).
10077] Such manipulations are well known in the art and can he performed in numerous ways. In some embodiments, the modifications may be performed using cloned sequences. In other embodiments, the modifications may be performed using synthetic DNA.
10078] Genetic manipulations include cloning large pieces of target DNA (e.g., chromosomes, genomes) and/or dividing and reorganizing target DNA based on ifinctional relations between genes, such as metabolic pathways or operons. Genetic manipulations also include introducing and removing metabolic pathways, recombining DNA into ftinctional units (e.g., metabolic pathways, synthetic operons), and/or determining sites of instability in large pieces of DNA (e.g., sites where a native or non-native host tends to delete or recombine a sequence of DNA).
[0079] Target DNA maybe DNA from a prokaryote. Target DNA may also be genornic DNA, mitochondrial DNA, or chloroplast DNA from a eukaryote. Examples of such organisms from which genomic andlor organeRe DNA may serve as target DNA include, hut are not limited to Z. mobi/is, algae (e.g., macroalgae or microalgae, such as C'h/amydomonas reinharciui), a rhodophyte, a chiorophyte, a heterokontophyte, a trihophyte, a glaucophyte, a chlorarachniophyte, a euglenoid, a haptophyte, a cryptomonad, a dinoflagellum, or a phytoplankton. One of skill in the art will recognize that these organisms are listed only as examples and that the methods disclosed herein are applicable to the large DNA from any organism, including bacteria, plants, ifingi, protists, and animals. Genetic manipulations of the present invention may include stabilizing large pieces of DNA by removing or inserting sequences that force transformed cells to preserve certain sequences of DNA and to stably maintain the sequences in its progeny. Genetic manipulations may also include altering codons of the target DNA, vector DNA, and/or synthetic DNA to reflect any codon bias of the host organism. Additionally, genetic manipulations of the present invention may include determining the minimal set of genes required for an organism to be viable. In another embodiment, the genetic manipulations of the present invention include determining the minimal set of genes required for a certain metabolic pathway to be created or maintained.
[0080] The genetic manipulations of the present invention may include determining redundant genes both within a genome, and between two genomes (e.g., redundancy between the nuclear and chloroplast genome). Additionally, the genetic manipulations of the present invention may include determining a functional sequence of DNA that could be artificially synthesized (e.g. the genes in a certain metabolic pathway, the genes of a functional genome). In another embodiment, the genetic manipulations of the present invention include creating DNA and genomes packaged into cassettes (e.g., sites within a vector where genes can be easily inserted or removed). The genetic manipulations of the present invention may also include creating a nuclear or organelle genome that is viable in multiple species (e.g. a transplantable chloroplast genome).
Furthermore, the genetic manipulations of the present invention may include a method for testing the viability of any of these manipulations or creations (e.g., transferring a shuttle vector back into a host system and assaying for survival).
100811 Vectors. Markers and Transformation [0082] A vector or other recombinant nucleic acid molecule may include a nucleotide sequence encoding a selectable marker. The term or "selectable marker" or "selection marker" refers to a polynucleotide (or encoded polypeptide) that confers a detectable phenotype. A selectable marker generally encodes a detectable polypeptide, for example, a green fluorescent protein or an enzyme such as luciferase, which, when contacted with an appropriate agent (a particular wavelength of light or luciferin, respectively) generates a signal that can be detected by eye or using appropriate instrumentation (Giacomin, P/ant Sci. 116:59-72, 1996; Scikantha, .1. Bacterio/. 178:121, 1996; Gerdes, FEES Let!. 389:44- 47, 1996; see, also, Jefferson, Eli JBO.1. 6:3901-3907, 1997, fi-glucuronidase). A selectable marker generally is a molecule that, when present or expressed in a cell, provides a selective advantage (or disadvantage) to the cell containing the marker, for example, the ability to grow in the presence of an agent that otherwise would kill the cell.
10083] A selectable marker can provide a means to obtain prokaryotic cells or plant cells or both that express the marker and, therefore, can be useffil as a component of a vector of the invention (see, for example, Bock, supra, 2001). Examples of selectable markers include, but are not limited to, those that confer antimetabolite resistance, for example, dihydrofolate reductase, which confers resistance to methotrexate (Reiss, P/ant Physio/. (Lfè Sci. Ac/v.) 13:143-149, 1994); neomycin phosphotransferase, which confers resistance to the aminoglycosides neomycin, kanamycin and paromycin (Herrera-Estrella, Ell/IBOJ. 2:987-995, 1983), hygro, which confers resistance to hygromycin (Marsh, Gene 32:48 1-485, 1984), trpll, which allows cells to utilize indole in place of tryptophan; hisD, which allows cells to utilize histinol in place of histidine (Hartman, Proc. NatL Acad. Sci., USA 85:8047, 1988); mannose-6-phosphate isomerase which allows cells to utilize mannose (WO 94/20627); omithine decarhoxylase, which confers resistance to the omithine decarhoxylase inhibitor, 2-(difluoromethyl)-DL-ornithine (DFMO; McConlogue, 1987, In: Current Communications in Molecular Biology, Cold Spring Harbor Laboratory ed.); and deaminase from Aspergi//us terreus, which confers resistance to Blasticidin S (Tamura, Biosci. Biotechnot Biochem. 59:2336-23 38, 1995). Additional selectable markers include those that confer herbicide resistance, for example, phosphinothricin acetyltransferase gene, which confers resistance to phosphinothricin (White et al., Nuct Acids Res. 18:1062, 1990; Spencer et al., Theor. App/. Genet. 79:625-63 1, 1990), a mutant EPSPV-synthase, which confers glyphosate resistance (Hinchee et al., BioTechno/ogy 91:915-922, 1998), a mutant acetolactate synthase, which confers irnidazotione or sutfonyturea resistance (Lee et at., EMBO 1 7:1241 -1248, 1988), a mutant psbA, which confers resistance to atrazine (Smeda et al., P/ant Physio/. 103:911-917, 1993), or a mutant protoporphyrinogen oxidase (see U.S. Pat. No. 5,767,373), or other markers conferring resistance to an herbicide such as glufosinate. Selectable markers include polynucleotides that confer dihydrofolate reductase (DHFR) or neomycin resistance for eukaryotic cells and tetracycline; ampicillin resistance for prokaiyotes such as E. co/i; and hleomycin, gentamycin, glyphosate, hygromycin, kanamycin, methotrexate, phleomycin, phosphinotricin, spectinomyc in, streptomycin, sulfonamide and sulfonylurea resistance in plants (see, for example, Maliga et aL, Methods in Plant Molecular Biology, Cold Spring Harbor Laboratory Press, 1995, page 39).
10084] Methods for nuclear and plastid transformation are routine and well Imown for introducing a polynucleotide into a plant cell chloroplast (see U.S. Pat. Nos. 5,451,513, 5,545,817, and 5,545,818; WO 95/16783; McBride et al., Proc. NaiL Acaci. Sci., USA 91:7301-7305, 1994). In some embodiments, chloroplast transformation involves introducing regions of chloroplast DNA flanking a desired nucleotide sequence, allowing for homologous recombination of the exogenous DNA into the target chloroplast genome. In some instances one to 1.5 kb flanking nucleotide sequences of chloroplast genomic DNA may be used. Using this method, point mutations in the cliloroplast 16S rRNA and rps 12 genes, which confer resistance to spectinomycin and streptomycin, can be utilized as selectable markers for transformation (Svab et al., Proc. Nat!. Acaci.
Sci., USA 87:8526-8530, 1990), and can result in stable homoplasmic transformants, at a frequency of approximately one per bombardments of target leaves.
[0085] Microprojectile mediated transformation also can he used to introduce a polynucleotide into a plant cell chloroplast (Klein et al., Nature 327:70-73, 1987). This method utilizes microprojectiles such as gold or tungsten, which are coated with tile desired polynucleotide by precipitation with calcium chloride, spermidine or polyethylene glycoL The microprojectile particles are accelerated at high speed into a plant tissue using a device such as the BIOLISTIC PD-bOO particle gun (BioRad; Hercules Calif.). Methods for the transformation using hiolistic methods are well known in the art (see, e.g.; Christou, Trends in P/ant Science 1:423-431, 1996). Microprojectile mediated transformation has been used, for example, to generate a variety of transgenic plant species, including cotton, tobacco, corn, hybrid poplar and papaya. Important cereal crops such as wheat, oat, barley, sorghum and rice also have been transformed using microprojectile mediated delivery (Duan et al., Nature Biotech. 14:494-498, 1996; Shimamoto, Curr. Op/n. Biotech. 5:158-162, 1994). The transformation of most dicotyledonous plants is possible with the methods described above. Transformation of monocotyledonous plants also can be transformed using, for example, biolistic methods as described above, protoplast transformation, electroporation of partially permeabilized cells, introduction of DNA using glass fibers, the glass bead agitation method, and the like.
[0086] Transformation frequency may be increased by replacement of recessive rRNA or r-protein antibiotic resistance genes with a dominant selectable marker, including, but not limited to the bacterial aadA gene (Svab and Maliga, Proc. NaiL Acad. ScL, USA 90:913-917, 1993). Approximately 15 to 20 cell division cycles following transformation are generally required to reach a homoplastidic state. It is apparent to one of skill in the art that a chloroplast may contain multiple copies of its genome, and therefore, the term "homoplasmic" or "homoplasmy" refers to the state where all copies of a particular locus of interest are substantially identical. Plastid expression, in which genes are inserted by homologous recombination into all of the several thousand copies of the circular plastid genome present in each plant cell, takes advantage of the enormous copy number advantage over nuclear-expressed genes to permit expression levels that can readily exceed 10% of the total soluble plant protein.
[0087] Any of the nucleotide sequences of target DNA, vector DNA, or synthetic DNA on tile vectors of the invention can thither include codons biased for expression of the nucleotide sequences in the organism transformed. In some instances, codons in the nucleotide sequences are A/T rich in a third nucleotide position of the codons. For example, at least 50% of the third nucleotide position of the codons may be A or T. In other instances, the codons are U/C rich, for example at least 50% of the third nucleotide positions of the codons may be U or C. [0088] The nucleotide sequences of the shuttle vectors of the present invention can he adapted for chloroplast expression.
For example, a nucleotide sequence herein can comprise a chloroplast specific promoter or chloroplast specific regulatory control region. The nucleotide sequences can also he adapted for nuclear expression. For example, a nucleotide sequence can comprise a nuclear specific promoter or nuclear specific regulatory control regions. Thc nuclear sequences can encode a protein with a targeting seqnence that encodes a chioroplast targeting protein (e.g., a chioroplast transit peptide), or a signal peptide that directs a protein to the endomembrane system for deposition in the endoplasmic reticulum or plasma membrane.
10089] In embodiments where a vector encodes genes capable of hid production, hid products are produced by altering the enzymatic content of the cell to increase the biosynthesis of specific thel molecules. For example, nucleotides sequences (e.g., an ORF isolated from an exogenous source) encoding biosynthetic enzymes can be introduced into the chloroplast of a photosynthetic organism. Nucleotide sequences encoding fuel biosynthetic enzynies can also be introduced into the nuclear genome of the photosynthetic organisms. Nucleotide sequences introduced into the nuclear genome can direct accumulation of the biosynthetic enzyme in tile cytoplasm of the cell, or may direct accumulation of the biosynthetic enzyme in the chloroplast of the photosynthetic organism.
[0090] Any of the nucleotide sequences herein may further comprise a regulatory control sequence. Regulatory control sequences can include one or more of the following: a promoter, an intron, an exon, processing elements, 3' untranslated region, 5' untranslated region, RNA stability elements, or translational enhancers A promoter may be one or more of tile following: a promoter adapted for expression in the organism, an algal promoter, a chloroplast promoter, and a nuclear promoter, any of which may be a native or synthetic promoters. A regulatory control sequence can he inducible or autoregulatable. A regulatory control sequence can include autologous and/or heterologous sequences. In some cases, control sequences can be flanked by a first homologous sequence and a second homologous sequence. The first and second homologous sequences can each he at least 500 nucleotides in length. The homologous sequences can allow for either homologous recombination or can act to insulate the heterologous sequence to facilitate gene expression.
[0091] Vectors may also comprise sequences involved in producing products useftil as biopharmaceuticals, such as, but not limited to, antibodies (including functional portions thereof), interleukins and other immune modulators, and antibiotics. See, e.g., Mayfieldet al., (2003)Proc. Nat'/Acad. ScL: 100 (438-42) and U.S. Pub. No. 2004/0014174.
[0092] Vectors of the present invention may comprise a cassette-able bacterial genome or portion thereof (e.g., a removable DNA fragment comprising a bacterial genome or functional portion thereof). Additionally, vectors of the present invention may comprise functional genomic units (e.g., a unit essential for metabolic processes, biochemical pathways, gene expression). Vectors of the present invention may comprise a transplantable bacterial genome or portion thereof Vectors of the present invention may comprise a transferable bacterial genome or portion thereof 10093] In some embodiments, the large piece of target DNA is modified. The modified DNA may comprise all genes necessary to carry out ethanologenesis, all genes required for the Entner-Duodorff pathway, the glucose tolerance pathway, the ethanol tolerance pathway, the carboxylic acid byproduct resistance pathway, the acetic acid tolerance pathway, the sugar transport pathway, sugar fermentation pathways, and/or the cellulose and hemicellulose digestive pathways.
100941 Hybrid cloning systems and methods of the invention combine the high versatility of yeast as a system for the capture and manipulation of a given nucleic acid and the high efficiency of bacterial systems for the amplification of such nucleic acid. Recombinational vectors relying on homologous recombination to mediate the isolation, manipulation and delivery of large nucleic acid fragments were constructed. The invention described herein also provides methods for using such recombinational cloning vectors to clone, to manipulate and to deliver large nucleic acids. Finally, the invention provides methods for using such recombinational cloning systems as potentiators of biochemical pathway analysis, organelle analysis, and synthetic chloroplast constmction.
10095] The vectors of the present invention may be introdnced into yeast. The yeast may be a suitable strain of Saccharornyces cerevisiae; however, other yeast models may be utilized. Introduction of vectors into yeast may allow for genetic manipulation of the vectors. Yeast vectors have been described extensively in the literature and methods of manipulating the same also are well known as discussed hereinafter (see e.g., Ketner et al. (1994) Proc. NaIL Acad. Sci. (USA) 91:6186 6190).
[0096] Following genetic manipulation, the cloning system may allow for the transition to a bacterial environment, suitable for the preparation of larger quantities of nucleic acids. Representative examples of a bacterial type vectors include, but are not limited to, the P1 artificial chromosome, bacterial artificial chromosome (BAC) and single copy plasmid F factors (Shizuya et al. (1992) Proc. Nail. Acad. ScL 89:8794 8797). Similarly, bacterial vectors are well known in the art (e.g., Ioannou et al. (1994) Nature 6:84 89). The invention also provides a shuttle vector comprising a yeast selectable marker, a bacterial selectable marker, a telomere, a centromere, a yeast origin of replication, andlor a bacterial origin of replication.
[0097] Shuttle vectors of tile present invention may enable homologous recombination in yeast to capture and to integrate in a vector of interest a target nucleic acid of interest. Shuttle vectors may allow for the manipulation of target DNA in any of the hosts to which the vectors can he introduced. In some embodiments, after desired manipulations, shuttle vector components may be removed, leaving just the modified target DNA. Such extraction of vector sequences can be performed using standard methodologies and may occur in any host cell. The target nucleic acid of interest can be a large nucleic acid, and can include, for example, a vector, such as a viral vector, including the foreign gene of interest contained therein. The target nucleic acid can also be a bacterial (including archaebacteria and eubacteria), viral, fiangal, protist, plant or animal genome, or a portion thereof For example, the target nucleic acid of one embodiment of the present invention comprises an entire prokaryotic genome. As an additional example, a target nucleic acid of the present invention may comprises the chloroplast genome of a eukaryotic organism.
[0098] Shuttle vectors according to the invention may comprise an appropriately oriented DNA that functions as a telomere in yeast and a centromere. Any suitable telomere may be used. Suitable telomeres include without limitation telomeric repeats from many organisms, which can provide telomeric function in yeast. The terminal repeat sequence in humans (TTAGGG)N, is identical to that in trypanosomes and similar to that in yeast ((TG)l3)N and Tetrahymena (TTGGG)N (Szostak & Blackburn (1982) Cell 29:245 255; Brown (1988) ESIBO 1 7:2377 2385; and Moyzis et al. (1988) Proc. NaiL Acad. ScL 8 5:6622 6626).
10099] The term "centromere" is used herein to identify a nucleic acid, which mediates the stable replication and precise partitioning of the vectors of the invention at meiosis and at mitosis thereby ensuring proper segregation into daughter cells.
Suitable centromeres include, without limitation, the yeast centromere, CEN4, which confers mitotic and meiotic stability on large linear plasmids (Murray & Szostak (1983) Nature 305:189 193; Carbon (1984) Cell 37:351 353; and Clark et al. (1990) Nature 287:504 509)).
[00100] In some embodiments, at least one of the two segments of the circular vector according to the invention includes at least one replication system that is functional in a host cell/particle of choice. As it will become apparent hereinafter, one of skill will realize that the manipulation, amplification and/or delivery of a target nucleic acid of choice may entail the use of more than one host cell/particle. Accordingly, more than one replication system functional in each host cell/particle of choice maybe included.
100101] When a host cell(s) is a prokaryote, particularly E. co/i, replication system(s) include those which are functional in prokaryotes, such as, for example, P1 plasmid replicon, on, P1 lytic replicon, CoIE1, BAC, single copy plasmid F factors and the like. Either one or both segments, and/or the circular vector, may further include a yeast origin of replication capable of supporting the replication of large nucleic acids. Non-limiting examples of replication regions according to the invention include the autonomously replicating sequence or "ARS element." ARS elements were identified as yeast sequences that conferred high-frequency transformation. Tetrahymena DNA termini have been used as ARS elements in yeast along with ARS1 and ARS4 (Kiss et at. (1981) Mol. Cell Biol. 1:535 543; Stinchcomb et at. (1979) Nature 282:39; and Barton & Smith (1986) Mo/i Ce//BioL 6:2354). For each segment (e.g., those corresponding to the yeast and bacterial elements of the gap-fitting shuttle vector) there may be two or more origins of replication.
[00102] The first and/or the second segment according to an aspect of the invention maybe joined in a circularized vector form (e.g., plasmid form). Circularization can occur in v/vu or in vitro using the segment of interest. Alternatively, a circular vector of interest can he used. As used herein, the term "vector" designates a plasmid or phage DNA or other nucleic acid into which DNA or other nucleic acid may be cloned. The vector may replicate autonomously in a host ccii and may he characterized thither by one or a small number of restriction endonuclease recognition sites at which such nucleic acids may be cut in a determinable fashion and into which nucleic acid fragments may be inserted. The vector ffirther may contain a selectable marker suitable for the identification of cells transformed with the vector.
100103] Target nucleic acids of the invention may vary considerably in complexity. The target nucleic acid may include viral, prokaryotic or eukaryotic DNA, cDNA, exonic (coding), and/or intronic (noncoding) sequences. Hence, the target nucleic acid of the invention may include one or more genes. A target nucleic acid may be a chromosome, genome, or operon and/or a portion of a chromosome, genome or operon. A target nucleic acid may comprise coding sequences for all tile genes in a pathway, the minimum complement of genes necessary for survival of an organelle, and/or the minimum complement of genes necessaiy for survival of an organism. A target nucleic acid may comprise Zymomonas mobi/is DNA sequence, including, but not limited to genomic DNA and/or cDNA. A target nucleic acid may comprise eukaryotic chloroplast DNA sequence, including but not limited to, chloroplast genome DNA and/or cDNA. A target nucleic acid may comprise cyanobacteria DNA, including but not limited to genomic DNA andior cDNA. The target nucleic acid also may he of any origin and/or nature.
100104] It may be desirable for the gene to also comprise a promoter operably linked to the coding sequence in order to effectively promote transcription. Enhancers, repressors and other regulatory sequences may also he included in order to modulate activity of the gene, as is well known in the art. A gene as provided herein can refer to a gene that is found in the genome of the individual host cell (i.e., endogenous) or to a gene that is not found in the genome of the individual host cell (i.e., exogenous or a "foreign gene"). Foreign genes maybe from the same species as the host or from different species. For transfection of a cell using DNA containing a gene with the intent that the gene will be expressed in the cell, the DNA may contain any control sequences necessary for expression of the gene in the required orientation for expression. The term "intron" as used herein, refers to a DNA sequence present in a given gene which is not translated into protein and is generally found between exons.
[00105] Genetic elements, or polynucleotides comprising a region that encodes a polypeptide or a region that regulates transcription or translation or other processes important to expression of the polypeptide in a host cell, or a polynucleotide comprising both a region that encodes a polypeptide and a region operably linked thereto that regulates expression. Genetic elements may be comprised within a vector that replicates as an episomal element; that is, as a molecule physically independent of the host cell genome. They may be comprised within mini-chromosomes, such as those that arise during amplification of transfected DNA by methotrexate selection in eukaryotic cells. Genetic elements also may be comprised within a host cell genome; not in their natural state but, rather, following manipulation such as isolation, cloning and introduction into a host cell in the form of purified DNA or in a vector, among others.
[00106] Vectors of the present invention may contain sufficient linear identity or similarity (homology) to have the ability to hybridize to a portion of a target nucleic acid made or which is single-stranded, such as a gene, a transcriptional control element or intragenic DNA. Without being bound to theory, such hybridization is ordinarily the result of base-specific hydrogen bonding between complementary strands, preferably to form Watson-Crick base pairs. As a practical matter, such homology can be inferred from the observation of a homologous recombination event. In some embodiments, such homology is from about S to about 1000 bases of the linear nucleic acid. In other embodiments, such homology is from about 12 to about 500 bases. One skilled in the art will appreciate that homology may extend over longer stretches of nucleic acids.
100107] Homologous recombination is a type of genetic recombination, a process of physical rearrangement occurring between two strands of DNA. Homologous recombination involves the alignment of similar sequences, a crossover between the aligned DNA strands, and breaking and repair of the DNA to produce an exchange of material between the strands. The process homologous recombination naturally occurs in organisms and is also utilized as a molecular biology technique for introducing genetic changes into organism.
[00108] The vectors of the invention may be modified further to include functional entities other than the target sequence which may find use in the preparation of the construct(s), amplification, transformation or transfection of a host cell, and--if applicable--for integration in a host cell. For example, the vector may comprise regions for integration into host DNA.
Integration may be into nuclear DNA of a host cell. In some embodiments, integration maybe into non-nuclear DNA, such as chloroplast DNA. Other thnctional entities of the vectors may include, but are not limited to, markers, linkers and restriction sites.
[00109] A target nucleic acid may include a regulatory nucleic acid. This refers to any sequence or nucleic acid which modulates (either directly or indirectly, and either up or down) the replication, transcription andlor expression of a nucleic acid controlled thereby. Control by such regulatory nucleic acid may make a nucleic acid constitutively or inducibly transcribed andlor translated. Any of the nucleotide sequences herein may ifirther comprise a regulatory control sequence.
Examples of regulatory control sequences can include, without limitation, one or more of the following: a promoter, an intron, an exon, processing elements, 3' untranslated region, 5' untranslated region, RNA stability elements, or translational enhancers. A promoter may be one or more of the following: a promoter adapted for expression in the organism (e.g., bactenal, ftingal, viral, plant, mammalian, or protist), an algal promoter, a chloroplast (or other plastid) promoter, a mitochondrial promoter, and a nuclear promoter, any ofwhich may be a native or synthetic promoters. A regulatory control sequence can be inducible or autoregulatable. A regulatory control sequence can include autologous and/or heterologous sequences. In some cases, control sequences can be flanked by a first homologous sequence and a second homologous sequence. The first and second homologous sequences can each be at least 500 nucleotides in length. The homologous sequences can allow for either homologous recombination or can act to insulate the heterologous sequence to facilitate gene expression.
100110] In some instances, target DNA, vector DNA or other DNA present in a shuttle vector of the present invention does not result in production of a polweptide product but rather allows for secretion of the product from the cell. In these cases, the nucleotide sequence may encode a protein that enhances or initiates or increases the rate of secretion of a product from an organism to the external environment. Thus, segments of vectors and/or vectors of the invention may include a transcriptional regulatoiy region such as, for example, a transcriptional initiation region. One skilled in the art will appreciate that a multitude of transcriptional initiation sequences have been isolated and are available, including thyrnidine kinase promoters, beta-actin promoters, immunogiobin promoters, methailothionein promoters, human cytomegalovirus promoters and SV4O promoters.
[00111] One embodiment of tile invention provides a method of producing a gap-filled vector. A gap-filled vector may undergo homologous recombination and insertion of a target nucleic acid according to the invention by filling in the region (gap) between the sequences homologous to the 5' and the 3 regions of the target nucleic acid. Hence, in some embodiments, one would contact the instant cloning system with a target nucleic acid under conditions that allow homologous recombination.
100112] Another method combines: (i) a first segment including a first nucleic acid homologous to the 5' terminus of a target nucleic acid, a first selectable marker and a first cyclization element; (ii) a target nucleic acid; and (iii) a second segment including a second nucleic acid homologous to the 3' terminus of a target nucleic acid, a second selectable marker and a second cyclization element, under conditions which allow homologous recombination. One embodiment of the invention produces a gap-filled vector by homologous recombination between the two arms and the target nucleic acid. The exchange between the homologous regions found in the arms and the target nucleic acid is effected by homologous recombination at any point between the homologous nucleic acids. With respect to a circular vector of the present invention, the "gap filling" essentially is insertion (i.e., suhcloning) of the target sequence into the vector.
[00113] Homologous recombination may be effected in vitro according to methodologies well known in the art. For example, the method of the invention can be practiced using yeast lysate preparations. Homologous recombination may take place in vivo. Hence, the method of the invention may he practiced using any host cell capable of supporting homologous recombination events such as, for example, bacteria, yeast and mammalian cells. One skilled in the art will appreciate that the choice of a suitable host depends on the particular combination of selectable markers used in the cloning system of the method.
100114] Techniques that may be used to introduce the vector into a host cell of interest include calcium phosphate/DNA coprecipitation, electroporation, hacterial-protoplast fusion, microinjection of DNA into the nucleus and so on. One of skill will appreciate that a number of protocols may be used virtually interchangeably, for example, to transfect mammalian cells, as set forth for example in Keown et al. (Meth. Enzymol. 185:527 537, 1990).
1001151 Transformation maybe achieved by using a soil bacterium, such as Agm bacteri urn turnefaciens. Agrobacteriurn tumefaciens may cany an engineered plasmid vector, or carrier of selected extra genes. Plant tissue, such as leaves, are cut in small pieces, eg. 1 Ox 10mm, and soaked for 10 minutes in a fluid containing suspended Agrohacterium. Some cells along the cut is transformed by the bacterium, that inserts its DNA into tile cell. Placed on selectable rooting and shooting media, the plants will regiow. Some plants species can be transformed just by dipping the flowers into suspension ofAgrobacteria and then planting the seeds in a selective medium.
100116] Another methodology is use of a "gene gun" approach. The gene gun is part of a method called tile biolistic (also known as hioballistic) method, and tinder certain conditions, DNA (or RNA) become "sticky," adhering to biologically inert particles such as metal atoms (usually tungsten or gold). By accelerating this DNA-particle complex in a partial vacuum and placing the target tissue within the acceleration path, DNA is effectively introduced. Uncoated metal particles could also be shot through a solution containing DNA surrounding the cell thus picking up the genetic material and proceeding into the living cell. A perforated plate stops the shell cartridge but allows the slivers of metal to pass through and into the living cells on the other side. The cells that take up the desired DNA, identified through the use of a marker gene (in plants the use of GUS is most common), are then cultured to replicate the gene and possibly cloned. The biolistic method is most useful for inserting genes into plant cells such as pesticide or herbicide resistance. Different methods have been used to accelerate the particles: these include pneumatic devices; instruments utilizing a mechanical impulse or macroprojectile; centripetal, magnetic or electrostatic forces; spray or vaccination guns; and apparatus based on acceleration by shock wave, such as electric discharge (for example, see Christou and McCabe, 1992, Agracetus, Inc. Particle Gun Transformation of Crop Plants Using Electric Discharge (ACCELLTM Technology).
100117] Transformation can be performed, for example, according to the method of Cohen et al. (Proc. NatI. Acad. Sci. USA, 69:2110 (1972)), the protoplast method (Mol. Gen. Genet., 168:111(1979)), or the competent method (J. Mol. Biol., 56:209 (1971)) when the hosts are bacteria (E. co/i, Bacillus suN//is, and such), the method of Hinnen et al. (Proc. Natl. Acad. Sci. USA, 75:1927 (1978)), or the lithium method (J. Bacteriol., 153:163 (1983)) when the host is S. cerevisiae, the method of Graham (Virology, 52:456 (1973)) when the hosts are animal cells, and the method of Summers et al. (Mol. Cell.
Biol., 3:2156-2165 (1983)) when the hosts are insect cells. Typically, following a transformation event, potential transformants are plated on nutrient media for selection and/or cultivation.
[00118] The nutrient media preferably comprises a carbon source, an inorganic nitrogen source, or an organic nitrogen source necessary for the growth of host cells (transformants). Examples of the carbon source are glucose, dextran, soluble starch, and sucrose, and examples of the inorganic or organic nitrogen source are ammonium salts, nitrates, amino acids, corn steep liquor, peptone, casein, meat extract, soy bean cake, and potato extract. If desired, tile media may comprise other nutrients (for example, an inorganic salt (for example, calcium chloride, sodium dihydrogenphosphate, and magnesium chloride), vitanñns, antibiotics (for example, tetracycline, neomycin, ampicillin, kanamycin, etc.). Media for some photosynthetic organisms may not require a carbon source as such organisms may be photoautotrophs and, thus, can produce their own carbon sources.
100119] Cultivation and/or selection are performed by methods known in the art. Cultivation and selection conditions such as temperature, pH of the media, and cultivation time are selected appropriately for the vectors, host cells and methods of the present invention. One of skill in the art will recognize that there are numerous specific media and cultivationlselection conditions which can be used depending on the type of host cell (transformant) and the nature of the vector (e.g., which selectable markers are present). The media herein are merely described by way of example and are not limiting.
[00120] When the hosts are bacteria, actinomycetes, yeast, or filamentous ftingi, media comprising the nutrient source(s) mentioned above are appropriate. When the host is E. co/i, examples of preferable media are LB media, M9 media (Miller et al. Exp. Mol. Genet., Cold Spring Harbor Laboratory, p.43 1(1972)), and so on. When the host is yeast, an example of medium is Burklioter minimal medium (Bostian, Proc. Nail. Acad. Sci. USA, 77:4505 (1980)).
100121] The selection of vectors in yeast may be accomplished by the use of yeast selectable markers. Examples include, but are not limited to, HJS3, TRPJ, URA3, LEU2 and ADE markers. In some embodiments of the invention, a vector or segment thereof may comprise two or more selectable markers. Thus, in one embodiment, a segment of a vector of the present invention may comprise an ADE marker to be lost upon homologous recombination with the target nucleic acid, and a H153 marker. The other segment may comprise a TRPJ marker. Selection is achieved by growing transformed cells on a suitable drop-out selection media (see e.g., Watson et al. (1992) Recombinant DNA, 2.sup.nd ed., Freeman and Co., New York, N.Y.). For example, HIS3 allows for selection of cells containing the first segment. TRFI allows for selection of cells containing the second segment. ADE allows screening and selection of clones in which homologous recombination took place. ADE enables color selection (red).
[00122] Recombinant yeast cells may be selected using the selectable markers described herein according to methods well known in the art. Hence, one skilled in the art will appreciate that recombinant yeast cells harboring a gap-filled vector of tile invention may be selected on the basis of the selectable markers included therein. For example, recombinant vectors canying HIS3 and TRPI may he selected by growing transformed yeast cells in the presence of drop-out selection media tacking histidine and tryptophan. Isolated positive clones may be purified further and analyzed to ascertain the presence and structure of the recombinant vector of the invention by, e.g., restriction analysis, electrophoresis, Southern blot analysis, polymerase chain reaction or the like. The invention further provides gap-filled vectors engineered according to the method of the invention. Such a vector is the product of homologous recombination between the segments or vectors of the invention and a target nucleic acid of choice. The invention also provides a prokaryotic cell and/or a eukaryotic host cell harboring the cloning system or vector according to the invention. The organism can be unicellular or multicellular. The organism may be naturally photosynthetic or naturally non-photosmthetic. Other examples of organisms that can be transformed include vascular and non-vascular organisms. When hosts, such as plant, yeast, animal, algal, or insect cells are used, a vector of the present invention may contain, at least, a promoter, an initiation codon, the polynucleotide encoding a protein, and a termination codon. The vectors of the present invention may also contain, if required, a polynucleotide for gene amplification (marker) that is usually used.
[00123] Products 100124] The vectors of the present invention may comprise sequences that result in production of a product naturally, or not naturally, produced in the organism comprising the vector. In some instances the product encoded by one or more sequences on a vector is a polypeptide, for example an enzyme. Enzymes utilized in practicing the present invention may be encoded by nucleotide sequences derived from any organism, including bacteria, plants, flingi and animals. Vectors may also comprise nucleotide sequences that affect the production or secretion of a product from the organism. In some instances, such nucleotide sequence(s) encode one or more enzymes that function in isoprenoid biosynthetic pathway. Examples of polypeptides in the isoprenoid biosynthetic pathway include synthases such as CS, Cl 0, Cl 5, C20, C30, and C40 synthases.
In some instances, the enzymes are isoprenoid producing enzymes. In some instances, an isoprenoid producing enzyme produces isoprenoids with two phosphate groups (e.g., GPP synthase, FPP synthase, DMAPP synthase). In other instances, isoprenoid producing enzymes produce isoprenoids with zero, one, three or more phosphates or may produce isoprenoids with other functional groups. Polynucleotides encoding enzymes and other proteins useftil in the present invention may he isolated and1or synthesized by any means known in the art, including, but not limited to cloning, sub-cloning, and PCR.
100125] An isoprenoid producing enzyme for usc in thc prcscnt invention may also be botryococcene synthase, f3-caryophyllene synthase, germacrene A synthase, 8-epicedrol synthase, valencene synthase, (+)-ö-cadinene synthase, gerrnacrene C synthase, (E)-13-farnesene synthase, casbene synthase, vetispiradiene synthase, 5-epi-aristolochene synthase, aristoichene synthase, a-humulene, (E,E)-a-famesene synthase, (-)-13-pinene synthase, y-terpinene synthase. limonene cyclase, linalool synthase, (+)-bornyl diphosphate synthase, levopimaradiene synthase, isopimaradiene synthase, (E)-y- bisabolene synthase, copalyl pyrophosphate swthase, kaurene synthase, longifolene synthase, y-humulene synthase, 8-sehnene synthase, I-phellandrene synthase, terpinolene synthase, (+)-3-carene synthase, syn-copalyl diphosphate synthase, a-terpineol synthase, syn-pimara-7, 1 5-diene synthase, ent-sandaaracopimaradiene synthase, sterner-13 -ene synthase, E-13-ocimene, S-linalool synthase, geraniol synthase, y-terpinene synthase, linalool synthase, E-13-ocimene synthase, epi-cedrol synthase, a-zingiberene synthase, guaiadiene synthase, cascariRadiene synthase, cis-muuroladiene synthase, aphidicolan-1 6b-ol synthase, elizabethatriene synthase, sandalol synthase, patchoutot synthase, zinzanol synthase, cedrol synthase, scareol synthase, copalol synthase, or manoot synthase.
100126] Other enzymes which may he produced by vectors of the present invention include biomass-degrading enzymes.
Non-limiting examples of biomass-degrading enzymes include: cellulolytic enzymes, hemicellulolytic enzymes, pectinolytic enzymes, xylanases, ligninolyti c enzymes, cellulases, cellobi ases, softening enzymes (e.g., endopolygalacturonase), amylases, lipases, proteases, RNAses, DNAses, inulinase, lysing enzymes, phospholipases, pectinase, pullulanase, glucose isomerase, endoxylanase, beta-xylosidase, alpha-L-arabinoffiranosidase, alpha-glucoronidase, aipha-galactosidase, acetylxylan esterase, and feruloyl esterase. Examples of genes that encode such enzymes include, but are not limited to, arnylases, cellulases, hemicellulases, (e.g., 1 -glucosidase, endocellulase, exocellulase), exo-13 -glucanase, endo-13 -glucanase and xylanse (endoxylanase and exoxylanse). Examples of ligninolytic enzymes include, but are not limited to, lignin peroxidase and manganese peroxidase from Phanerochaete cliryosospor/um. One of skill in the art will recognize that these enzymes are only a partial list of enzymes which could be used in the present invention.
[00127] The present invention contemplates making enzymes that contribute to the production of fatty acids, lipids or oils by transforming host cells (e.g., alga cells such as C. rein/iara'tii, D. sal/na, H. pluvalis and cyanobacterial cells) and/or organisms comprising host cells with nucleic acids encoding one or more different enzymes. In some embodiments the enzymes that contribute to the production of fatty acids, lipids or oils are anabolic enzymes. Some examples of anabolic enzymes that contribute to the synthesis of fatty acids include, hut are not limited to, acetyl-CoA carboxylase, ketoreductase, thioesterase, malonyltransferase, dehydratase, acyl-CoA ligase, ketoacylsynthase, enoylreductase and a desaturase. In some embodiments the enzymes are catabolic or biodegrading enzymes. In some embodiments, a single enzyme is produced.
100128] Some host cells may be transformed with multiple genes encoding one or more enzymes. For example, a single transformed cell may contain exogenous nucleic acids encoding enzymes that make up an entire fatty acid synthesis pathway.
One example of a pathway might include genes encoding an acetyl CoA carboxylase, a malonyltransferase, a ketoacylsynthase, and a thioesterase. Cells transformed with entire pathways and/or enzymes extracted from them, can synthesize complete fatty acids or intermediates of the fatty acid synthesis pathway. In some embodiments constructs may contain multiple copies of tile same gene, and/or multiple genes encoding the same enzyme from different organisms, andlor multiple genes with mutations in one or more parts of the coding sequences.
[00129] In some instances, a product (e.g. fuel, fragrance, insecticide) is a hydrocarbon-rich molecule, e.g. a terpene. A terpene (classified by the number of isoprene units) can be a hemiterpene, monoterpene, sesquiterpene, diterpene, triterpene, or tetraterpene. In specific embodiments the terpene is a terpenoid (aka isoprenoid), such as a steroid or carotenoid.
Subclasses of carotenoids include carotenes and xanthophylls. In specific embodiments, a fuel product is limonene, 1, 8- cineo le, u-pinene, camphene, (+)-sahinene, myrcene, abietadiene, taxadiene, famesyl pyrophosphate, amorphadiene, (E)-u-bisaholene, beta carotene, alpha carotene, lycopene, or diapophytoene. Some of these terpenes are pure hydrocarbons (e.g. limonene) and others are hydrocarbon derivatives (e.g. cineole).
[00130] Examples of fuel products include petrochemical products and their precursors and all other substances that may be useful in the petrochemical industry. Fuel products include, for example, petroleum products, and precursors of petroleum, as well as petrochemicals and precursors thereof The fuel product may be used for generating substances, or materials, useful in the petrochemical industry, inctuding petroleum products and petrochemicals. The ftiel or thel products may be used in a combustor such as a boiler, kiln, dryer or ftirnace. Other examptes of combustors are internal combustion engines such as vehicte engines or generators, inctuding gasoline engines, dieset engines, jet engines, and others. Fuel products may also he used to produce plastics, resins, fibers, etastomers, lubricants, and gets.
[001311 Examples of products contemptated herein include hydrocarbon products and hydrocarbon derivative products. A hydrocarbon product is one that consists of only hydrogen molecules and carbon molecules. A hydrocarbon derivative product is a hydrocarbon product with one or more heteroatoms, wherein the heteroatom is any atom that is not hydrogen or carbon. Examples of heteroatoms include, but not limited to, nitrogen, oxygen, sulfur, and phosphorus. Some products are hydrocarbon-rich, wherein as least 50%, 60%, 70%, 80%, 90%, or 95% of the product by weight is made up carbon and hydrogen.
[00132] Fuel products, such as hydrocarbons, may be precursors or products conventionally derived from crude oil, or petroleum, such as, but not limited to, liquid petroleum gas, naptha (ligroin), gasoline, kerosene, diesel, lubricating oil, heavy gas, coke, asphalt, tar, and waxes. For example, fuel products may include small alkanes (for example, 1 to approximately 4 carbons) such as methane, ethane, propane, or butane, which may be used for heating (such as in cooking) or making plastics.
Fuet products may also include motecules with a carbon backbone of approximately 5 to approximately 9 carbon atoms, such as naptha or ligroin, or their precursors. Other fuel products may be about 5 to about 12 carbon atoms or cycloalkanes used as gasotine or motor fitel. Molecules and aromatics of approximatety 10 to approximately 15 carbons, such as kerosene, or its precursors, may also be fliel products. Fuel products may also include molecules, or their precursors, with more than 1 2 carbons, such as used for lubricating oil. Other thel products include heavy gas or fuel oil, or their precursors, typically containing alkanes, cycloallcanes, and aromatics of approximately 20 to approximately 70 carbons. Fuel products also includes other residuals from crude oil, such as coke, asphalt, tar, and waxes, generally containing multiple rings with about or more carbons, and their precursors.
[00133] Host Cells and Owanisms 1001341 Examples of organisms that can be transformed using the vectors and methods herein include vascular and non-vascular organisms. The organism can be prokaroytic or eukaroytic. The organism can be unicellular or multicellular.
[00135] Eukaryotic cells, such as a fungal cell (e.g., Saccharomyces cerevisiac, Schizosaceliaromyces pombe or Usti/ago maydis) may be transformed using the methods and compositions of the present invention. Methods for introducing nucleic acids in a fiingaL'yeast cells are wett known in the art. Hence, such a step may be accomplished by conventional transformation methodologies. Non-timiting examples of suitabte methodologies include electroporation, alkali cations protocots and spheroplast transformation.
100136] Examples of non-vascular photosynthetic organisms include hryophtyes, such as marchantiophytes or anthocerotophytes. In some instances the organism is a cyanobacteria. In some instances, the organism is algae (e.g., macroalgae or microalgae). The algae can be unicellular or multicellular algae. In some instances tile organism is a rhodophyte, chlorophyte, heterokontophyte, tribophyte, glaucophyte, chlorarachniophyte, euglenoid, haptophyte, cryptomonad, dinoflagellum, or phytoplankton.
[00137] The methods of the present invention are exemplified using the microalga, C. reinhardtii. The use of microalgae to express a polypeptide or protein complex according to a method of the invention provides the advantage that large populations of the microalgae can be grown, including commercially (Cyanotech Corp.; Kailua-Kona HI), thus allowing for production and, if desired, isolation of large amounts of a desired product. However, the ability to express, for example, functional polypeptides, including protein complexes, in tile chloroplasts of any plant and/or modifly the chloroplasts or any plant allows for production of crops of such plants and, therefore, the ability to conveniently produce large amounts of the polypeptides. Accordingly, tile methods of the invention can he practiced using any plant having chloroplasts, including, for example, macroalgae, for example, marine algae and seaweeds, as well as plants that grow in soil, for example, corn (Zea mavs), Brassica sp. (e.g., B. nap us, B. rapa, B.juncea), particularly those Brassica species useful as sources of seed oil, alfalfa (Medicago saliva), rice (Orvza saliva) , rye (Secale cereale), sorghum (Sorghum bico/or, Sorghum vulgare), millet (e.g., pearl millet (Penniselum glaucum), proso millet (Panicurn Tnhliaceum), foxtail millet (Setaria ita/ica), finger millet (Eleusine coracana)), sunflower (He/ianthus annuus), safflower (Carthamus tinctorius), wheat (Triticum aestivum), soybean (Glycine max), tobacco (Nicotiana tabacum), potato (So/an urn tuberosum), peanuts (Arachis hjpogaea), cotton (Gossypium barbadense, Gossypium hirsutum), sweet potato (Ipomoea batatus), cassaya (Manihot escu/enta), coffee (Cofea spp.), coconut (Cocos nucifera), pineapple Ananas comosus), citrus trees (Citrus spp.), cocoa (Theobroma cacao), tea (Came//ia sin ensis), banana (Musa spp.), avocado (Persea u/ti/ane), fig (Ficus casica), guava (Psidiurn guajava), mango (Mangfera indica), olive (0/ca europaea), papaya (Carica papaya), cashew (Anacardium occidenta/e), macadamia (Macadamia integrfo/ia), almond (Prunus amygda/us), sugar beets (Beta vu/garis), sugar cane (Saccliarum spp.), oats, duckweed (Lemna), barley, tomatoes (Lycopersicon escu/entum), lettuce (e.g., Lactuca saliva), green beans (Phaseo/us vu/garis), lima beans (Phaseo/us /irnensis), peas (Lathyrus spp.), and members of the genus Cucurnis such as cucumber (C. sativus), cantaloupe (C. canla/upensis), and musk melon (C. me/u). Omamentals such as azalea (Rhododendron spp.), hydrangea (Macrophyl/a hydrangea), hibiscus (Hibiscus rosasanensis), roses (Rosa spp.), tulips (Tu/ipa spp.), daffodils (Narcissus spp.), petunias (Petunia hybrida), carnation (Dianthus caryophyllus), poinsettia (Euphorbiapuicherrima), and chrysanthemum are also included. Additional omamentals useful for practicing a method of the invention include impatiens, Begonia, Pelargonium, Viola, Cyclamen, Verbena, Vinca, Tagetes, Primula, Saint Paulia, Agertum, Amaranthus, Antihirrhinum, Aquilegia, Cineraria, Clover, Cosmo, Cowpea, Dahlia, Datura. Delphinium, Gerbera, Gladiolus, Gloxinia, Ilippeastrum, Mesembryanthemum, Salpiglossos, and Zinnia. Conifers that may be employed in practicing the present invention include, for example, pines such as loblolly pine (Pin us taeda), slash pine (Pin us el/iotii), ponderosa pine (Pinus ponderosa), lodgepole pine (Pinus contorta), and Monterey pine (Pinus radiata), Douglas-fir (Pseudotsuga menziesii); Western hemlock (Tsuga ultilane); Sitka spruce (Picea g/auca); redwood (Sequoia sempervirens); true firs such as silver fir (Abies amabi/is) and balsam fir (Abies ba/samea); and cedars such as Western red cedar (TI-ui/a p/icata) and Alaska yellow-cedar (Chamaecyparis nootkatensis).
100138] Leguminous plants useful for practicing a method of the invention include beans and peas. Beans include guar, locust bean, fenugreek, soybean, garden beans, cowpea, mung bean, lima bean, fava bean, lentils, chickpea, etc. Legumes include, but are not limited to, Arachis, e.g., peanuts, Vicia, e.g., crown vetch, hairy vetch, adzuki bean, mung bean, and chickpea, Lup in us, e.g., lupine, trifolium, Phaseo/us, e.g., common bean and lima bean, Pisurn, e.g., field bean, Me/i/otus, e.g., clover, Medicago, e.g., alfalfa, Lotus, e.g., trefoil, lens, e.g., lentil, and false indigo. Preferred forage and turf grass for use in the methods of the invention include alfalfa, orchard grass, tall fescue, perennial ryegrass, creeping bent grass, and recitop. Other plants useful in the invention include Acacia, aneth, artichoke, arugula, blackberry, canola, cilantro, clementines, escarole, eucalyptus, fennel, grapefruit, honey dew, jicama, kiwifruit, lemon, lime, mushroom, nut, olca, orange, parsley, persimmon, plantain, pomegranate, poplar, radiata pine, radicchio, Southern pine, sweetgum, tangerine, triticale, vine, yams, apple, pear, quince, cherry, apricot, melon, hemp, buckwheat, grape, raspberiy, chenopodium, blueberry, nectarine, peach, plum, strawberry, watermelon, eggplant, pepper, cauliflower, Brassica, e.g., broccoli, cabbage, ultilan sprouts, onion, carrot, leek, beet, broad bean, celery, radish, pumpkin, endive, gourd, garlic, snapbean, spinach, squash, turnip, ultilane, chicoiy, groundnut and zucchini. Thus, tile compositions contemplated herein include host organisms comprising any of the above nucleic acids. The host organism can he any chloroplast-containing organism.
100139] The term "plant" is used broadly herein to refer to a eukaryotic organism containing plastids, particularly chloroplasts, and includes any such organism at any stage of development, or to part of a plant, including a plant cutting, a plant cell, a plant cell culture, a plant organ, a plant seed, and a plantlet. A plant cell is the structural and physiological unit of the plant, comprising a protoplast and a cell wall. A plant cell can be in the form of an isolated single cell or a cultured cell, or can be part of higher organized unit, for example, a plant tissue, plant organ, or plant. Thus, a plant cell can be a protoplast, a gamete producing cell, or a ccli or collection of cells that can regenerate into a whole plant. As such, a seed, which comprises multiple plant cells and is capable of regenerating into a whole plant, is considered plant cell for purposes of this disclosure. A plant tissue or plant organ can be a seed, protoplast, callus, or any other groups of plant cells that is organized into a structural or ftinctional unit. Particularly useful parts of a plant include harvestable parts and parts useful for propagation of progeny plants. A harvestable part of a plant can be any usetlil part of a plant, for example, flowers, pollen, seedlings, tubers, leaves, stems, fruit, seeds, roots, and the like. A part of a plant useful for propagation includes, for example, seeds, fnuts, cuttings, seedlings, tubers, rootstocks, and the like.
100140] Eukaryotic host cells maybe a fuingal cell (e.g., £ cerevisiac, Sz. pombe or U. maydis). Examples of prokaryotic host cells include E. co/i and B. subtilis, cyanobacteria and photosynthetic bacteria (e.g. species of the genus Synechocystis or the genus Synechococcus or the genus Athrospira). Examples of non-vascular plants which may be a host organism (or the source of target DNA) include bryophtyes, such as marchantiophytes or anthocerotophytes. In some instances, the organism is algae (e.g., maeroalgae or microalgae, such as Ch/amydomonas reinhardtii, Chore//a vu/garis, Duna/ie//a sauna, llaernatococcuspluvalis, Scenedesrnus ssp.). The algae can be unicellular or multicellular algae. In some instances the organism is a rhodophyte, chlorophyte, heterokontophyte, trihophyte, glaucophyte, chlorarachniophyte, euglenoid, haptophyte, cryptomonad, dino flagellum, or phytoplankton. In other instancesOne of skill in the art will recognize that these organisms are given merely as examples and other organisms may be substituted where appropriate positive and negative selectable markers are available.
[00141] Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may he made thereto without departing from the spirit or scope of the appended claims.
EXAMPLES
Example 1: DNA Purification and Analysis 100142] DNA is isolated and analyzed according to methods known in the art, [00143J To prepare DNA from Chiamydomonas reinhardtii to use as a template for PCR, i06 algae cells (from agar plate or liquid culture) are suspended in 10 mM EDTA and heated to 95 ©C for 10 minutes, then cooled to near 23 ©C. The solution is added to the PCR mixture directly.
[00144] To prepare purified chloroplast DNA from Ch/amya'omonas reinhardtii, 5x108 algae cells are collected from liquid culture by centrifugation at 3000 x g for 10 mm, washed once with water, centritliged at 3000 x g for 10 mm, resuspended in mL of lysis solution (10 mlvi Tris pH=8.0, 10mM EDTA, 150 mM NaCI, 2% SDS, 2% Sarkosyl, and 25 ug/mL Pronase (Roche)), and incubated at 37CC for 1 hour. The lysate is then gently extracted with phenol/chloroform followed by two chloroform washes. Total DNA is isolated by ethanol precipitation and resuspension in resuspension buffer (10 mM Tris p11=7.4, 1 mM EDTA, and 0.1 mg/nt RNase). Chloroplast DNA can be purified by adding of denaturing solution (200 mM NaOH and 1% SDS (w/v)) is added to the resuspended DNA and inverted several times. Neutralizing solution (3.0 M potassium acetate, pH=5.5) is added, mixed, incubated on ice for 10 mm and centrifuged at 15000 RPM for 30 mm. The supernatant is decanted and applied to a QJAGEN-tip 500 and the DNA is isolated according to the QIAGEN Plasmid Maxi Kit.
[00145] An alternative method for preparing purified chloroplast DNA from Chiamydomonas reinhardtii involves embedding algae cells or purified chloroplasts in low-melt agarose plugs to prevent shearing of the DNA. Chloroplasts are isolated by lysing whole cells in a nitrogen decompression chamber and separating intact cells and debris from the chloroplasts by percoll density gradient centrifiagation. To lyse the cells and/or chloroplasts, the plugs are incubated at 55CC for 36 hours in lysis buffer (0.5 M EDTA, 1% Sarkosyl, 0.2 mg/mL proteinase K). When lysis is complete, plugs are washed 3 times with TE, and then stored in storage buffer (10 mM Tris pH=7.4, 1 mM EDTA). To release chloroplast DNA into solution, the plugs are washed 3 times with 30 mM NaCI, and melted at 65CC for 10 mm. The melted plugs are shifted to 42 C and treated with f3-agarase (New England Biolabs) for 1 hour. The solution of DNA can he used directly for downstream applications or ethanol precipitated to concentrate the sample.
100146] To prepare DNA from yeast to use as a template for PCR, 106 yeast cells (from agar plate or liquid culture) are suspended in lysis buffer (6mM KHPO4, pH=7.5, 6mM NaC1, 3% glycerol, 1U/mL zymolyase) and heated to 37©C for 30 mm, 95 ©C for 10 minutes, then cooled to near 23 ©C. The solution is added to the PCR mixture directly.
[00147J To prepare plasmid DNA from yeast, desired clones are grown in selective liquid media (e.g., CSM-Trp) to saturation at 30©C. Cells are collected by centriffigation at 3000 x g for 10 minutes and resuspended in 150 uL of lysis buffer (1 M sorbitol, 0.1 M sodium citrate, 0.06 M EDTA pH=7.0, 100mM beta-mercaptoethanol, and 2.5 mg/mL zymolyase). The solution is incubated for 1 hr at 3TC. 300 uL of denaturing solution (1% SDS and 0.2N NaOH) is added and solution is incubated at 60©C for 15 mm. 150 uL of neutralizing solution (3M potassium acetate, pH4. 8) is added and the solution is incubated on ice for 10 mm. The solution is centritliged at 14,000 RPM for 10 mm and the supernatant is transferred to another tube. 1 mL of isopropanol is added, the mixture is gently mixed and centriftiged at 14,000 RPM for 10 mm. The pellet is washed once with I mL of 70% ethanol and centrifuged at 14,000 RPM for 10 mm. The DNA pellet is air-dried and resuspended in 60 nL of resuspension buffer (10mM Ti-is pH=7.4, 1 mM EDTA, and 0.1 mg/mL RNase).
100148] To prepare plasmid DNA from bacteria, cells are grown to saturation at 37©C in LB containing the appropriate antibiotic (Kan or Amp). If the DNA of interest contains standard replication elements, cells are harvested by centriftigation.
If the DNA of interest contains P1 replication elements, saturated cell cultures are diluted 1:20 in LB+Kan+IPTG and grown for 4 hours at 37@C, then harvested. The Plasmid Maxi kit (QIAGEN) is used to prepare plasmid DNA from the cell pellets.
[00149] For illustrative purposes, and without limiting the invention to the specific methods described, DNA samples prepared from algae, yeast, or bacteria (in plugs or in solution) are analyzed by pulse-field gel electrophoresis (PFGE), or digested with the appropriate restriction endonuclease (e.g., Smal) and analyzed by PFGE, conventional agarose gel electrophoresis, and/or Southern blot. Standard protocols usethl for these purposes are frilly described in Gemmill et al. (in "Advances in Genome Biology", Vol. 1, "Unfolding The Genome," pp 217 251, edited by Ram S. Verma).
[00150] One of skill will appreciate that many other methods known in the art maybe substituted in lieu of the ones specifically described or referenced.
Example 2: Transformation methods [00151] E. co/i strains DHIOB or Genehog are made electrocompetent by growing the cells to an OD 600 of 0.7, then collected and washed twice with ice-cold 10% glycerol, flash frozen in a dry-ice ethanol bath and kept at -80°C. Total yeast or algae DNA is prepared and electroporated into E. co/i by using, for example, a 0.1 cm cuvette at 1,800 V, 200 ohms and mF in a Bio-Rad Gene Pulsar Electroporator. Cells are allowed to recover and clones are selected on agar growth media containing one or more antibiotics, such as kanamycin (50 jig/nt), ampicillin (100 jig/mL), gentamycin (50 jig/nt), tetracycline (51 jig/nt), or chloramphenicol (34 jig/nt).
[00152] Yeast strains YPH8S7, YPH8S8 or AB1380 may be transformed by the lithium acetate method as described in Sheistl & Geitz (Curr. Genet. 16:339 346, 1989) and Shemrnn et al., "Laboratory Course Manual Methods in Yeast Genetics" (Cold Spring Harbor Laboratoiy Press, Cold Spring Harbor, 1986) or a spheroplast method such as the one described by Sipiczki et al., Curr. Microhiol., 12(3): 169-173 (1985). Yeast transformants are selected and screened on agar media lacking amino and/or nucleic acids, such as tryptophan, leucine, or uracil. Standard methods for yeast growth and phenotype testing are employed as described by Sherman et al., supra.
[00153] Algae strains csc I 37c (mt+), WI. 1, or Wi-i may be transformed by particle bombardment. Cells are grown to late log phase (approximately 7 days) in TAP medium in the presence or absence of 0.5 mM 5-fluorodeoxyuridine (Gorman and Levine, Proc. NaIL Acad. Sci., USA 54:1665-1669, 1965, which is incorporated herein by reference) at 23°C under constant illumination of 450 Lux on a rotary shaker set at 100 rpm. Fifty ml of cells are harvested by centrifugation at 4,000xg at 23°C for S mm. The supematant is decanted and cells resuspended in 4 ml TAP medium for subsequent chloroplast transformation by particle bombardment (Cohen et al., supra, 1998).
[00154] One of skill will appreciate that many other transformation methods known in the art may be substituted in lieu of the ones specifically described or referenced herein.
Example 3: A hybrid gap-filling vector to capture a chloroplast genome [00155] In this example, a system is estabhshed using a hybrid gap-fllhng vector to capture chloroplast DNA (FIG. 1). The hybrid gap filling vector backbone contains yeast elements that allow it to function as a yeast artificial plasmid (YAP) and bacterial elements that allow it to function as a plasmid artificial chromosome (PAC). The yeast elements include a yeast selection marker sequence (e.g. TRPJ or LEU2), a yeast centromere sequence (CEN), and a yeast autonomously replicating nucleotide sequence (ARS). Bacterial elements include a P1 or bacterial origin of replication sequence and a bacterial selection maker sequence (e.g. Kanr).
100156] To manipulate the hybrid gap-filling vector, the vector pDOCI (SEQ ID NO. 1) was generated. Portions of pTRP-AU (FIG. 2) were amplified using PCR primer pairs that anneal to sites surrounding the region encompassing TEL, ADE2, and URA3. One pair amplifies a region within the yeast elements (SEQ ID NOs. 21 and 22) and the other pair amplifies a region within the bacterial elements (SEQ ID NOs. 23 and 24). The PCR products were assembled into a single DNA fiagment by PCR assembly using a single primer pair (SEQ ID NOs. 21 and 24). The assembled product was digested with NotI and ligated to NotI-digested pUC-SE (SEQ ID NO. 2) to form pDOCI (SEQ ID NO. 1).
[00157] To adapt the hybrid gap-filling vector to capture cliloroplast DNA, the vector pDOCI-10 (SEQ ID NO. 3) was generated. Portions of the C. reinhardtii chloroplast genome were PCR amplified using two primer pairs specific for two adjacent regions (SEQ ID NOs. 25 and 26 and SEQ ID NOs. 27 and 28) near the pshD locus. (Fig. 3; indicated by number 10 surrounded by a box). Each PCR product was digested with NotI and 1-Scel and ligated to pDOCI (SEQ ID NO. 1) that was digested with 1-Scel to form pDOCI-1O (SEQ ID NO. 3).
100158] To adapt pDOCI-10 to confer antibiotic resistance in algae, a selection marker was cloned. pSE-3HB-Kan (SEQ ID NO. 4), which contains a kanamycin resistance encoding gene from bacteria, which is regulated by the 5' UTR and promoter sequence for the alpA gene from C. reinhardtii and the 3' UTR sequence for the rbcL gene from from C. reinhardtii, was digested with SnaBI, which liberated the kanamycin resistance cassette. The cassett was ligated to SnaBI-digested pDOCI-to form pDOCI-10-Kan (SEQ ID NO. 5).
[00159] The hybrid gap-filling for capturing chloroplast DNA, pTRP-10-Kan (SEQ ID NO. 6), was constructed using recombination in yeast (Fig. 2). Briefly, pDOCI-1 0-Kan was digested with Pad and AscI to liberate the cassette that introduces chloroplast genorne-specific elements into the hybrid gap-filling vector. This cassette was transformed along with pTRP-AU into the yeast strain YPH858 using the lithium acetate method. Homologous recombination takes place in vivo in the transformed yeast cells. Transformants that correctly integrated with cassette were isolated based on growth on C SM-Tip agar media containing 5-fluorooratic acid (5-FOA) and by red color. 5-FOA selects for clones that lack a functional URA3 gene and the red color results when the ADE2 gene is eliminated. Plasmid DNA was isolated from yeast clones that were giown in CSM-Trp liquid media and transformed into E. co/i (DH1 OB). To generate large amounts of pTRP-1O-Kan, DH1OB cells harboring pTRP-1O-Kan were grown to saturation at 37CC in LB+Kan (50 ug/mL), and then diluted 1:20 in LB+Kan+IPTG and grown for 4 hours at 37C. DNA was prepared from the bacterial culture using the Plasmid Maxi kit (QIAGEN).
[00160] The composition of the vector was verified by DNA sequencing of the entire plasmid.
Example 4: Vectors to stabilize and/or modify chloro�last genome DNA in an exogenous host [00161] Often, large pieces of lieterologous DNA are instable in host organisms such as yeast or bacteria. This may be due to multiple factors, including, hut not limited to, the presence of toxic gene products or codon bias and/or lack of selective pressure. Therefore, the target DNA within the shuttle vector may be altered within yeast or bacteria. For example, certain portions of a target DNA sequence (e.g., coding regions or promoters) may be deleted or moved by recombination within the host organism. In a similar way, when a shuttle vector carrying the target DNA is transferred back to the organism (or a closely related species) that donated the target DNA, the target DNA can become unstable.
100162] Such sites of instability and susceptible sequences are readily discovered by determining which pieces of genomic DNA elude capture or disappear over time. These sites can be detected by comparing initially isolated gap-filling target DNA plasmids with plasmids isolated from transformed strains which have been sequentially passaged in the laboratory under conditions which select for the presence of the plasmid-encoded selectable marker (e.g., TRP1) or by comparison with native target DNA (e.g., C. reinhardtii chloroplast DNA). Such comparison may be performed, for example, by restriction fragment length polymorphism (RFLP) analysis or direct sequencing. One of skill in the art will recognize that there are multiple other protocols and methods to determine such differences.
[00163] Once identified, such sites and sequences can be forced to remain through selection of markers. Fig. 4 shows examples of arrangements of selectable markers in the multiple cloning site of a vector.
[00164] To generate a stabilization vector containing yeast and algae stability elements, the region of DNA in pTrp-AU encompassing the ADE2 and URA3 genes was liberated by digestion with Sf11 followed by gel purification of the desired fragment. The fragment was treated with Klenow fragment to create blunt ends and ligated to Pm/I-degested pSE-3 HB-Strep (SEQ ID NO. 7), creating pSE-31-ffl-Strep-AU (Fig. 4B). pSE-3HB-Strep is a vector that targets a streptomycin resistance encoding gene from bacteria, which is regulated by the 5' UTR and promoter sequence for the alpA gene from C. reinhardlil and the 3' UTR sequence for the rhcL gene from C. reinhardiii, to the 3HB locus of the C. reinhardili chloroplast genome.
100165] To generate vectors that target other regions of the chloroplast genome, 800-1000 bp regions were amplified using PCR primer pairs that anneal to 5' and 3' regions flanking the sites indicated by numbered circles in Fig. 3 (site 1-5', SEQ ID NOs. 29 and 30; site 1-3', SEQ ID NOs. 31 and 32; site 3-5', SEQ ID NOs. 33 and 34; site 3-3', SEQ ID NOs. 35 and 36; site 4-5', SEQ ID NOs. 37 and 38; site 4-3', SEQ ID NOs. 39 and 40; site 5-5', SEQ ID NOs. 41 and 42; site 5-3', SEQ ID NOs.
43 and 44; and site 7-5', SEQ ID NOs. 45 and 46; site 7-3', SEQ ID NOs. 47 and 48). Each pair of PCR products was digested with NotI and 1-Scel, mixed, and ligated to NotI-digested pUC-SE (SEQ ID NO. 2), producing plasmids pUC 1, pUC3, pUC4, pUC5 and pUC7 (named for their position of integration).
[00166] Pairs of yeast selection markers were constructed so that multiple stabilization sites could be employed simultaneously (FIG. 4B). Each marker pair contains the URA3 gene (SEQ ID NO. 8), which was PCR amplified from pRS416. Each marker pair also contains the LEU2 gene (SEQ ID NO. 9) amplified from pRS415, the HIS3 gene (SEQ ID NO. 10) amplified from pRS4I 3, the ADE2 gene (SEQ ID NO. 11) amplified from pTrp-AU, the LYS2 gene (SEQ ID NO.
12) amplified from S. cerevisiae genomic DNA, or the kanMX6 gene (SEQ ID NO. 13) from pFA6a-kanMX6, which confers resistance to the antiffingal agent G41 8. The primers used for the URA3 gene add the XmaI restriction site to the 5' end (SEQ ID NO. 49) and Sail and SacIl to the 3' end (SEQ ID NO. 50). The primers used for the LEU2, H153, ADE2, LYS2, and G418 genes add the XmaI restriction site to the 5' end (SEQ ID NO. 51 for LEU2, SEQ ID NO. 52 for H153, SEQ ID NO. 53 forADE2, SEQ ID NO. 54 for LYS2, and SEQ ID NO. 55 for G4JK) and Sa/l. FseI, and SpeI sites to the 3' end (SEQ ID NO. 56 for LEU2, SEQ ID NO. 57 for HJS3, SEQ ID NO. 58 for ADE2, SEQ ID NO. 59 for LYS2, and SEQ ID NO. 60 for G418'). Each PCR product was digested with XmaI and Sail, mixed pairwise, and ligated into the desired integration vector, resulting in pUC1-URA3/ADE2, pUC3-URA3/LEU2, pUC4-URA3/H153, pUC5-URA3/ADE2, and pUC7-URA3/LYS2. URA3 is used in each case because it allows for positive and negative selection. Marker pairs can he introduced based on selection for either gene (in the case of a single modification), the non-URA3 gene in the case of two or more modification. Then the markers can be removed by introducing DNA with terminal sequences homologous to those surrounding the marker pairs and selecting for growth on minimal media containing 5-FOA.
100167] To promote sequence stability in bacteria, antibiotic resistance markers were cloned into the yeast selection marker pairs. The bacterial stability markers include, but are not limited to, the ampicillin resistance gene (Ampr, SEQ ID NO. 14) amplified from pET-21 a, the tetracycline resistance gene (Tef, SEQ ID NO. 15) amplified from pBR322, the chloramphenicol resistance gene (Camr, SEQ ID NO. 16) amplified from pETeoco-1, and the gentamycin resistance gene (Gentf, SEQ ID NO. 17) amplified from pJQ200. For each gene, primer pairs (SEQ ID NOs. 61 and 62 for Ampr, SEQ ID NOs. 63 and 64 for Tetf, SEQ ID NOs. 65 and 66 for Camr, and SEQ ID NOs. 67 and 68 for Genf) that add XmaI sites to both the 5' and 3' ends were used to PCR amplify the antibiotic resistance fragment. Each PCR product was digested with XmaI and ligated into XmaI-digested pUC1 -URA3/ADE2, pUC3-URA3/LEU2, pUC4-URA3/HIS3, pUCS-URA3/ADE2, and pUC7-URA3/LYS2. Fig. 4C shows the arrangement of the yeast and bacterial stability markers.
Example 5: Introduction of hybrid and stabilization vectors into a chloroplast genome [00168] To generate a C. rein/iardtii chloroplast genome that contains a hybrid vector with or without a stabilization vector, pTRP-1O-Kan and pSE-3HB-Strep-AU were transformed into algae cells. pTRP-10-Kan was digested with Nod to linearize tile vector such that the chloroplast targeting elements on are on each end (FIG. 5). pSE-3 HB-Strep-AU was transformed as circular DNA.
100169] For these experiments, all transformations are carried out on C. reinhardtii strain I 37c (mt+). Cells are grown to late log phase (approximately 7 days) in tile presence of 0.5 mM 5-fluorodeoxyuridine in TAP medium (Gorman and Levine, Proc. NaIL Acad. Sci., USA 54:1665-1669, 1965, which is incorporated herein by reference) at 23°C under constant illumination of 450 Lux on a rotary shaker set at 100 rpm. Fifty ml of cells are harvested by centrifugation at 4,000xg at 23°C for S mm. The supematant is decanted and cells resuspended in 4 ml TAP medium for subsequent chloroplast transformation by particle bombardment (Cohen et al., supra, 1998). All transformations are carried out under kanamycin selection (100 ig/ml) in which resistance is conferred by the gene encoded by the segment in Fig. 5 labeled "Kan." (Chlamydomonas Stock Center, Duke University).
[00170] PCR is used to identif' transformed strains. For PCR analysis, 106 algae cells (from agar plate or liquid culture) are suspended in 10mM EDTA and heated to 95©C for 10 minutes, then cooled to near 23CC. A PCR cocktail consisting of reaction buffer, MgCl2, dNTPs, PCR primer pair(s), DNA polymerase, and water is prepared. Algae lysate in EDTA is added to provide a template for the reaction. The magnesium concentration is varied to compensate for amount and concentration of algae lysate and EDTA added. Annealing temperature gradients are employed to determine optimal annealing temperature for specific primer pairs.
100171] Fig. 6 shows examples of isolated algae strains that contain pTrp-10-Kan with and without pSE-3HB-Strep-AU.
Strains that integrated pTRP-1O-Kan were identified using any of a set of primer pairs that amplify different regions in the vector backbone (Lane 1, SEQ ID NOs. 69 and 70; Lane 2, SEQ ID NOs. 71 and 72; Lane 3, SEQ ID NOs. 73 and 74; Lane 4, SEQ ID NOs. 75 and 76; Lane 5, SEQ ID NOs. 77 and 78; Lane 6, SEQ ID NOs. 79 and 80; Lane 7, SEQ ID NOs. 81 and 82; Lane 8, SEQ ID NOs. 83 and 84; and Lane 9, SEQ ID NOs. 85 and 86) or primer pairs that span the junction between pTrp-10-Kan DNA and chloroplast genome DNA (Lane 10, SEQ ID NOs. 87 and 88; Lane 11, SEQ ID NOs. 89 and 90). To identify strains that have integrated pSE-3HB-Strep-AU, primer pairs (SEQ ID NOs. 91 and 92) were used which amplify regions within the ADE2 gene. Desired clones are those that yield PCR products of expected size.
Example 6: Capture of a chloroplast genome into an exogenous host 100172] In this example, C. reinhara'ill chloroplast DNA is isolated using standard techniques as described above. C. reinhara'ill chioroplast DNA containing tile pTRP-10-Kan vector with or without pSE-3HB-Strep-AU was used to transform bacteria. Electrocompetent E. co/i strains DH10B or Genehog were transformed and selected on LB agar growth medium with kanamycin (50 mg/I). DNA from individual clones was isolated by growing the cells to saturation at 37©C in LB liquid growth medium with kanamycin (50 mg/I). Saturated cell cultures are diluted 1:20 in LB+Kan+IPTG and grown at 37©C for 4 hours. The Plasmid Maxi kit (QIAGEN) is used to prepare plasmid DNA from the isolated clones.
[00173] Fig. 7A shows the restriction analysis of two types of clones obtained from bacterial transformation (Clone 1 and Clone 2) compared to the parent hybrid vector (Clone C). Clones 1 and 2 are composed of >100kb of DNA while the parent hybrid vector is composed of only 23 kb of DNA, demonstrating that large portions of DNA were indeed captured by the hybrid vector. Restriction mapping indicates that Clone 1 comprises approximately half of the chloroplast genome (FIG.
8A). DNA sequencing of the regions flanking the hybrid vector indicate that a recombination event occurred between the 3' UTR of the C. reinhara'iii kanamycin resistance cassette (which is the 3' UTR from the rheL gene in C. rein/zardiii) and the 3' UTR of the C. rein/ian/ill streptomycin resistance cassette (which is the 3' UTR from the rbcL gene in C. rein/ian/ill).
Clone 1 retained the C. reinhare/ill kanamycin resistance cassette, hut lost the C. reinhare/ill streptomycin resistance cassette.
Restriction mapping indicates that Clone 2 also comprises approximately half of the chloroplast genome (FIG. 8B).
However, DNA sequencing of the regions flanking the hybrid vector indicate that a different recombination event occurred to give rise to Clone 2. The 5' UTR of the C. reinharc/ill kanamycin resistance cassette (which is the 5' UTR from the aipA gene in C. reinharc/ill) recombined with the 5' UTR of the aipA gene in the C. reinharc/ill chloroplast genome and the inverted repeat B (IR-B in FIG. 8) recombined with inverted repeat A (IR-A in FIG. 8). Clone 2 lost both the C. reinharc/ill kanamycin resistance cassette and the C. reinharc/ili streptomycin resistance cassette.
[00174] To demonstrate that the hybrid vector would support stable replication in yeast, Clone 1 was transformed into the yeast strain AB 1380 by the lithium acetate method and transfomants were selected on CSM-Trp agar media. Transformants were PCR screened using a pmer pair (SEQ ID NOs 97 and 98) that amplifies a region with the chloroplast genome DNA of Clone 1. Desired clones are those that give rise to a PCR product of expected size. Individual PCR-positive clones were streaked to generate multiple clones per isolate. DNA was prepared from the isolated yeast clones and transformed into bacteria. Bacteria were PCR screened using a primer pair (SEQ ID NOs 97 and 98) that amplifies a region within the chloroplast genome DNA of Clone 1. Desired clones are those that give PCR products of expected size. DNA was prepared from the isolated bacterial clones and analyzed by restriction digest with EeaRI. Fig. 7B shows that all isolated clones have restriction maps that are identical to the originally isolated Clone 1. Thus, the hybrid vector supports stable replication in yeast.
[00175] To determine if the captured DNA is indeed chloroplast genome DNA, a Southem blot was performed. Clones 1 and 2 prepared from bacteria were digested with i/caRT, separated by gel electrophoresis, transferred to a membrane, and probed with radioactive Hint/lIT-digested total DNA from C. reinharc/ili. Fig. 7C shows that the DNA in Clones 1 and 2 give rise to a signal, thus indicating that the captured DNA is chloroplast genome DNA.
Example 7: Reintroduction of chloroplast genome DNA into algae [00176] For these experiments, all transformations are carried out on either C. reinhan/ili strain Wi. 1, which expresses SAA from the endogenouspshA loci, or Wi-i, which expresses LuxAB from the endogenouspshA loci. Both W1,1 and Wi-i are resistant to spectinomycin by virtue of transformation of p228, which introduces a mutation in the 165 rRNA. Cells are grown to late log phase (approximately 7 days) in TAP medium (Gorman and Levine, Proc. Nail. Acad. Sci., USA 54:1665- 1669, 1965, which is incorporated herein by reference) at 23°C tinder constant illumination of 450 Lox on a rotary shaker set at 100 rpm. Fifty ml of cells are harvested by centrifugation at 4,000xg at 23°C for 5 mm. The supernatant is decanted and cells resuspended in 4 ml HSM medium for subsequent chloroplast transformation by particle bombardment (Cohen et al., supra, 1998). All transformations are carried out on HSM agar.
[00177] Transformants were selected by growth on HSM, indicating that function of the psbA gene locus was restored.
Clones were also subsequently checked for growth on TAP, TAP with spectinomycin (150 p.g/ml),TAP with kanamycin (100 ig/ml), HSM, and HSM with kanamycin (100 ig/ml). Fig. 9 shows that Wi-i transformed with Clone us able to grow on all media types. Fig. 9 also shows that Wi-i transformed with Clone 2 is unable to grow on media containing kanamycin, which is expected since Clone 2 does not contain a Kan resistance marker.
Example 8: Modification of Chloroplasts for Producing biomass-degrading enzymes [00178] To modify capttued clilorop last genome DNA for production of a xylanase, an algae expression cassette was cloned into the yeast marker vectors described in EXAMPLE 4. Briefly, a C. reinhardtii cliloroplast expression vector was digested with Spel to liberate a fragment of DNA (SEQ ID NO. 18) with xylanase from T reesei regulated by the 5' UTR for the pshD gene from C. reinhardiii and the 3' UTR for the psbA gene from C. reinhardtii. The fragment was treated with Klenow fragment to create blunt ends and cloned into SinaI XmaI) site between the yeast markers in pUCI-URA3/ADE2, pUC3-URA3/LEU2, and pUC4-URA3/HIS3. Fig. 1OA shows the arrangement of the various elements in the new vectors.
100179] Chloroplast genome DNA was modified by transforming the modification vector into yeast that harbored the captured DNA. For transformation, all modification vectors were linearized by digestion with NotI. Yeast harboring Clone 1 (from EXAMPLE 6) were grown to saturation in CSM-Trp media at 30CC, then diluted 1:20 in YPAD and grown for 4 hours at 30CC. Yeast were transformed using the lithium-acetate method and transformants were selected for by growth on CSM-Ura media. Transformants were propagated on CSM-Trp-Ura media and then PCR screened using primers specific for the xylanase expression cassette (SEQ ID NOs 95 and 96) and a region within the chloroplast genome DNA (SEQ ID NOs 97 and 98). Desired clones are those that give PCR products of expected size for both reactions. DNA was prepared fiom the isolated yeast clones and transformed into bacteria. Bacteria were PCR screened using primers specific for the xylanase expression cassette (SEQ ID NOs 95 and 96) and a region within the chloroplast genome DNA (SEQ ID NOs 97 and 98).
Desired clones are those that give PCR products of expected size for both reactions. DNA was prepared from the isolated bacterial clones and analyzed by restriction digest with EcoRI. Fig. lOB shows that clones were isolated that have restriction maps that are consistent with integration of the xylanase expression cassette in the desired position.
100180] For these experiments, all transformations are carried out on either C. reinhardtii strain Wi. 1, which expresses SAA from the endogenous psbA loci, or Wi-i, which expresses LuxAB from the endogenous psbA loci. Both Wi. 1 and Wi -1 are resistant to spectinomycin by virtue of transformation of p228, which introduces a mutation in the 16S rRNA. Cells are grown to late log phase (approximately 7 days) in TAP medium (Gorman and Levine, Proc. Nail. Acad. Sci., USA 54:1665- 1669, 1965, which is incorporated herein by reference) at 23°C under constant illumination of 450 Lux on a rotary shaker set at 100 rpm. Fifty ml of cells are harvested by centrifugation at 4,000xg at 23°C for 5 mi The supematant is decanted and cells resuspended in 4 ml HSM medium for subsequent chiloroplast transformation by particle bombardment (Cohen et al., supra, 1998). All transformations are carried out on HSM agar.
100181] Transformants were identified by growth on HSM, indicating that function of the psbA gene locus was restored.
PCR is used to identify transformants that also contain the endoxylanase expression cassette. For PCR analysis, 106 algae cells (from agar plate or liquid culture) are suspended in 10 mlvi EDTA and heated to 95C for 10 minutes, then cooled to near 23 ©C. A PCR cocktail consisting of reaction buffer, MgC12, dNTPs, PCR primer pair(s) (Table 2), DNA polynTierase, and water is prepared. Algae lysate in EDTA is added to provide a template for the reaction. The magnesium concentration is varied to compensate for amount and concentration of algae lysate and EDTA added. Annealing temperature gradients are employed to determine optimal annealing temperature for specific primer pairs.
[00182] To identify strains that have the endoxylanase expression cassette, a primer pair (SEQ ID NOs 95 and 96) was used which amplifies a region within the endoxylanase expression cassette. Desired clones are those that yield PCR products of expected size. Fig. 1 1A shows that multiple algae strains were obtained that contain the endoxylanase expression cassette (PCR products indicated with asterisk).
[00183] To deteimine whether thnctional xylanase is expressed, enzyme activity is examined. Patches of cells (approximately 2mg per patch) from TAP agar plates containing kanamycin (100 ig/mL)were resuspended in 50 ut of 100mM sodium acetate pH 4.8 in a round bottom 96 well plate (Corning). Resuspended cells were lysed by addition of 20u1 of BugBuster Protein Extraction Reagent (Novagen) and shaken for five minutes at room temperature. Cell lysate (50u1) was transferred to a black 96 well plate, and the chlorophyll fluorescence of the resulting wells was measured in a SpectraMax M2 rnicroplate reader (Molecular Devices), with an excitation wavelength of 440 nm and an emission wavelength of 740 nm, with a 695 nm cutoff filter. The measured chlorophyll signal in RFUs (relative fluorescence units) was used to normalize the xylanase activity signal to the amount of biomass added to the reaction.
[00184] After measurement of the chlorophyll fluorescence, xylanase substrate was added. EnzCheck Ultra Xylanase substrate (Invitrogen) was dissolved at a concentration of SOug/ml in 100mM sodium acetate pH 4.8, and SOul of substrate was added to each well of the microplate. The fluorescent signal was measured in a SpectraMax M2 microplate reader (Molecular Devices), with an excitation wavelength of 360 nm and an emission wavelength of 460 nm, without a cutoff fitter and with the plate chamber set to 42 degrees Celsius. The fluorescence signal was measured for 15 minutes, and the enzyme velocity was calculated with Softmax Pro v5.2 (Molecular Devices). Enzyme velocities were recorded as RFU/rninute.
Enzyme specific activities were calculated as milliRFU per minute per RFU of chlorophyll fluorescence. Fig. 1 lB shows that multiple algae strains containing the xylanase expression cassette at site 1, 3, and 4 (see FIGS. 3 and 10) were obtained that produce functional xylanase enzyme.
Example 9: Modification of a chloroplast genome to produce terpenes 100185] To modify captured chioroplast genome DNA for production of an FPP synthase, an algae expression cassette was cloned into the yeast marker vectors described in EXAMPLE 4. Briefly, a C. reinhardtii chloroplast expression vector was digested with Spef to liberate a fragment of DNA (SEQ ID NO. 19) with FPP syrithase from G. ga//us regulated by the 5' UTR for the psbD gene from C. reinhardtii and the 3' UTR for the psbA gene from C. reinhardtii. The fragment was treated with Klenow fragment to create blunt ends and cloned into SrnaI (XmaI) site between the yeast markers in pUC 1-URA3/ADE2, pUC3-URA3/LEU2, and pUC4-URA3/HIS3. Fig. 1OA shows the arrangement of the various elements in the new vectors.
[00186] Chloroplast genome DNA was modified by transforming the modification vector into yeast that harbored the captured DNA. For transformation, all modification vectors were linearized by digestion with Nod. Yeast harboring Clone 1 (from EXAMPLE 6) were grown to saturation in CSM-Trp media at 30CC, then diluted 1:20 in YPAD and grown for 4 honrs at 30CC. Yeast were transformed using tile lithium-acetate method and transformants were selected for by growth on CSM-Ura media. Transformants were propagated on CSM-Trp-Ura media and then PCR screened using primers specific for the FPP synthase expression cassette (SEQ ID NOs 95 and 99) and a region within the chloroplast genome DNA (SEQ ID NOs 97 and 98). Desired clones are those that gave PCR products of expected size for both reactions. DNA was prepared from the isolated yeast clones and transformed into bacteria. Bacteria were PCR screened using primers specific for the FPP synthase expression cassette (SEQ ID NOs 95 and 99) and a region within the chioropiast genome DNA (SEQ IDs 97 and 98). Desired clones are those that gave PCR products of expected size for both reactions. DNA was prepared from the isolated bacterial clones and analyzed by restriction digest. Fig. 10C shows that clones were isolated that have restriction maps that are consistent with integration of the FPP synthase expression cassette in the desired position.
[00187] For these experiments, all transformations are carried out on either C. reinhara'tii strain W 1.1, which expresses SAA from the endogenous pshA loci, or Wi-i, which expresses LuxAB from the endogenous pshA loci. Both W 1.1 and Wi-i are resistant to spectinomycin by virtue of transformation of p228, which introduces a mutation in the 1 6S rRNA. Cells are grown to late log phase (approximately 7 days) in TAP medium (Gorman and Levine, Proc. Nail. Acad. Sci., USA 54:1665- 1669, 1965, which is incorporated herein by reference) at 23°C tinder constant illumination of 450 Lux on a rotary shaker set at 100 rpm. Fifty ml of cells are harvested by centrifugation at 4,000xg at 23°C for 5 mm. The supernatant is decanted and cells resuspended in 4 ml HSM medium for subsequent chloroplast transformation by particle bombardment (Cohen et al., supra, 1998). All transformations are carried out on HSM agar.
[00188] Transformants were identified by growth on HSM, indicating that function of the pshA gene locus was restored.
PCR is used to identify transformants that also contain the FPP synthase expression cassette. For PCR analysis, 106 algae cells (from agar plate or liquid culture) are suspended in 10 mM EDTA and heated to 95©C for 10 minutes, then cooled to near 23 ©C. A PCR cocktail consisting of reaction buffer, MgCI2, dNTPs, PCR primer pair(s), DNA polymerase, and water is prepared. Algae lysate in EDTA is added to provide a template for the reaction. The magnesium concentration is varied to compensate for amount and concentration of algae lysate and EDTA added. Annealing temperature gradients are employed to determine optimal annealing temperature for specific primer pairs.
100189] To identify strains that have the FPP synthase expression cassette, a primer pair was used which amplifies a region within the endoxylanase expression cassette. Desired clones are those that yield PCR products of expected size. Multiple algae strains were obtained that contain the FPP synthase expression cassette at (FIG. 12, PCR products indicated with asterisk).
Example 11: Gap-filling a partial chloroplast genome [00190] In this example, a system is established using a hybrid gap-filling vector to capture chloroplast DNA by recombination in yeast (FIG. 13). To adapt the hybrid gap-filling vector to capture chloroplast DNA, the vector pDOCI- 115A10 (SEQ ID NO. 20) was generated. Portions of the C. reinhardtii chloroplast genome were PCR amplified using two primer pairs specific for a region adjacent the psbD gene (AlO, SEQ ID NOs. 27 and 28) and a region adjacent the near the psbH gene (B5, SEQ ID NOs. 787 and 788). Each PCR product was digested with Nod and 1-Scel and ligated to pDOCI (SEQ ID NO. 1) that was digested with 1-Scel to form pDOCI-85A10 (SEQ ID NO. 20).
[00191] The hybrid gap-filling for capturing chloroplast DNA, pTRP-B5A1O, was constructed using recombination in yeast.
Briefly, pDOCI-BSA1O (SEQ ID NO. 20) was digested with Pad and AscI to liberate tile cassette that introduces chloroplast genome-specific elements into the hybrid gap-filling vector. This cassette was transformed along with pTRP-AU into the yeast strain YPH858 using the lithium acetate method. Homologous recombination takes place in vivo in the transformed yeast cells. Transformants that correctly integrated with cassette were isolated based on growth on CSM-Trp agar media containing 5-fluorooratic acid (5-FOA) and by red color. 5-FOA selects for clones that lack a functional URA3 gene and the red color results when the ADE2 gene is eliminated. Plasmid DNA was isolated from yeast clones that were grown in CSM-Trp liquid media and transformed into E. co/i (DH1 011). To generate large amounts of pTRP-l 0-Kan, DH1 011 cells harboring pTRP-10-Kan were grown to saturation at 37©C in LB-l-Kan (50 ug/mL), and then diluted 1:20 in LB-l-Kan-l-IPTG and grown for 4 hours at 37©C. DNA was prepared from the bacterial culture using the Plasmid Maxi kit (QIAGEN).
[00192] The desired genomic DNA is captured by using the sites in a gap filling vector that have high homology to the regions of the target genomic DNA (indicated by Al 0 and B5 in FIG. 13). Linearized gap fitting vector DNA and chtoroptast genome DNA are used to transform S. cerevisiae using the lithium acetate or spheroptast methods as described in EXAMPLE 2. Homologous recombination takes place in vivo in the transformed yeast cells. Once the target DNA is captured by the vector via homologous recombination, tile DNA can be stably replicated in both yeast and bacterial systems.
As indicated in FIG. 1, the gap filling vector contains the selectable marker TRP1. Therefore, the yeast cells are plated on tryptophan-free medium to screen for positive transformants. Transformed strains growing on the tryptophan-free medium are screened for the presence of target DNA inserts in the gap filling plasmid. Such screening can be by any known method in the art, for example, restriction enzyme digestion, PCR andlor gel electrophoresis.
100193] Yeast transformants screened by PCR using primers specific for chloroplast genome DNA (SEQ IDs 89 and 90).
Desired clones are those that give a PCR product of expected size. DNA is prepared from the isolated yeast clones and transformed into bacteria. Bacterial transformants are PCR screened using primers specific for chloroplast genome DNA (SEQ IDs 89 and 90). Desired clones are those that give a PCR product of expected size. DNA is prepared from the isolated bacterial clones and analyzed by restriction digest with EcoRI.
Example 12: Gap-fitting a complete chloroplast genorne [00194] In this example, a system is established using a hybrid gap-fitting vector to capture a complete chloroplast genome by recombination in yeast (FIG. 14). The hybrid gap-filling for capturing chloroplast DNA, pTRP-lO, was constructed using recombination in yeast. Briefly, pDOCI-10 (described in EXAMPLE 3, SEQ ID NO. 3) was digested with Fad and AscI to liberate the cassette that introduces chloroplast genome-specific elements into the hybrid gap-filling vector. This cassette was transformed along with pTRP-AU into the yeast strain YPHS5S using the lithium acetate method. Homologous recombination takes place in vivo in the transformed yeast cells. Transformants that correctly integrated with cassette were isolated based on growth on CSM-Trp agar media containing 5-fluorooratic acid (5-FOA) and by red color. 5-FOA selects for clones that lack a ftinctional URA3 gene and the red color results when the ADE2 gene is eliminated. Plasmid DNA was isolated fi-om yeast clones that were grown in CSM-Trp liquid media and transformed into F. co/i (DHI OB). To generate large amounts of pTRP-l0-Kan, DH1OB cells harboring pTRP-10-Kan were grown to saturation at 37©C in LB+Kan (50 ug/nTh), and then diluted 1:20 in LB+Kan+IPTG and grown for 4 hours at 37©C. DNA was prepared from the bacterial culture using the Plasmid Maxi kit (QIAGEN).
[00195] The desired genomic DNA is captured by using the sites in a gap filling vector that have high homology to the adjacent regions of the target genomic DNA (indicated by AlO and BlO in FIG. 14). Linearized gap filling vector DNA and chloroplast genome DNA are used to transform S. cerevisiae using the lithium acetate or spheroplast methods as described in EXAMPLE 2. Homologous recombination takes place in vivo in the transformed yeast cells. Once the target DNA is captured by the vector via homologous recombination, the DNA can he stably replicated in both yeast and bacterial systems.
As indicated in FIG. 1, the gap filling vector contains the selectable marker TRP 1. Therefore, the yeast cells are plated on tryptophan-free medium to screen for positive transformants. Transformed strains growing on the tryptophan-free medium are screened for the presence of target DNA inserts in the gap filling plasmid. Such screening can be by any known method in the art, for example, restriction enzyme digestion, PCR and/or gel electrophoresis.
[00196J Yeast transformants screened by PCR using primers specific for chioropiast genome DNA (SEQ IDs 89 and 90).
Desired clones are those that give a PCR product of expected size. DNA is prepared from the isolated yeast clones and transformed into bacteria. Bacterial transformants are PCR screened using primers specific for chloroplast genome DNA (SEQ IDs 89 and 90). Desired clones are those that give a PCR product of expected size. DNA is prepared from the isolated bacterial clones and analyzed by restriction digest with EcoRI.
[00197] Example 13: Reassembly on a complete chioroplast enome [001981 In some instances, tile chloroplast genome may he divided into different plasmids, which, in total, comprise the entirety of the genome (FIG. 15). In such instances, capture of smaller portions may facilitate rapid and complex modification of multiple positions within the genome. The chloroplast genome fragments are then combined to reform a complete (and possibly modified) chloroplast genome.
100199] In this example, the chloroplast is divided between two vectors. One vector consists of the chloroplast genome DNA from B5 to AlO, or nucleotide 76,400 to 176,500 (according to the sequence available from NCBI, NC_005353), respectively. This vector may be obtained by the procedure describe in EXAMPLE 11. The other vector consists of the cliloroplast genome DNA from B 10 to A5, or nucleotide 176,500 to 76,400 (according to the sequence available from NCBI, NC 005353), respectively. This vector is the same one as Clone 1 described in may be obtained by the procedure described in EXAMPLE 6. Both vector share the hybrid vector sequence and can use that as a region of homology for recombination.
In this example, the recombination event insert the hybrid vector sequenc between regions A 10 and B 10 (Fig. 5). However, there is no homology sufficient to facilitate recombination that joins regions AS and B5 (Fig. 5). Thus, a third vector is added that has selectable markers between sequences homologous to A5 and BS.
100200] The chloroplast genome is reassembled by combining all three vectors and transforming S. cerevisiae using the lithium acetate or spheroplast methods as described in EXAMPLE 2. Homologous recombination takes place in vivo in the transformed yeast cells. Once the target DNA is created via homologous recombination, the DNA can be stably replicated in both yeast and bacterial systems. As indicated in Fig. 15, the third vector contains the selectable markers URA3 and ADE2.
Therefore, the yeast cells are plated on tryptophan-free medium to screen for positive transforrnants. Transformed strains growing on the uracil and/or adenine-free medium are screened for the presence of target DNA inserts in the gap filling plasmid. Such screening can be by any known method in the art, for example, restriction enzyme digestion, PCR and/or gel electrophoresis.
[00201] Yeast transformants screened by PCR using primers specific for chloroplast genome DNA (SEQ IDs 89 and 90).
Desired clones are those that give a PCR product of expected size. DNA is prepared from the isolated yeast clones and transformed into bacteria. Bacterial transformants are PCR screened using primers specific for chloroplast genome DNA (SEQ IDs 89 and 90). Desired clones are those that give a PCR product of expected size. DNA is prepared from the isolated bacterial clones and analyzed by restriction digest with EcoRI.
Example 14: Vectors and methods to remove regions chioroplast genome DNA in an exogenous host 100202] To generate vectors that remove regions of chioroplast genome DNA, 800-1000 bp regions of chioroplast DNA are amplified using PCR primer pairs that anneal to 5' and 3' regions flanking the sites indicated in Fig. 4 (site 1-5', SEQ ID NOs. 1079 and 1080; site 1-3', SEQ ID NOs. 1125 and 1126; site 3-5', SEQ ID NOs. 1083 and 1084; site 3-3', SEQ ID NOs.
ll29and 1130;site4-5', SEQIDNOs. 1087and1088;site4-3', SEQIDNOs. 1133 and 1134;sites-5', SEQIDNOs. 789 and 790; site 5-3', SEQ ID NOs. 787 and 788; and site 7-5', SEQ ID NOs. 1091 and 1092; site 7-3', SEQ ID NOs. 1089 and 1090). Pairs of PCR products from the 5' and 3' regions for different sites are digested with Nod and 1-Scel, mixed, and ligated to Nod-digested pUC-SE (SEQ ID NO. 2). Pairs of yeast selection markers (described in EXAMPLE 4) are cloned between the 5' and 3' fragments using Sail.
[00203] Regions of chlorop last genome DNA are removed by transforming the deletion vector into yeast that harbor the captured DNA. For transformation, all modification vectors were linearized by digestion with No 11. Yeast harboring tile desired clone are grown to saturation in CSM-Trp media at 30t, then diluted 1:20 in YPAD and grown for 4 hours at 3OC.
Yeast were transformed using the lithium-acetate method and transformants were selected for by growth on CSM-Ura media.
Transformants were propagated on CSM-Trp-Ura media and then PCR screened using primers specific for the targeted region and a region of the chioroplast genome DNA not targeted by the deletion vector. Desired clones are those that give not product for the targeted region, hut do give a PCR product of expected size for the untargeted area. DNA is prepared from the isolated yeast clones and transformed into bacteria. Bacteria PCR screened using primers specific for the targeted region and a region of the chloroplast genome DNA not targeted by the deletion vector. Desired clones are those that give not product for the targeted region, but do give a PCR product of expected size for the untargeted area. DNA is prepared from the isolated bacterial clones and analyzed by restriction digest.
[00204] Various modifications, processes, as well as numerous structures that may be applicable herein will be apparent.
Various aspects, features or embodiments may have been explained or described in relation to understandings, beliefs, theories, underlying assumptions, and/or working or prophetic examples, although it wilt he understood that any particular understanding, belief, theory, underlying assumption, andlor working or prophetic example is not limiting. Although the various aspects and features may have been described with respect to various embodiments and specific examples herein, it will he understood that any of same is not limiting with respect to the hill scope of the appended claims or other claims that maybe associated with this application.
Sequence Listing SEQ ID NO. 1 <211> 4572 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 1 tcgtgtagat aactacgata cgggagggct taccatctgg ccccagtgct gcaatgatac 60 cgcgagaccc acgctcaccg gctccagatt tatcagcaat aaaccagcca gccggaaggg 120 ccgagcgcag aagtggtcct gcaactttat ccgcctccat ccagtctatt aattgttgcc 180 gggaagctag agtaagtagt tcgccagtta atagtttgcg caacgttgtt gccattgcta 240 caggcatcgt ggtgtcacgc tcgtcgtttg gtatggcttc attcagctcc ggttcccaac 300 gatcaaggcg agttacatga tcccccatgt tgtgcaaaaa agcggttagc tccttcggtc 360 ctccgatcgt tgtcagaagt aagttggccg cagtgttatc actcatggtt atggcagcac 420 tgcataattc tcttactgtc atgccatccg taagatgctt ttctgtgact ggtgagtact 480 caaccaagtc attctgagaa tagtgtatgc ggcgaccgag ttgctcttgc ccggcgtcaa 540 tacgggataa taccgcgcca catagcagaa ctttaaaagt gctcatcatt ggaaaacgtt 600 cttcggggcg aaaactctca aggatcttac cgctgttgag atccagttcg atgtaaccca 660 ctcgtgcacc caactgatct tcagcatctt ttactttcac cagcgtttct gggtgagcaa 720 aaacaggaag gcaaaatgcc gcaaaaaagg gaataagggc gacacggaaa tgttgaatac 780 tcatactctt cctttttcaa tattattgaa gcatttatca gggttattgt ctcatgagcg 840 gatacatatt tgaatgtatt tagaaaaata aacaaatagg ggttccgcgc acatttcccc 900 gaaaagtgcc acctgacgtc taagaaacca ttattatcat gacattaacc tataaaaata 960 ggcgtatcac gaggcccttt cgtctcgcgc gtttcggtga tgacggtgaa aacctctgac 1020 acatgcagct cccggagacg gtcacagctt gtctgtaagc ggatgccggg agcagacaag 1080 cccgtcaggg cgcgtcagcg ggtgttggcg ggtgtcgggg ctggcttaac tatgcggcat 1140 cagagcagat tgtactgaga gtgcaccata gggcggccgc ggcgcgccgt tccggatctg 1200 catcctgcga tgcagatccg gaacataatg gtgcagggcg ctgacttccg cgtttccaga 1260 ctttacgaaa cacggaaacc gaagaccatt catgttgttg ctcaggtcgc agacgttttg 1320 cagcagcagt cgcttcacgt tcgctcgcgt atcggtgatt cattctgcta accagtaagg 1380 caaccccgcc agcctagccg ggtcctcaac gacaggagca cgatcatgcg cacccgtggc 1440 caggacccaa cgctgcccga gatgcgccgc gtgcggctgc tggagatggc ggacgcgatg 1500 gatatgttct gccaagggtt ggtttgcgca ttcacagttc tccgcaagaa ttgattggct 1560 ccaattcttg gagtggtgaa tccgttagcg aggtgccgcc ggcttccatt caggtcgagg 1620 tggcccggct ccatgcaccg cgacgcaacg cggggaggca gacaaggtat agggcggcgc 1680 ctacaatcca tgccaacccg ttccatgtgc tcgccgaggc ggcataaatc gccgtgacga 1740 tcagcggtcc aatgatcgaa gttaggctgg taagagccgc gagcgatcct tgaagctgtc 1800 cctgatggtc gtcatctacc tgcctggaca gcatggcctg caacgcgggc atcccgatgc 1860 cgccggaagc gagaagaatc ataatgggga aggccatcca gcctcgcgtc gcgaacgcca 1920 gcaagacgta gcccagcgcg tcggccgcca tgccggcgat aatggcctgc ttctcgccga 1980 aacgtttggt ggcgggacca gtgacgaagg cttgagcgag ggcgtgcaag attccgaata 2040 ccgcaagcga caggccgatc atcgtcgcgc tccagcgaaa gcggtcctcg ccgaaaatga 2100 cccagagcgc tgccggcacc tgtcctacga gttgcatgat aaagaagaca gtcataagtg 2160 cggcgacgat agtcatgccc cgcgcccacc ggaaggagct gactgggttg aaggctctca 2220 agggcatcgg tcgagcttga cattgtagga cgtttaaaca ttaccctgtt atccctaggc 2280 cggcctaaga aaccattatt atcatgacat taacctataa aaataggcgt atcacgaggc 2340 cctttcgtct tcaagaaatt cggtcgaaaa aagaaaagga gagggccaag agggagggca 2400 ttggtgacta ttgagcacgt gagtatacgt gattaagcac acaaaggcag cttggagtat 2460 gtctgttatt aatttcacag gtagttctgg tccattggtg aaagtttgcg gcttgcagag 2520 cacagaggcc gcagaatgtg ctctagattc cgatgctgac ttgctgggta ttatatgtgt 2580 gcccaataga aagagaacaa ttgacccggt tattgcaagg aaaatttcaa gtcttgtaaa 2640 agcatataaa aatagttcag gcactccgaa atacttggtt ggcgtgtttc gtaatcaacc 2700 taaggaggat gttttggctc tggtcaatga ttacggcatt gatatcgtcc aactgcatgg 2760 agatgagtcg tggcaagaat accaagagtt cctcggtttg ccagttatta aaagactcgt 2820 atttccaaaa gactgcaaca tactactcag tgcagcttca cagaaacctc attcgtttat 2880 tcccttgttt gattcagaag caggtgggac aggtgaactt ttggattgga actcgatttc 2940 tgactgggtt ggaaggcaag agagccccga aagcttacat tttatgttag ctggtggact 3000 gacgccagaa aatgttggtg atgcgcttag attaaatggc gttattggtg ttgatgtaag 3060 cggaggtgtg gagacaaatg gtgtaaaaga ctctaacaaa atagcaaatt tcgtcaaaaa 3120 tgctaagaaa taggttatta ctgagtagta tttatttaag tattgtttgt gcacttgcct 3180 gcaggccttt tgaaaagcaa gcataaaaga tctaaacata aaatctgtaa aataacaaga 3240 tgtaaagata atgctaaatc atttggcttt ttgattgatt gtacaggaaa atatacatcg 3300 ttaattaagc ggccgcgagc ttggcgtaat catggtcata gctgtttcct gtgtgaaatt 3360 gttatccgct cacaattcca cacaacatac gagccggaag cataaagtgt aaagcctggg 3420 gtgcctaatg agtgagctaa ctcacattaa ttgcgttgcg ctcactgccc gctttccagt 3480 cgggaaacct gtcgtgccag ctgcattaat gaatcggcca acgcgcgggg agaggcggtt 3540 tgcgtattgg gcgctcttcc gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc 3600 tgcggcgagc ggtatcagct cactcaaagg cggtaatacg gttatccaca gaatcagggg 3660 ataacgcagg aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg 3720 ccgcgttgct ggcgtttttc cataggctcc gcccccctga cgagcatcac aaaaatcgac 3780 gctcaagtca gaggtggcga aacccgacag gactataaag ataccaggcg tttccccctg 3840 gaagctccct cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct 3900 ttctcccttc gggaagcgtg gcgctttctc atagctcacg ctgtaggtat ctcagttcgg 3960 tgtaggtcgt tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct 4020 gcgccttatc cggtaactat cgtcttgagt ccaacccggt aagacacgac ttatcgccac 4080 tggcagcagc cactggtaac aggattagca gagcgaggta tgtaggcggt gctacagagt 4140 tcttgaagtg gtggcctaac tacggctaca ctagaagaac agtatttggt atctgcgctc 4200 tgctgaagcc agttaccttc ggaaaaagag ttggtagctc ttgatccggc aaacaaacca 4260 ccgctggtag cggtggtttt tttgtttgca agcagcagat tacgcgcaga aaaaaaggat 4320 ctcaagaaga tcctttgatc ttttctacgg ggtctgacgc tcagtggaac gaaaactcac 4380 gttaagggat tttggtcatg agattatcaa aaaggatctt cacctagatc cttttaaatt 4440 aaaaatgaag ttttaaatca atctaaagta tatatgagta aacttggtct gacagttacc 4500 aatgcttaat cagtgaggca cctatctcag cgatctgtct atttcgttca tccatagttg 4560 cctgactccc cg 4572 SEQ ID NO. 2 <211> 2474 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 2 tcgcgcgttt cggtgatgac ggtgaaaacc tctgacacat gcagctcccg gagacggtca 60 cagcttgtct gtaagcggat gccgggagca gacaagcccg tcagggcgcg tcagcgggtg 120 ttggcgggtg tcggggctgg cttaactatg cggcatcaga gcagattgta ctgagagtgc 180 accatagggc ggccgccagc tggaattcta cgtactgcag agtactgcgg ccgcgagctt 240 ggcgtaatca tggtcatagc tgtttcctgt gtgaaattgt tatccgctca caattccaca 300 caacatacga gccggaagca taaagtgtaa agcctggggt gcctaatgag tgagctaact 360 cacattaatt gcgttgcgct cactgcccgc tttccagtcg ggaaacctgt cgtgccagct 420 gcattaatga atcggccaac gcgcggggag aggcggtttg cgtattgggc gctcttccgc 480 ttcctcgctc actgactcgc tgcgctcggt cgttcggctg cggcgagcgg tatcagctca 540 ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtg 600 agcaaaaggc cagcaaaagg ccaggaaccg taaaaaggcc gcgttgctgg cgtttttcca 660 taggctccgc ccccctgacg agcatcacaa aaatcgacgc tcaagtcaga ggtggcgaaa 720 cccgacagga ctataaagat accaggcgtt tccccctgga agctccctcg tgcgctctcc 780 tgttccgacc ctgccgctta ccggatacct gtccgccttt ctcccttcgg gaagcgtggc 840 gctttctcat agctcacgct gtaggtatct cagttcggtg taggtcgttc gctccaagct 900 gggctgtgtg cacgaacccc ccgttcagcc cgaccgctgc gccttatccg gtaactatcg 960 tcttgagtcc aacccggtaa gacacgactt atcgccactg gcagcagcca ctggtaacag 1020 gattagcaga gcgaggtatg taggcggtgc tacagagttc ttgaagtggt ggcctaacta 1080 cggctacact agaagaacag tatttggtat ctgcgctctg ctgaagccag ttaccttcgg 1140 aaaaagagtt ggtagctctt gatccggcaa acaaaccacc gctggtagcg gtggtttttt 1200 tgtttgcaag cagcagatta cgcgcagaaa aaaaggatct caagaagatc ctttgatctt 1260 ttctacgggg tctgacgctc agtggaacga aaactcacgt taagggattt tggtcatgag 1320 attatcaaaa aggatcttca cctagatcct tttaaattaa aaatgaagtt ttaaatcaat 1380 ctaaagtata tatgagtaaa cttggtctga cagttaccaa tgcttaatca gtgaggcacc 1440 tatctcagcg atctgtctat ttcgttcatc catagttgcc tgactccccg tcgtgtagat 1500 aactacgata cgggagggct taccatctgg ccccagtgct gcaatgatac cgcgagaccc 1560 acgctcaccg gctccagatt tatcagcaat aaaccagcca gccggaaggg ccgagcgcag 1620 aagtggtcct gcaactttat ccgcctccat ccagtctatt aattgttgcc gggaagctag 1680 agtaagtagt tcgccagtta atagtttgcg caacgttgtt gccattgcta caggcatcgt 1740 ggtgtcacgc tcgtcgtttg gtatggcttc attcagctcc ggttcccaac gatcaaggcg 1800 agttacatga tcccccatgt tgtgcaaaaa agcggttagc tccttcggtc ctccgatcgt 1860 tgtcagaagt aagttggccg cagtgttatc actcatggtt atggcagcac tgcataattc 1920 tcttactgtc atgccatccg taagatgctt ttctgtgact ggtgagtact caaccaagtc 1980 attctgagaa tagtgtatgc ggcgaccgag ttgctcttgc ccggcgtcaa tacgggataa 2040 taccgcgcca catagcagaa ctttaaaagt gctcatcatt ggaaaacgtt cttcggggcg 2100 aaaactctca aggatcttac cgctgttgag atccagttcg atgtaaccca ctcgtgcacc 2160 caactgatct tcagcatctt ttactttcac cagcgtttct gggtgagcaa aaacaggaag 2220 gcaaaatgcc gcaaaaaagg gaataagggc gacacggaaa tgttgaatac tcatactctt 2280 cctttttcaa tattattgaa gcatttatca gggttattgt ctcatgagcg gatacatatt 2340 tgaatgtatt tagaaaaata aacaaatagg ggttccgcgc acatttcccc gaaaagtgcc 2400 acctgacgtc taagaaacca ttattatcat gacattaacc tataaaaata ggcgtatcac 2460 gaggcccttt cgtc 2474 SEQ ID NO. 3 211> 6638 212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 3 tcgtgtagat aactacgata cgggagggct taccatctgg ccccagtgct gcaatgatac 60 cgcgagaccc acgctcaccg gctccagatt tatcagcaat aaaccagcca gccggaaggg 120 ccgagcgcag aagtggtcct gcaactttat ccgcctccat ccagtctatt aattgttgcc 180 gggaagctag agtaagtagt tcgccagtta atagtttgcg caacgttgtt gccattgcta 240 caggcatcgt ggtgtcacgc tcgtcgtttg gtatggcttc attcagctcc ggttcccaac 300 gatcaaggcg agttacatga tcccccatgt tgtgcaaaaa agcggttagc tccttcggtc 360 ctccgatcgt tgtcagaagt aagttggccg cagtgttatc actcatggtt atggcagcac 420 tgcataattc tcttactgtc atgccatccg taagatgctt ttctgtgact ggtgagtact 480 caaccaagtc attctgagaa tagtgtatgc ggcgaccgag ttgctcttgc ccggcgtcaa 540 tacgggataa taccgcgcca catagcagaa ctttaaaagt gctcatcatt ggaaaacgtt 600 cttcggggcg aaaactctca aggatcttac cgctgttgag atccagttcg atgtaaccca 660 ctcgtgcacc caactgatct tcagcatctt ttactttcac cagcgtttct gggtgagcaa 720 aaacaggaag gcaaaatgcc gcaaaaaagg gaataagggc gacacggaaa tgttgaatac 780 tcatactctt cctttttcaa tattattgaa gcatttatca gggttattgt ctcatgagcg 840 gatacatatt tgaatgtatt tagaaaaata aacaaatagg ggttccgcgc acatttcccc 900 gaaaagtgcc acctgacgtc taagaaacca ttattatcat gacattaacc tataaaaata 960 ggcgtatcac gaggcccttt cgtctcgcgc gtttcggtga tgacggtgaa aacctctgac 1020 acatgcagct cccggagacg gtcacagctt gtctgtaagc ggatgccggg agcagacaag 1080 cccgtcaggg cgcgtcagcg ggtgttggcg ggtgtcgggg ctggcttaac tatgcggcat 1140 cagagcagat tgtactgaga gtgcaccata gggcggccgc ggcgcgccgt tccggatctg 1200 catcctgcga tgcagatccg gaacataatg gtgcagggcg ctgacttccg cgtttccaga 1260 ctttacgaaa cacggaaacc gaagaccatt catgttgttg ctcaggtcgc agacgttttg 1320 cagcagcagt cgcttcacgt tcgctcgcgt atcggtgatt cattctgcta accagtaagg 1380 caaccccgcc agcctagccg ggtcctcaac gacaggagca cgatcatgcg cacccgtggc 1440 caggacccaa cgctgcccga gatgcgccgc gtgcggctgc tggagatggc ggacgcgatg 1500 gatatgttct gccaagggtt ggtttgcgca ttcacagttc tccgcaagaa ttgattggct 1560 ccaattcttg gagtggtgaa tccgttagcg aggtgccgcc ggcttccatt caggtcgagg 1620 tggcccggct ccatgcaccg cgacgcaacg cggggaggca gacaaggtat agggcggcgc 1680 ctacaatcca tgccaacccg ttccatgtgc tcgccgaggc ggcataaatc gccgtgacga 1740 tcagcggtcc aatgatcgaa gttaggctgg taagagccgc gagcgatcct tgaagctgtc 1800 cctgatggtc gtcatctacc tgcctggaca gcatggcctg caacgcgggc atcccgatgc 1860 cgccggaagc gagaagaatc ataatgggga aggccatcca gcctcgcgtc gcgaacgcca 1920 gcaagacgta gcccagcgcg tcggccgcca tgccggcgat aatggcctgc ttctcgccga 1980 aacgtttggt ggcgggacca gtgacgaagg cttgagcgag ggcgtgcaag attccgaata 2040 ccgcaagcga caggccgatc atcgtcgcgc tccagcgaaa gcggtcctcg ccgaaaatga 2100 cccagagcgc tgccggcacc tgtcctacga gttgcatgat aaagaagaca gtcataagtg 2160 cggcgacgat agtcatgccc cgcgcccacc ggaaggagct gactgggttg aaggctctca 2220 agggcatcgg tcgagcttga cattgtagga cgtttaaaca ttaccctgtt atccctagga 2280 tcctacgtat acatactccg aaggaggaca aatttattta ttgtggtaca ataaataagt 2340 ggtacaataa ataaattgta tgtaaacccc ttccccttcg ggacgtcccc ttacgggaat 2400 ataaatatta gtggcagttg cctgccaaca aatttattta ttgtattaac ataggcagtg 2460 gcggtaccac tgccactggc gtcctaatat aaatattggg caactaaagt ttatcgcagt 2520 attaacatag gcagtggcgg taccactgcc actggcgtcc tccttcggag tatgtaaacc 2580 tgctaccgca gcaaataaat tttattctat tttaatacta caatatttag attcccgtta 2640 ggggataggc caggcaattg tcactggcgt catagtatat caatattgta acagattgac 2700 accctttaag taaacatttt ttttaggatt catatgaaat taaatggata tttggtacat 2760 ttaattccac aaaaatgtcc aatacttaaa atacaaaatt aaaagtatta gttgtaaact 2820 tgactaacat tttaaatttt aaattttttc ctaattatat attttacttg caaaatttat 2880 aaaaatttta tgcattttta tatcataata ataaaacctt tattcatggt ttataatata 2940 ataattgtga tgactatgca caaagcagtt ctagtcccat atatataact atatataacc 3000 cgtttaaaga tttatttaaa aatatgtgtg taaaaaatgc ttatttttaa ttttatttta 3060 tataagttat aatattaaat acacaatgat taaaattaaa taataataaa tttaacgtaa 3120 cgatgagttg tttttttatt ttggagatac acgcaatgac aattgcgatc ggtacatatc 3180 aagagaaacg cacatggttc gatgacgctg atgactggct tcgtcaagac cgtttcgtat 3240 tcgtaggttg gtcaggttta ttactattcc cttgtgctta ctttgcaact ccggtccggc 3300 ggccgcctcg agacgacttg tccgcttcat cagacacggc tttcctaacc atcaatggtg 3360 gattttcagg aaagacgttt aaagaagtgg cataaagttt atttgttgaa gaattggttt 3420 tgtttccatt caaagaattg ttagggataa aactttgcat ttttttataa tttgttataa 3480 gtttttcaaa cttatatgtt tttaaaaatg catttaattg cttattaatg cgttcatttt 3540 gtaatgtttc aataggtctt gcttgcgcta atcgcagtat tcccgatact ttgtctgctt 3600 gtttttcggg tattgagaat aagtaagtat aatgatttaa aaaagtcatg ttttgattaa 3660 atctttttta tatggttaaa aacattatgg tatatctaaa taaatttatt ttttactaaa 3720 tctccaattt gcaatttaga gatataatta aaactataaa gttatttaag ttaatttgta 3780 atcaaatcca acacaaaaat gtttttatat agttaacatg ttaaatttaa catatgttaa 3840 acaactaaaa ttctgtaaca gagaacaata aaataaatgc tagattttgt gtaatgccga 3900 agtatattta tatacttccc tttcaaaaaa ataaatactc ttgccactaa aattcatttg 3960 cctaggacgt ccccttcccc ttacgggatg tttatatact aggacgtccc cttcccctta 4020 cgggatattt atatactccg aaggacgtcc ccttcgggca aataaatttt agtggcagtt 4080 gcctgccaac tgcctaggca agtaaactta gggattttaa tgcaataaat aaatttgtcc 4140 ccttacggga cgtcagtggc agttgcctgc caactgccta atataaatat tagtggatat 4200 ttatatactc cgaaggaggc agttacctgc caactgccga ggcaaataaa ttttagtggc 4260 agtggtaccg ccactgcctg ctccctcctt ccccttcggg caagtaaact tagcatgttg 4320 tcgacattac cctgttatcc ctaggccggc ctaagaaacc attattatca tgacattaac 4380 ctataaaaat aggcgtatca cgaggccctt tcgtcttcaa gaaattcggt cgaaaaaaga 4440 aaaggagagg gccaagaggg agggcattgg tgactattga gcacgtgagt atacgtgatt 4500 aagcacacaa aggcagcttg gagtatgtct gttattaatt tcacaggtag ttctggtcca 4560 ttggtgaaag tttgcggctt gcagagcaca gaggccgcag aatgtgctct agattccgat 4620 gctgacttgc tgggtattat atgtgtgccc aatagaaaga gaacaattga cccggttatt 4680 gcaaggaaaa tttcaagtct tgtaaaagca tataaaaata gttcaggcac tccgaaatac 4740 ttggttggcg tgtttcgtaa tcaacctaag gaggatgttt tggctctggt caatgattac 4800 ggcattgata tcgtccaact gcatggagat gagtcgtggc aagaatacca agagttcctc 4860 ggtttgccag ttattaaaag actcgtattt ccaaaagact gcaacatact actcagtgca 4920 gcttcacaga aacctcattc gtttattccc ttgtttgatt cagaagcagg tgggacaggt 4980 gaacttttgg attggaactc gatttctgac tgggttggaa ggcaagagag ccccgaaagc 5040 ttacatttta tgttagctgg tggactgacg ccagaaaatg ttggtgatgc gcttagatta 5100 aatggcgtta ttggtgttga tgtaagcgga ggtgtggaga caaatggtgt aaaagactct 5160 aacaaaatag caaatttcgt caaaaatgct aagaaatagg ttattactga gtagtattta 5220 tttaagtatt gtttgtgcac ttgcctgcag gccttttgaa aagcaagcat aaaagatcta 5280 aacataaaat ctgtaaaata acaagatgta aagataatgc taaatcattt ggctttttga 5340 ttgattgtac aggaaaatat acatcgttaa ttaagcggcc gcgagcttgg cgtaatcatg 5400 gtcatagctg tttcctgtgt gaaattgtta tccgctcaca attccacaca acatacgagc 5460 cggaagcata aagtgtaaag cctggggtgc ctaatgagtg agctaactca cattaattgc 5520 gttgcgctca ctgcccgctt tccagtcggg aaacctgtcg tgccagctgc attaatgaat 5580 cggccaacgc gcggggagag gcggtttgcg tattgggcgc tcttccgctt cctcgctcac 5640 gactcgctg cgctcggtcg ttcggctgcg gcgagcggta tcagctcact caaaggcggt 5700 aatacggtta tccacagaat caggggataa cgcaggaaag aacatgtgag caaaaggcca 5760 gcaaaaggcc aggaaccgta aaaaggccgc gttgctggcg tttttccata ggctccgccc 5820 ccctgacgag catcacaaaa atcgacgctc aagtcagagg tggcgaaacc cgacaggact 5880 ataaagatac caggcgtttc cccctggaag ctccctcgtg cgctctcctg ttccgaccct 5940 gccgcttacc ggatacctgt ccgcctttct cccttcggga agcgtggcgc tttctcatag 6000 ctcacgctgt aggtatctca gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca 6060 cgaacccccc gttcagcccg accgctgcgc cttatccggt aactatcgtc ttgagtccaa 6120 cccggtaaga cacgacttat cgccactggc agcagccact ggtaacagga ttagcagagc 6180 gaggtatgta ggcggtgcta cagagttctt gaagtggtgg cctaactacg gctacactag 6240 aagaacagta tttggtatct gcgctctgct gaagccagtt accttcggaa aaagagttgg 6300 tagctcttga tccggcaaac aaaccaccgc tggtagcggt ggtttttttg tttgcaagca 6360 gcagattacg cgcagaaaaa aaggatctca agaagatcct ttgatctttt ctacggggtc 6420 tgacgctcag tggaacgaaa actcacgtta agggattttg gtcatgagat tatcaaaaag 6480 gatcttcacc tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata 6540 tgagtaaact tggtctgaca gttaccaatg cttaatcagt gaggcaccta tctcagcgat 6600 ctgtctattt cgttcatcca tagttgcctg actccccg 6638 SEQ ID NO. 4 <211> 7855 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 4 gtgcactctc agtacaatct gctctgatgc cgcatagtta agccagcccc gacacccgcc 60 aacacccgct gacgcgccct gacgggcttg tctgctcccg gcatccgctt acagacaagc 120 tgtgaccgtc tccgggagct gcatgtgtca gaggttttca ccgtcatcac cgaaacgcgc 180 gagacgaaag ggcctcgtga tacgcctatt tttataggtt aatgtcatga taataatggt 240 ttcttagacg tcaggtggca cttttcgggg aaatgtgcgc ggaaccccta tttgtttatt 300 tttctaaata cattcaaata tgtatccgct catgagacaa taaccctgat aaatgcttca 360 ataatattga aaaaggaaga gtatgagtat tcaacatttc cgtgtcgccc ttattccctt 420 ttttgcggca ttttgccttc ctgtttttgc tcacccagaa acgctggtga aagtaaaaga 480 tgctgaagat cagttgggtg cacgagtggg ttacatcgaa ctggatctca acagcggtaa 540 gatccttgag agttttcgcc ccgaagaacg ttttccaatg atgagcactt ttaaagttct 600 ctatgtggc gcggtattat cccgtattga cgccgggcaa gagcaactcg gtcgccgcat 660 acactattct cagaatgact tggttgagta ctcaccagtc acagaaaagc atcttacgga 720 tggcatgaca gtaagagaat tatgcagtgc tgccataacc atgagtgata acactgcggc 780 caacttactt ctgacaacga tcggaggacc gaaggagcta accgcttttt tgcacaacat 840 gggggatcat gtaactcgcc ttgatcgttg ggaaccggag ctgaatgaag ccataccaaa 900 cgacgagcgt gacaccacga tgcctgtagc aatggcaaca acgttgcgca aactattaac 960 tggcgaacta cttactctag cttcccggca acaattaata gactggatgg aggcggataa 1020 agttgcagga ccacttctgc gctcggccct tccggctggc tggtttattg ctgataaatc 1080 tggagccggt gagcgtgggt ctcgcggtat cattgcagca ctggggccag atggtaagcc 1140 ctcccgtatc gtagttatct acacgacggg gagtcaggca actatggatg aacgaaatag 1200 acagatcgct gagataggtg cctcactgat taagcattgg taactgtcag accaagttta 1260 ctcatatata ctttagattg atttaaaact tcatttttaa tttaaaagga tctaggtgaa 1320 gatccttttt gataatctca tgaccaaaat cccttaacgt gagttttcgt tccactgagc 1380 gtcagacccc gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat 1440 ctgctgcttg caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga 1500 gctaccaact ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt 1560 tcttctagtg tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata 1620 cctcgctctg ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac 1680 cgggttggac tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg 1740 ttcgtgcaca cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg 1800 tgagctatga gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag 1860 cggcagggtc ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct 1920 ttatagtcct gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc 1980 aggggggcgg agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt 2040 ttgctggcct tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg 2100 tattaccgcc tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga 2160 gtcagtgagc gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg 2220 gccgattcat taatgcagct ggcacgacag gtttcccgac tggaaagcgg gcagtgagcg 2280 caacgcaatt aatgtgagtt agctcactca ttaggcaccc caggctttac actttatgct 2340 tccggctcgt atgttgtgtg gaattgtgag cggataacaa tttcacacag gaaacagcta 2400 tgaccatgat tacgccaagc tcgcggccgc agtactctgc agattttatg caaaattaaa 2460 gtcttgtgac aacagctttc tccttaagtg caaatatcgc ccattctttc ctcttttcgt 2520 atataaatgc tgtaatagta ggatgtcgta cccgtaaagg tacgacattg aatattaata 2580 tactcctaag tttactttcc caatatttat attaggacgt ccccttcggg taaataaatt 2640 ttagtggcag tggtaccgcc actccctatt ttaatactgc gaaggaggca gttggcaggc 2700 aactcgtcgt tcgcagtata taaatatcca ctaatattta tattcccgta aggggacgtc 2760 ccgaagggga aggggaaaga agcagtcgcc tccttgcgaa aaggtttact tgcccgacca 2820 gtgaaaagca tgctgtaaga tataaatcta ccctgaaagg gatgcatttc accataatac 2880 tatacaaatg gtgttaccct ttgaggatca taacggtgct actggaatat atggtctctt 2940 catggataga cgatagccat ttatttaccc attaagggga cattagtggc ctgtcactgc 3000 tccttacgag acgccagtgg acgttcgtcc tagaaaattt atgcgctgcc tagaagcccc 3060 aaaagggaag tttactgact cgttagagcg tgcgctaaca ggtttaaata cttcaatatg 3120 tatattagga cgccggtggc agtggtaccg ccactgccac cgtcggagga cgtcccttac 3180 ggtatattat atactaggat tttaatactc cgaaggaggc agtggcggta ccactgccac 3240 taatatttat attcccgtaa gggacgtcct ccttcggagt atgtaaacat tctaagttta 3300 cttgcccaat atttatatta ggcagttggc aggcaactgc tagctctcct ccttcggagt 3360 atgtaaacat cgcagtatat aaatatccac taatatttat attcccgtaa ggggacgtcc 3420 cgaaggggaa ggggaaggac gtcagtggca gttgcctgcc aactgcctag gcaagtaaac 3480 ttaggagtat ataaatatag gcagtcgcgg taccactgcc actgacgtcc tgccaactgc 3540 ctaggcaagt aaacttaagt ggcactaaaa tgcatttgcc cgaaggggaa ggaggacgcc 3600 agtggcagtg gtaccgccac tgcctccttc ggagtattaa aatcctagta tgtaaatctg 3660 ctagcgcagg aaataaattt tattctattt atatactccg ttaggaggta agtaaacccc 3720 ttccccttcg ggacgtcagt gcagttgcct gccaactgcc taatataaat attagaccac 3780 taaagtttgg caactgccaa ctgttgtcct tcggaggaaa aaaaatggtt aactcgcaag 3840 cagttaacat aactaaagtt tgttacttta ccgaagacgt ttaccctttc tcggttaagg 3900 agacggagac agttgcactg tgactgccta gtatagcaat tttgtttttg tttatatgct 3960 cgacaaaatg actttcataa aaatataaag tagttagcta gttattttat atcactataa 4020 ctagggttct cagaggcacc gaagtcactt gtaaaaatag tactttttaa cttgtttaat 4080 cttcgtgttc ttcaaaagga tcacgtaatt tttttgaagg tggaccaaaa ctaacataaa 4140 ctgaatagcc agttacactt aacagaagaa accataaaaa aaaggtaaag aaaaaagctg 4200 gactttccat agctcattta ataataaaat tattctcttt tcaacatatc tcttagatag 4260 ttcaaaagac ttgacgactg tgtcccacat ttttaaacaa aattaatcta ctcaaaattt 4320 tgccctgaga aagaataact tacttcgttt ttgcagtagc cattcatgtc actttgaaac 4380 tgtccttaca aagttaaaca ttaattaaaa attatttaat ttttatataa caaatattat 4440 attaaataaa aaatgaacaa agaacttcta agatcgtctt tagtgagtaa ttaaagagtt 4500 ttacttacca gacaaggcag ttttttcatt cttttaaagc aggcagttct gaaggggaaa 4560 agggactgcc tactgcggtc ctaggtaaat acatttttat gcaatttatt tcttgtgcta 4620 gtaggtttct atactcacaa gaagcaaccc cttgacgaga gaacgttatc ctcagagtat 4680 ttataatcct gagagggaat gcactgaaga atattttcct tattttttac agaaagtaaa 4740 taaaatagcg ctaataacgc ttaattcatt taatcaatta tggcaacagg aacttctaaa 4800 gctaaaccat caaaagtaaa ttcagacttc caagaacctg gtttagttac accattaggt 4860 actttattac gtccacttaa ctcagaagca ggtaaagtat taccaggctg gggtacaact 4920 gttttaatgg ctgtatttat ccttttattt gcagcattct tattaatcat tttagaaatt 4980 tacaacagtt ctttaatttt agatgacgtt tctatgagtt gggaaacttt agctaaagtt 5040 tcttaatttt atttaacaca aacataaaat ataaaactgt ttgttaaggc tagctgctaa 5100 gtcttctttt cgctaaggta aactaagcaa ctcaaccata tttatattcg gcagtggcac 5160 cgccaactgc cactggcctt ccgttaagat aaacgcgtgg atctcacgtg actagtgata 5220 tctacgtaat cgatgaattc gatcccattt ttataactgg atctcaaaat acctataaac 5280 ccattgttct tctcttttag ctctaagaac aatcaattta taaatatatt tattattatg 5340 ctataatata aatactatat aaatacattt acctttttat aaatacattt accttttttt 5400 taatttgcat gattttaatg cttatgctat cttttttatt tagtccataa aacctttaaa 5460 ggaccttttc ttatgggata tttatatttt cctaacaaag caatcggcgt cataaacttt 5520 agttgcttac gacgcctgtg gacgtccccc ccttcccctt acgggcaagt aaacttaggg 5580 attttaatgc aataaataaa tttgtcctct tcgggcaaat gaattttagt atttaaatat 5640 gacaagggtg aaccattact tttgttaaca agtgatctta ccactcacta tttttgttga 5700 attttaaact tatttaaaat tctcgagaaa gattttaaaa ataaactttt ttaatctttt 5760 atttattttt tcttttttcg tatggaattg cccaatatta ttcaacaatt tatcggaaac 5820 agcgttttag agccaaataa aattggtcag tcgccatcgg atgtttattc ttttaatcga 5880 aataatgaaa ctttttttct taagcgatct agcactttat atacagagac cacatacagt 5940 gtctctcgtg aagcgaaaat gttgagttgg ctctctgaga aattaaaggt gcctgaactc 6000 atcatgactt ttcaggatga gcagtttgaa tttatgatca ctaaagcgat caatgcaaaa 6060 ccaatttcag cgcttttttt aacagaccaa gaattgcttg ctatctataa ggaggcactc 6120 aatctgttaa attcaattgc tattattgat tgtccattta tttcaaacat tgatcatcgg 6180 ttaaaagagt caaaattttt tattgataac caactccttg acgatataga tcaagatgat 6240 tttgacactg aattatgggg agaccataaa acttacctaa gtctatggaa tgagttaacc 6300 gagactcgtg ttgaagaaag attggttttt tctcatggcg atatcacgga tagtaatatt 6360 tttatagata aattcaatga aatttatttt ttagaccttg gtcgtgctgg gttagcagat 6420 gaatttgtag atatatcctt tgttgaacgt tgcctaagag aggatgcatc ggaggaaact 6480 gcgaaaatat ttttaaagca tttaaaaaat gatagacctg acaaaaggaa ttatttttta 6540 aaacttgatg aattgaattg attccaagca ttatctaaaa tactctgcag gcacgctagc 6600 ttgtactcaa gctcgtaacg aaggtcgtga ccttgctcgt gaaggtggcg acgtaattcg 6660 ttcagcttgt aaatggtctc cagaacttgc tgctgcatgt gaagtttgga aagaaattaa 6720 attcgaattt gatactattg acaaacttta atttttattt ttcatgatgt ttatgtgaat 6780 agcataaaca tcgtttttat ttttatggtg tttaggttaa atacctaaac atcattttac 6840 atttttaaaa ttaagttcta aagttatctt ttgtttaaat ttgcctgtct ttataaatta 6900 cgatgtgcca gaaaaataaa atcttagctt tttattatag aatttatctt tatgtattat 6960 attttataag ttataataaa agaaatagta acatactaaa gcggatgtag cgcgtttatc 7020 ttaacggaag gaattcggcg cctacgtacc cgggtcgcga ggatccacgc gttaatagct 7080 cacttttctt taaatttaat ttttaattta aaggtgtaag caaattgcct gacgagagat 7140 ccacttaaag gatgacagtg gcgggctact gcctacttcc ctccgggata aaatttattt 7200 gaaaaacgtt agttacttcc taacggagca ttgacatccc catatttata ttaggacgtc 7260 cccttcgggt aaataaattt tagtggacgt ccccttcggg caaataaatt ttagtggaca 7320 ataaataaat ttgttgcctg ccaactgcct aggcaagtaa acttgggagt attaaaatag 7380 gacgtcagtg gcagttgcct gccaactgcc tatatttata tactgcgaag caggcagtgg 7440 cggtaccact gccactggcg tcctaatata aatattgggc aactaaagtt tatagcagta 7500 ttaacatcct atatttatat actccgaagg aacttgttag ccgataggcg aggcaacaaa 7560 tttatttatt gtcccgtaaa aggatgcctc cagcatcgaa ggggaagggg acgtcctagg 7620 ccataaaact aaagggaaat ccatagtaac tgatgttata aatttataga ctccaaaaaa 7680 cagctgcgtt ataaataact tctgttaaat atggccaagg ggacaggggc actttcaact 7740 aagtgtacat taaaaattga caattcaatt ttttttaatt ataatatata tttagtaaaa 7800 tataacaaaa agcccccatc gtctaggtag aattccagct ggcggccgcc ctatg 7855 SEQ ID NO. 5 <211> 8458 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 5 tcgtgtagat aactacgata cgggagggct taccatctgg ccccagtgct gcaatgatac 60 cgcgagaccc acgctcaccg gctccagatt tatcagcaat aaaccagcca gccggaaggg 120 ccgagcgcag aagtggtcct gcaactttat ccgcctccat ccagtctatt aattgttgcc 180 gggaagctag agtaagtagt tcgccagtta atagtttgcg caacgttgtt gccattgcta 240 caggcatcgt ggtgtcacgc tcgtcgtttg gtatggcttc attcagctcc ggttcccaac 300 gatcaaggcg agttacatga tcccccatgt tgtgcaaaaa agcggttagc tccttcggtc 360 ctccgatcgt tgtcagaagt aagttggccg cagtgttatc actcatggtt atggcagcac 420 tgcataattc tcttactgtc atgccatccg taagatgctt ttctgtgact ggtgagtact 480 caaccaagtc attctgagaa tagtgtatgc ggcgaccgag ttgctcttgc ccggcgtcaa 540 tacgggataa taccgcgcca catagcagaa ctttaaaagt gctcatcatt ggaaaacgtt 600 cttcggggcg aaaactctca aggatcttac cgctgttgag atccagttcg atgtaaccca 660 ctcgtgcacc caactgatct tcagcatctt ttactttcac cagcgtttct gggtgagcaa 720 aaacaggaag gcaaaatgcc gcaaaaaagg gaataagggc gacacggaaa tgttgaatac 780 tcatactctt cctttttcaa tattattgaa gcatttatca gggttattgt ctcatgagcg 840 gatacatatt tgaatgtatt tagaaaaata aacaaatagg ggttccgcgc acatttcccc 900 gaaaagtgcc acctgacgtc taagaaacca ttattatcat gacattaacc tataaaaata 960 ggcgtatcac gaggcccttt cgtctcgcgc gtttcggtga tgacggtgaa aacctctgac 1020 acatgcagct cccggagacg gtcacagctt gtctgtaagc ggatgccggg agcagacaag 1080 cccgtcaggg cgcgtcagcg ggtgttggcg ggtgtcgggg ctggcttaac tatgcggcat 1140 cagagcagat tgtactgaga gtgcaccata gggcggccgc ggcgcgccgt tccggatctg 1200 catcctgcga tgcagatccg gaacataatg gtgcagggcg ctgacttccg cgtttccaga 1260 ctttacgaaa cacggaaacc gaagaccatt catgttgttg ctcaggtcgc agacgttttg 1320 cagcagcagt cgcttcacgt tcgctcgcgt atcggtgatt cattctgcta accagtaagg 1380 caaccccgcc agcctagccg ggtcctcaac gacaggagca cgatcatgcg cacccgtggc 1440 caggacccaa cgctgcccga gatgcgccgc gtgcggctgc tggagatggc ggacgcgatg 1500 gatatgttct gccaagggtt ggtttgcgca ttcacagttc tccgcaagaa ttgattggct 1560 ccaattcttg gagtggtgaa tccgttagcg aggtgccgcc ggcttccatt caggtcgagg 1620 tggcccggct ccatgcaccg cgacgcaacg cggggaggca gacaaggtat agggcggcgc 1680 ctacaatcca tgccaacccg ttccatgtgc tcgccgaggc ggcataaatc gccgtgacga 1740 tcagcggtcc aatgatcgaa gttaggctgg taagagccgc gagcgatcct tgaagctgtc 1800 cctgatggtc gtcatctacc tgcctggaca gcatggcctg caacgcgggc atcccgatgc 1860 cgccggaagc gagaagaatc ataatgggga aggccatcca gcctcgcgtc gcgaacgcca 1920 gcaagacgta gcccagcgcg tcggccgcca tgccggcgat aatggcctgc ttctcgccga 1980 aacgtttggt ggcgggacca gtgacgaagg cttgagcgag ggcgtgcaag attccgaata 2040 ccgcaagcga caggccgatc atcgtcgcgc tccagcgaaa gcggtcctcg ccgaaaatga 2100 cccagagcgc tgccggcacc tgtcctacga gttgcatgat aaagaagaca gtcataagtg 2160 cggcgacgat agtcatgccc cgcgcccacc ggaaggagct gactgggttg aaggctctca 2220 agggcatcgg tcgagcttga cattgtagga cgtttaaaca ttaccctgtt atccctagga 2280 tcctacgtaa tcgatgaatt cgatcccatt tttataactg gatctcaaaa tacctataaa 2340 cccattgttc ttctctttta gctctaagaa caatcaattt ataaatatat ttattattat 2400 gctataatat aaatactata taaatacatt taccttttta taaatacatt tacctttttt 2460 ttaatttgca tgattttaat gcttatgcta tcttttttat ttagtccata aaacctttaa 2520 aggacctttt cttatgggat atttatattt tcctaacaaa gcaatcggcg tcataaactt 2580 tagttgctta cgacgcctgt ggacgtcccc cccttcccct tacgggcaag taaacttagg 2640 gattttaatg caataaataa atttgtcctc ttcgggcaaa tgaattttag tatttaaata 2700 tgacaagggt gaaccattac ttttgttaac aagtgatctt accactcact atttttgttg 2760 aattttaaac ttatttaaaa ttctcgagaa agattttaaa aataaacttt tttaatcttt 2820 tatttatttt ttcttttttc gtatggaatt gcccaatatt attcaacaat ttatcggaaa 2880 cagcgtttta gagccaaata aaattggtca gtcgccatcg gatgtttatt cttttaatcg 2940 aaataatgaa actttttttc ttaagcgatc tagcacttta tatacagaga ccacatacag 3000 tgtctctcgt gaagcgaaaa tgttgagttg gctctctgag aaattaaagg tgcctgaact 3060 catcatgact tttcaggatg agcagtttga atttatgatc actaaagcga tcaatgcaaa 3120 accaatttca gcgctttttt taacagacca agaattgctt gctatctata aggaggcact 3180 caatctgtta aattcaattg ctattattga ttgtccattt atttcaaaca ttgatcatcg 3240 gttaaaagag tcaaaatttt ttattgataa ccaactcctt gacgatatag atcaagatga 3300 ttttgacact gaattatggg gagaccataa aacttaccta agtctatgga atgagttaac 3360 cgagactcgt gttgaagaaa gattggtttt ttctcatggc gatatcacgg atagtaatat 3420 ttttatagat aaattcaatg aaatttattt tttagacctt ggtcgtgctg ggttagcaga 3480 tgaatttgta gatatatcct ttgttgaacg ttgcctaaga gaggatgcat cggaggaaac 3540 tgcgaaaata tttttaaagc atttaaaaaa tgatagacct gacaaaagga attatttttt 3600 aaaacttgat gaattgaatt gattccaagc attatctaaa atactctgca ggcacgctag 3660 cttgtactca agctcgtaac gaaggtcgtg accttgctcg tgaaggtggc gacgtaattc 3720 gttcagcttg taaatggtct ccagaacttg ctgctgcatg tgaagtttgg aaagaaatta 3780 aattcgaatt tgatactatt gacaaacttt aatttttatt tttcatgatg tttatgtgaa 3840 tagcataaac atcgttttta tttttatggt gtttaggtta aatacctaaa catcatttta 3900 catttttaaa attaagttct aaagttatct tttgtttaaa tttgcctgtc tttataaatt 3960 acgatgtgcc agaaaaataa aatcttagct ttttattata gaatttatct ttatgtatta 4020 tattttataa gttataataa aagaaatagt aacatactaa agcggatgta gcgcgtttat 4080 cttaacggaa ggaattcggc gcctacgtat acatactccg aaggaggaca aatttattta 4140 ttgtggtaca ataaataagt ggtacaataa ataaattgta tgtaaacccc ttccccttcg 4200 ggacgtcccc ttacgggaat ataaatatta gtggcagttg cctgccaaca aatttattta 4260 ttgtattaac ataggcagtg gcggtaccac tgccactggc gtcctaatat aaatattggg 4320 caactaaagt ttatcgcagt attaacatag gcagtggcgg taccactgcc actggcgtcc 4380 tccttcggag tatgtaaacc tgctaccgca gcaaataaat tttattctat tttaatacta 4440 caatatttag attcccgtta ggggataggc caggcaattg tcactggcgt catagtatat 4500 caatattgta acagattgac accctttaag taaacatttt ttttaggatt catatgaaat 4560 taaatggata tttggtacat ttaattccac aaaaatgtcc aatacttaaa atacaaaatt 4620 aaaagtatta gttgtaaact tgactaacat tttaaatttt aaattttttc ctaattatat 4680 attttacttg caaaatttat aaaaatttta tgcattttta tatcataata ataaaacctt 4740 tattcatggt ttataatata ataattgtga tgactatgca caaagcagtt ctagtcccat 4800 atatataact atatataacc cgtttaaaga tttatttaaa aatatgtgtg taaaaaatgc 4860 ttatttttaa ttttatttta tataagttat aatattaaat acacaatgat taaaattaaa 4920 taataataaa tttaacgtaa cgatgagttg tttttttatt ttggagatac acgcaatgac 4980 aattgcgatc ggtacatatc aagagaaacg cacatggttc gatgacgctg atgactggct 5040 tcgtcaagac cgtttcgtat tcgtaggttg gtcaggttta ttactattcc cttgtgctta 5100 ctttgcaact ccggtccggc ggccgcctcg agacgacttg tccgcttcat cagacacggc 5160 tttcctaacc atcaatggtg gattttcagg aaagacgttt aaagaagtgg cataaagttt 5220 atttgttgaa gaattggttt tgtttccatt caaagaattg ttagggataa aactttgcat 5280 ttttttataa tttgttataa gtttttcaaa cttatatgtt tttaaaaatg catttaattg 5340 cttattaatg cgttcatttt gtaatgtttc aataggtctt gcttgcgcta atcgcagtat 5400 tcccgatact ttgtctgctt gtttttcggg tattgagaat aagtaagtat aatgatttaa 5460 aaaagtcatg ttttgattaa atctttttta tatggttaaa aacattatgg tatatctaaa 5520 taaatttatt ttttactaaa tctccaattt gcaatttaga gatataatta aaactataaa 5580 gttatttaag ttaatttgta atcaaatcca acacaaaaat gtttttatat agttaacatg 5640 ttaaatttaa catatgttaa acaactaaaa ttctgtaaca gagaacaata aaataaatgc 5700 tagattttgt gtaatgccga agtatattta tatacttccc tttcaaaaaa ataaatactc 5760 ttgccactaa aattcatttg cctaggacgt ccccttcccc ttacgggatg tttatatact 5820 aggacgtccc cttcccctta cgggatattt atatactccg aaggacgtcc ccttcgggca 5880 aataaatttt agtggcagtt gcctgccaac tgcctaggca agtaaactta gggattttaa 5940 tgcaataaat aaatttgtcc ccttacggga cgtcagtggc agttgcctgc caactgccta 6000 atataaatat tagtggatat ttatatactc cgaaggaggc agttacctgc caactgccga 6060 ggcaaataaa ttttagtggc agtggtaccg ccactgcctg ctccctcctt ccccttcggg 6120 caagtaaact tagcatgttg tcgacattac cctgttatcc ctaggccggc ctaagaaacc 6180 attattatca tgacattaac ctataaaaat aggcgtatca cgaggccctt tcgtcttcaa 6240 gaaattcggt cgaaaaaaga aaaggagagg gccaagaggg agggcattgg tgactattga 6300 gcacgtgagt atacgtgatt aagcacacaa aggcagcttg gagtatgtct gttattaatt 6360 tcacaggtag ttctggtcca ttggtgaaag tttgcggctt gcagagcaca gaggccgcag 6420 aatgtgctct agattccgat gctgacttgc tgggtattat atgtgtgccc aatagaaaga 6480 gaacaattga cccggttatt gcaaggaaaa tttcaagtct tgtaaaagca tataaaaata 6540 gttcaggcac tccgaaatac ttggttggcg tgtttcgtaa tcaacctaag gaggatgttt 6600 tggctctggt caatgattac ggcattgata tcgtccaact gcatggagat gagtcgtggc 6660 aagaatacca agagttcctc ggtttgccag ttattaaaag actcgtattt ccaaaagact 6720 gcaacatact actcagtgca gcttcacaga aacctcattc gtttattccc ttgtttgatt 6780 cagaagcagg tgggacaggt gaacttttgg attggaactc gatttctgac tgggttggaa 6840 ggcaagagag ccccgaaagc ttacatttta tgttagctgg tggactgacg ccagaaaatg 6900 ttggtgatgc gcttagatta aatggcgtta ttggtgttga tgtaagcgga ggtgtggaga 6960 caaatggtgt aaaagactct aacaaaatag caaatttcgt caaaaatgct aagaaatagg 7020 ttattactga gtagtattta tttaagtatt gtttgtgcac ttgcctgcag gccttttgaa 7080 aagcaagcat aaaagatcta aacataaaat ctgtaaaata acaagatgta aagataatgc 7140 taaatcattt ggctttttga ttgattgtac aggaaaatat acatcgttaa ttaagcggcc 7200 gcgagcttgg cgtaatcatg gtcatagctg tttcctgtgt gaaattgtta tccgctcaca 7260 attccacaca acatacgagc cggaagcata aagtgtaaag cctggggtgc ctaatgagtg 7320 agctaactca cattaattgc gttgcgctca ctgcccgctt tccagtcggg aaacctgtcg 7380 tgccagctgc attaatgaat cggccaacgc gcggggagag gcggtttgcg tattgggcgc 7440 tcttccgctt cctcgctcac tgactcgctg cgctcggtcg ttcggctgcg gcgagcggta 7500 tcagctcact caaaggcggt aatacggtta tccacagaat caggggataa cgcaggaaag 7560 aacatgtgag caaaaggcca gcaaaaggcc aggaaccgta aaaaggccgc gttgctggcg 7620 tttttccata ggctccgccc ccctgacgag catcacaaaa atcgacgctc aagtcagagg 7680 tggcgaaacc cgacaggact ataaagatac caggcgtttc cccctggaag ctccctcgtg 7740 cgctctcctg ttccgaccct gccgcttacc ggatacctgt ccgcctttct cccttcggga 7800 agcgtggcgc tttctcatag ctcacgctgt aggtatctca gttcggtgta ggtcgttcgc 7860 tccaagctgg gctgtgtgca cgaacccccc gttcagcccg accgctgcgc cttatccggt 7920 aactatcgtc ttgagtccaa cccggtaaga cacgacttat cgccactggc agcagccact 7980 ggtaacagga ttagcagagc gaggtatgta ggcggtgcta cagagttctt gaagtggtgg 8040 cctaactacg gctacactag aagaacagta tttggtatct gcgctctgct gaagccagtt 8100 accttcggaa aaagagttgg tagctcttga tccggcaaac aaaccaccgc tggtagcggt 8160 ggtttttttg tttgcaagca gcagattacg cgcagaaaaa aaggatctca agaagatcct 8220 ttgatctttt ctacggggtc tgacgctcag tggaacgaaa actcacgtta agggattttg 8280 gtcatgagat tatcaaaaag gatcttcacc tagatccttt taaattaaaa atgaagtttt 8340 aaatcaatct aaagtatata tgagtaaact tggtctgaca gttaccaatg cttaatcagt 8400 gaggcaccta tctcagcgat ctgtctattt cgttcatcca tagttgcctg actccccg 8458 SEQ ID NO. 6 211> 22908 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 6 tgaatttatc agatctaact gaggagtaag aaacccccat gtcaaagaaa aacagaccaa 60 caattgggcg aacccttaat ccttcaatat taagcggatt tgatagttct tcagcctctg 120 gcgatcgagt cgagcaggta ttcaagttat caactggtcg ccaggccaca tttattgaag 180 aggtaatacc tccgaaccag gtagaaagcg atacctttgt tgatcagcat aacaacgggc 240 gtgaccaggc atctcttacg ccaaaatcat taaaaagtat ccgaagcact attaagcatc 300 agcaatttta ccctgcaata ggtgttagac gggctacagg gaaaattgaa attttggatg 360 gttcccggcg tcgagcttct gccatcttag agaacgtagg gttgcgggtt ttagtcacgg 420 accaggagat cagcgttcag gaagcgcaaa atttagcgaa agacgttcag acagcattgc 480 agcacagcat tcgagaaata ggtctgcgtt tgatgcgaat gaaaaatgat gggatgagtc 540 agaaggatat tgcagccaaa gaagggctgt ctcaggcgaa ggtcacgcgt gctctccagg 600 cagcgagtgc tccggaagaa ttagtcgccc ttttccctgt gcagtcggaa ttaacctttt 660 cggactacaa aacgctttgt gctgttggcg acgaaatggg gaacaagaat ttagagtttg 720 atcagcttat tcaaaacata tccccggaaa taaacgacat cttatccatt gaagaaatgg 780 ccgaagatga agttaaaaat aaaatcctgc gcttgataac aaaggaagcc tcactactca 840 cggataaagg ttctaaagat aagtccgtag ttactgaatt atggaaattt gaggacaagg 900 atcgctttgc aaggaagcgc gtgaaaggcc gtgcattttc ttatgagttt aatcgactct 960 caaaagagtt acaggaagaa ctcgacagga tgattgggca tatccttaga aagagcctcg 1020 ataaaaagcc gaagccttaa actttcgcca ttcaaatttc actattaact gactgttttt 1080 aaagtaaatt actctaaaat ttcaaggtga aatcgccacg atttcacctt ggattttacc 1140 ttcctcccct cctcccgaaa aaaataaaaa aattgcttgt cacgagaaag tcaacaagtg 1200 actttcaata aaatctcttc cgaaaaggga ttcacacaag tgccttgtgt ttaaggaaga 1260 gtaaattgag taacttacgc gaataccaga atcgtattgc agatatcgca aaacgctcta 1320 aagctgtgct tggctgggca agcactgcgc agttcggtac tgataaccaa ttcattaaag 1380 atgatgccgc gcgtgccgca tctatccttg aagctgcacg taaagacccg gtttttgcgg 1440 gtatctctga taatgccacc gctcaaatcg ctacagcgtg ggcaagtgca ctggctgact 1500 acgccgcagc acataaatct atgccgcgtc cggaaattct ggcctcctgc caccagacgc 1560 tggaaaactg cctgatagag tccacccgca atagcatgga tgccactaat aaagcgatgc 1620 tggaatctgt cgcagcagag atgatgagcg tttctgacgg tgttatgcgt ctgcctttat 1680 tcctcgcgat gatcctgcct gttcagttgg gggcagctac cgctgatgcg tgtaccttca 1740 ttccggttac gcgtgaccag tccgacatct atgaagtctt taacgtggca ggttcatctt 1800 ttggttctta tgctgctggt gatgttctgg acatgcaatc cgtcggtgtg tacagccagt 1860 tacgtcgccg ctatgtgctg gtggcaagct ccgatggcac cagcaaaacc gcaaccttca 1920 agatggaaga cttcgaaggc cagaatgtac caatccgaaa aggtcgcact aacatctacg 1980 ttaaccgtat taagtctgtt gttgataacg gttccggcag cctacttcac tcgtttacta 2040 atgctgctgg tgagcaaatc actgttacct gctctctgaa ctacaacatt ggtcagattg 2100 ccctgtcgtt ctccaaagcg ccggataaag gcactgagat cgcaattgag acggaaatca 2160 atattgaagc cgctcctgag ctgatcccgc tgatcaacca cgaaatgaag aaatacaccc 2220 tgttcccaag tcagttcgtt atcgcggctg agcacacggt acaggcggcg tatgaagcac 2280 agcgtgaatt tggtctggac ctgggttccc tacagttccg caccctgaag gaatacctgt 2340 ctcatgaaca ggatatgctg cgtcttcgca tcatgatctg gcgcactctt gcgaccgaca 2400 cctttgacat cgctctgccg gttaaccagt cctttgatgt atgggcaacc atcattcgtg 2460 gcaaattcca gactgtatat cgcgacatta ttgagcgcgt taaatcttct ggtgcgatgg 2520 ggatgtttgc tggtgctgat gcagcatctt tcttcaaaca gttgccgaag gatttcttcc 2580 agccagccga agactatatc cagactccgt atgttcacta catcggtacc ccatttagga 2640 ccacccacag cacctaacaa aacggcatca gccttcttgg aggcttccag cgcctcatct 2700 ggaagtggaa cacctgtagc atcgacctgc aggggggggg gggcgctgag gtctgcctcg 2760 tgaagaaggt gttgctgact cataccaggc ctgaatcgcc ccatcatcca gccagaaagt 2820 gagggagcca cggttgatga gagctttgtt gtaggtggac cagttggtga ttttgaactt 2880 ttgctttgcc acggaacggt ctgcgttgtc gggaagatgc gtgatctgat ccttcaactc 2940 agcaaaagtt cgatttattc aacaaagccg ccgtcccgtc aagtcagcgt aatgctctgc 3000 cagtgttaca accaattaac caattctgat tagaaaaact catcgagcat caaatgaaac 3060 tgcaatttat tcatatcagg attatcaata ccatattttt gaaaaagccg tttctgtaat 3120 gaaggagaaa actcaccgag gcagttccat aggatggcaa gatcctggta tcggtctgcg 3180 attccgactc gtccaacatc aatacaacct attaatttcc cctcgtcaaa aataaggtta 3240 tcaagtgaga aatcaccatg agtgacgact gaatccggtg agaatggcaa aagcttatgc 3300 atttctttcc agacttgttc aacaggccag ccattacgct cgtcatcaaa atcactcgca 3360 tcaaccaaac cgttattcat tcgtgattgc gcctgagcga gacgaaatac gcgatcgctg 3420 ttaaaaggac aattacaaac aggaatcgaa tgcaaccggc gcaggaacac tgccagcgca 3480 tcaacaatat tttcacctga atcaggatat tcttctaata cctggaatgc tgttttcccg 3540 gggatcgcag tggtgagtaa ccatgcatca tcaggagtac ggataaaatg cttgatggtc 3600 ggaagaggca taaattccgt cagccagttt agtctgacca tctcatctgt aacatcattg 3660 gcaacgctac ctttgccatg tttcagaaac aactctggcg catcgggctt cccatacaat 3720 cgatagattg tcgcacctga ttgcccgaca ttatcgcgag cccatttata cccatataaa 3780 tcagcatcca tgttggaatt taatcgcggc ctcgagcaag acgtttcccg ttgaatatgg 3840 ctcataacac cccttgtatt actgtttatg taagcagaca gttttattgt tcatgatgat 3900 atatttttat cttgtgcaat gtaacatcag agattttgag acacaacgtg gctttccccc 3960 ccccccctgc aggtcgatag cagcaccacc aattaaatga ttttcgaaat cgaacttgac 4020 attggaacga acatcagaaa tagctttaag aaccttaatg gcttcggctg tgatttcttg 4080 accaacgtgg tcacctggca aaacgacgat cttcttaggg gcagacatta gaatggtata 4140 tccttgaaat atatatatat attgctgaaa tgtaaaaggt aagaaaagtt agaaagtaag 4200 acgattgcta accacctatt ggaaaaaaca ataggtcctt aaataatatt gtcaacttca 4260 agtattgtga tgcaagcatt tagtcatgaa cgcttctcta ttctatatga aaagccggtt 4320 ccggcgctct cacctttcct ttttctccca atttttcagt tgaaaaaggt atatgcgtca 4380 ggcgacctct gaaattaaca aaaaatttcc agtcatcgaa tttgattctg tgcgatagcg 4440 cccctgtgtg ttctcgttat gttgaggaaa aaaataatgg ttgctaagag attcgaactc 4500 ttgcatctta cgatacctga gtattcccac agttaactgc ggtcaagata tttcttgaat 4560 caggcgcctt agaccgctcg gccaaacaac caattacttg ttgagaaata gagtataatt 4620 atcctataaa tataacgttt ttgaacacac atgaacaagg aagtacagga caattgattt 4680 tgaagagaat gtggattttg atgtaattgt tgggattcca tttttaataa ggcaataata 4740 ttaggtatgt agatatacta gaagttctcc tcgacgctct cccttatgcg actcctgcat 4800 taggaagcag cccagtagta ggttgaggcc gttgagcacc gccgccgcaa ggaatggtgc 4860 atgcaaggag atggcgccca acagtccccc ggccacgggg cctgccacca tacccacgcc 4920 gaaacaagcg ctcatgagcc cgaagtggcg agcccgatct tccccatcgg tgatgtcggc 4980 gatataggcg ccagcaaccg cacctgtggc gccggtgatg ccggccacga tgcgtccggc 5040 gtagaggatc tacaactcca cttattgtta ggtagaattg tccgttagtt gtttattaat 5100 tgcaataatg gggcgtccag ttttggcaac agtgtcctct taccaggaca cctatgagtt 5160 tgcctcatgg caaactagag gtgttgaaag tatgcatggt tataattaga gcaattcatt 5220 accctctgaa tcctgccggt ataccccatt gttcgttatc tttatttttg gctaaaaccg 5280 cattaagagc ttcgtttacc gtcatgcaat gcggtaggtt atcgaagttt gatatcccgc 5340 caatatcagg cgaacgcttg ttcttcaggt aagcatattt ccgcgcagcc gcctctactt 5400 tctgcttgaa ctcatgtttt tgagtgcgtt ttttggataa ccgcagattg tcagcctttg 5460 cttttgcctt agcgatccat gaagtcaatt ttttgaggct ggttgttccg gcaccgccgg 5520 aaactgatct ttttgttttt ttaacttgtg acttcttatt ctttattgcc acgtcatcct 5580 gacaggggga gggggtatca ttttgacatg ggggtgtgga taaaaaatta aataaagcca 5640 atgtcttagc gagaacagct ttaaccttgg ttgccgctga agagatcttt aatttgcttt 5700 ctatcagcgc atttttggct tgttgtgcga aggccaaaaa ggatggtgta aaccggtaca 5760 ggttagcgcg acgttcacgg tgatcgccga taacaatctc tacagacaga attcctttgt 5820 ttacagcttc acggaatgca cgaacgacgg ttgattggct ataaccagtt tctgccgcga 5880 tcaggcggtg aggcttgtga atgaagtatt cactggttgt tgccgcgaga tttgcacatt 5940 gcgacaggat atgcccggcg ctacgggata gaccggagtg tgttacaaag caggccaatt 6000 catagccaga aaaagtaaaa tcgctcatcg ttatacagct caggaaagtg actttagcca 6060 gcattacaat gctggtggtt cttactacgt ctgttagcgc gttgccgcga caggtaccag 6120 cacaccagca tcaagcaatc gcttcatcag ccactgctga cctttgccgg ttatacgagt 6180 cgtgaaagaa atcctgcttc cattgcttgt atcgatcacg gtttctttaa gggtgaaata 6240 cccacgagat atgtattctt gtttggggac gttcctgcgt tcaccggttg cgatcagaat 6300 tccgttatca cgcaaccagg tgaagagata gttttggccc aggccgagca ctttggcata 6360 gttgccgatt agaaccccgc tggcggtagc aacgcgttca gcgaattcga ctttaggtgc 6420 atccataagc attttttgct ccagccgttg cttttgctct gccaggtcgg cagccaaacg 6480 gagagcttca gggagactct gcggaatagc aggttgtaat cttccggttc gatagtcgat 6540 aaatgtctgg tttaccttca gccgaaacgc gggagaaatc cagcctgcgt actccacagc 6600 gagcaattca tgggcaaaag tgccgccgcc acggccttcg acctgcaggc atgcaagctt 6660 ggcgtaatca tggtcatagc tgtttcctgt gtgaaattgt tatccgctca caattccaca 6720 caacatacga gccggaagca taaagtgtaa agcctggggt gcctaatgag tgagctaact 6780 cacattaatt gcgttgcgct cactgcccgc tttccagtcg ggaaacctgt cgtgccaggt 6840 agtcgatatg gtgcactctc agtacaatct gctctgatgc cgcatagtta agccagtata 6900 cactccgcta tcgctacgtg actgggtcat ggctgcgccc cgacacccgc caacacccgc 6960 tgacgcgccc tgacgggctt gtctgctccc ggcatccgct tacagacaag ctgtgaccgt 7020 ctccgggagc tgcatgtgtc agaggttttc accgtcatca ccgaaacgcg cgaggcagct 7080 gcggtaaagc tcatcagcgt ggtcgtgaag cgattcacag atgtctgcct gttcatccgc 7140 gtccagctcg ttgagtttct ccagaagcgt taatgtctgg cttctgataa agcgggccat 7200 gttaagggcg gttttttcct gtttggtcac tgatgcctcc gtgtaagggg gatttctgtt 7260 catgggggta atgataccga tgaaacgaga gaggatgctc acgatacggg ttactgatga 7320 tgaacatgcc cggttactgg aacgttgtga gggtaaacaa ctggcggtat ggatgcggcg 7380 ggaccagaga aaaatcactc agggtcaatg ccagcgcttc gttaatacag atgtaggtgt 7440 tccacagggt agccagcagc atcctgcgat gcagatccgg aacataatgg tgcagggcgc 7500 tgacttccgc gtttccagac tttacgaaac acggaaaccg aagaccattc atgttgttgc 7560 tcaggtcgca gacgttttgc agcagcagtc gcttcacgtt cgctcgcgta tcggtgattc 7620 attctgctaa ccagtaaggc aaccccgcca gcctagccgg gtcctcaacg acaggagcac 7680 gatcatgcgc acccgtggcc aggacccaac gctgcccgag atgcgccgcg tgcggctgct 7740 ggagatggcg gacgcgatgg atatgttctg ccaagggttg gtttgcgcat tcacagttct 7800 ccgcaagaat tgattggctc caattcttgg agtggtgaat ccgttagcga ggtgccgccg 7860 gcttccattc aggtcgaggt ggcccggctc catgcaccgc gacgcaacgc ggggaggcag 7920 acaaggtata gggcggcgcc tacaatccat gccaacccgt tccatgtgct cgccgaggcg 7980 gcataaatcg ccgtgacgat cagcggtcca atgatcgaag ttaggctggt aagagccgcg 8040 agcgatcctt gaagctgtcc ctgatggtcg tcatctacct gcctggacag catggcctgc 8100 aacgcgggca tcccgatgcc gccggaagcg agaagaatca taatggggaa ggccatccag 8160 cctcgcgtcg cgaacgccag caagacgtag cccagcgcgt cggccgccat gccggcgata 8220 atggcctgct tctcgccgaa acgtttggtg gcgggaccag tgacgaaggc ttgagcgagg 8280 gcgtgcaaga ttccgaatac cgcaagcgac aggccgatca tcgtcgcgct ccagcgaaag 8340 cggtcctcgc cgaaaatgac ccagagcgct gccggcacct gtcctacgag ttgcatgata 8400 aagaagacag tcataagtgc ggcgacgata gtcatgcccc gcgcccaccg gaaggagctg 8460 actgggttga ggctctcaag ggcatcggtc gagcttgaca ttgtaggacg tttaaacatt 8520 accctgttat ccctaggatc ctacgtaatc gatgaattcg atcccatttt tataactgga 8580 tctcaaaata cctataaacc cattgttctt ctcttttagc tctaagaaca atcaatttat 8640 aaatatattt attattatgc tataatataa atactatata aatacattta cctttttata 8700 aatacattta cctttttttt aatttgcatg attttaatgc ttatgctatc ttttttattt 8760 agtccataaa acctttaaag gaccttttct tatgggatat ttatattttc ctaacaaagc 8820 aatcggcgtc ataaacttta gttgcttacg acgcctgtgg acgtcccccc cttcccctta 8880 cgggcaagta aacttaggga ttttaatgca ataaataaat ttgtcctctt cgggcaaatg 8940 aattttagta tttaaatatg acaagggtga accattactt ttgttaacaa gtgatcttac 9000 cactcactat ttttgttgaa ttttaaactt atttaaaatt ctcgagaaag attttaaaaa 9060 taaacttttt taatctttta tttatttttt cttttttcgt atggaattgc ccaatattat 9120 tcaacaattt atcggaaaca gcgttttaga gccaaataaa attggtcagt cgccatcgga 9180 tgtttattct tttaatcgaa ataatgaaac tttttttctt aagcgatcta gcactttata 9240 tacagagacc acatacagtg tctctcgtga agcgaaaatg ttgagttggc tctctgagaa 9300 attaaaggtg cctgaactca tcatgacttt tcaggatgag cagtttgaat ttatgatcac 9360 taaagcgatc aatgcaaaac caatttcagc gcttttttta acagaccaag aattgcttgc 9420 tatctataag gaggcactca atctgttaaa ttcaattgct attattgatt gtccatttat 9480 ttcaaacatt gatcatcggt taaaagagtc aaaatttttt attgataacc aactccttga 9540 cgatatagat caagatgatt ttgacactga attatgggga gaccataaaa cttacctaag 9600 tctatggaat gagttaaccg agactcgtgt tgaagaaaga ttggtttttt ctcatggcga 9660 tatcacggat agtaatattt ttatagataa attcaatgaa atttattttt tagaccttgg 9720 tcgtgctggg ttagcagatg aatttgtaga tatatccttt gttgaacgtt gcctaagaga 9780 ggatgcatcg gaggaaactg cgaaaatatt tttaaagcat ttaaaaaatg atagacctga 9840 caaaaggaat tattttttaa aacttgatga attgaattga ttccaagcat tatctaaaat 9900 actctgcagg cacgctagct tgtactcaag ctcgtaacga aggtcgtgac cttgctcgtg 9960 aaggtggcga cgtaattcgt tcagcttgta aatggtctcc agaacttgct gctgcatgtg 10020 aagtttggaa agaaattaaa ttcgaatttg atactattga caaactttaa tttttatttt 10080 tcatgatgtt tatgtgaata gcataaacat cgtttttatt tttatggtgt ttaggttaaa 10140 tacctaaaca tcattttaca tttttaaaat taagttctaa agttatcttt tgtttaaatt 10200 tgcctgtctt tataaattac gatgtgccag aaaaataaaa tcttagcttt ttattataga 10260 atttatcttt atgtattata ttttataagt tataataaaa gaaatagtaa catactaaag 10320 cggatgtagc gcgtttatct taacggaagg aattcggcgc ctacgtatac atactccgaa 10380 ggaggacaaa tttatttatt gtggtacaat aaataagtgg tacaataaat aaattgtatg 10440 taaacccctt ccccttcggg acgtcccctt acgggaatat aaatattagt ggcagttgcc 10500 tgccaacaaa tttatttatt gtattaacat aggcagtggc ggtaccactg ccactggcgt 10560 cctaatataa atattgggca actaaagttt atcgcagtat taacataggc agtggcggta 10620 ccactgccac tggcgtcctc cttcggagta tgtaaacctg ctaccgcagc aaataaattt 10680 tattctattt taatactaca atatttagat tcccgttagg ggataggcca ggcaattgtc 10740 actggcgtca tagtatatca atattgtaac agattgacac cctttaagta aacatttttt 10800 ttaggattca tatgaaatta aatggatatt tggtacattt aattccacaa aaatgtccaa 10860 tacttaaaat acaaaattaa aagtattagt tgtaaacttg actaacattt taaattttaa 10920 attttttcct aattatatat tttacttgca aaatttataa aaattttatg catttttata 10980 tcataataat aaaaccttta ttcatggttt ataatataat aattgtgatg actatgcaca 11040 aagcagttct agtcccatat atataactat atataacccg tttaaagatt tatttaaaaa 11100 tatgtgtgta aaaaatgctt atttttaatt ttattttata taagttataa tattaaatac 11160 acaatgatta aaattaaata ataataaatt taacgtaacg atgagttgtt tttttatttt 11220 ggagatacac gcaatgacaa ttgcgatcgg tacatatcaa gagaaacgca catggttcga 11280 tgacgctgat gactggcttc gtcaagaccg tttcgtattc gtaggttggt caggtttatt 11340 actattccct tgtgcttact ttgcaactcc ggtccggcgg ccgcctcgag acgacttgtc 11400 cgcttcatca gacacggctt tcctaaccat caatggtgga ttttcaggaa agacgtttaa 11460 agaagtggca taaagtttat ttgttgaaga attggttttg tttccattca aagaattgtt 11520 agggataaaa ctttgcattt ttttataatt tgttataagt ttttcaaact tatatgtttt 11580 taaaaatgca tttaattgct tattaatgcg ttcattttgt aatgtttcaa taggtcttgc 11640 ttgcgctaat cgcagtattc ccgatacttt gtctgcttgt ttttcgggta ttgagaataa 11700 gtaagtataa tgatttaaaa aagtcatgtt ttgattaaat cttttttata tggttaaaaa 11760 cattatggta tatctaaata aatttatttt ttactaaatc tccaatttgc aatttagaga 11820 tataattaaa actataaagt tatttaagtt aatttgtaat caaatccaac acaaaaatgt 11880 ttttatatag ttaacatgtt aaatttaaca tatgttaaac aactaaaatt ctgtaacaga 11940 gaacaataaa ataaatgcta gattttgtgt aatgccgaag tatatttata tacttccctt 12000 tcaaaaaaat aaatactctt gccactaaaa ttcatttgcc taggacgtcc ccttcccctt 12060 acgggatgtt tatatactag gacgtcccct tccccttacg ggatatttat atactccgaa 12120 ggacgtcccc ttcgggcaaa taaattttag tggcagttgc ctgccaactg cctaggcaag 12180 taaacttagg gattttaatg caataaataa atttgtcccc ttacgggacg tcagtggcag 12240 ttgcctgcca actgcctaat ataaatatta gtggatattt atatactccg aaggaggcag 12300 ttacctgcca actgccgagg caaataaatt ttagtggcag tggtaccgcc actgcctgct 12360 ccctccttcc ccttcgggca agtaaactta gcatgttgtc gacattaccc tgttatccct 12420 aggccggcct aagaaaccat tattatcatg acattaacct ataaaaatag gcgtatcacg 12480 aggccctttc gtcttcaaga aattcggtcg aaaaaagaaa aggagagggc caagagggag 12540 ggcattggtg actattgagc acgtgagtat acgtgattaa gcacacaaag gcagcttgga 12600 gtatgtctgt tattaatttc acaggtagtt ctggtccatt ggtgaaagtt tgcggcttgc 12660 agagcacaga ggccgcagaa tgtgctctag attccgatgc tgacttgctg ggtattatat 12720 gtgtgcccaa tagaaagaga acaattgacc cggttattgc aaggaaaatt tcaagtcttg 12780 taaaagcata taaaaatagt tcaggcactc cgaaatactt ggttggcgtg tttcgtaatc 12840 aacctaagga ggatgttttg gctctggtca atgattacgg cattgatatc gtccaactgc 12900 atggagatga gtcgtggcaa gaataccaag agttcctcgg tttgccagtt attaaaagac 12960 tcgtatttcc aaaagactgc aacatactac tcagtgcagc ttcacagaaa cctcattcgt 13020 ttattccctt gtttgattca gaagcaggtg ggacaggtga acttttggat tggaactcga 13080 tttctgactg ggttggaagg caagagagcc ccgaaagctt acattttatg ttagctggtg 13140 gactgacgcc agaaaatgtt ggtgatgcgc ttagattaaa tggcgttatt ggtgttgatg 13200 taagcggagg tgtggagaca aatggtgtaa aagactctaa caaaatagca aatttcgtca 13260 aaaatgctaa gaaataggtt attactgagt agtatttatt taagtattgt ttgtgcactt 13320 gcctgcaggc cttttgaaaa gcaagcataa aagatctaaa cataaaatct gtaaaataac 13380 aagatgtaaa gataatgcta aatcatttgg ctttttgatt gattgtacag gaaaatatac 13440 atcgcagggg gttgactttt accatttcac cgcaatggaa tcaaacttgt tgaagagaat 13500 gttcacaggc gcatacgcta caatgacccg attcttgcta gccttttctc ggtcttgcaa 13560 acaaccgccg gcagcttagt atataaatac acatgtacat acctctctcc gtatcctcgt 13620 aatcattttc ttgtatttat cgtcttttcg ctgtaaaaac tttatcacac ttatctcaaa 13680 tacacttatt aaccgctttt actattatct tctacgctga cagtaatatc aaacagtgac 13740 acatattaaa cacagtggtt tctttgcata aacaccatca gcctcaagtc gtcaagtaaa 13800 gatttcgtgt tcatgcagat agataacaat ctatatgttg ataattagcg ttgcctcatc 13860 aatgcgagat ccgtttaacc ggaccctagt gcacttaccc cacgttcggt ccactgtgtg 13920 ccgaacatgc tccttcacta ttttaacatg tggaattaat tctaaatcct ctttatatga 13980 tctgccgata gatagttcta agtcattgag gttcatcaac aattggattt tctgtttact 14040 cgacttcagg taatgaaatg agatgatact tgcttatctc atagttaact ggcataaatt 14100 ttagtatagg ttaactctaa gaggtgatac ttatttactg taaaactgtg acgataaaac 14160 cggaaggaag aataagaaaa ctcgaactga tctataatgc ctattttctg taaagagttt 14220 aagctatgaa agcctcggca ttttggccgc tcctaggtag tgcttttttt ccaaggacaa 14280 aacagtttct ttttcttgag caggttttat gtttcggtaa tcataaacaa taaataaatt 14340 atttcattta tgtttaaaaa taaaaaataa aaaagtattt taaattttta aaaaagttga 14400 ttataagcat gtgacctttt gcaagcaatt aaattttgca atttgtgatt taggcaaaag 14460 ttactatttc tggctcgtgt aatatatgta tgctaatgtg aacttttaca aagtcgatat 14520 ggacttagtc aaaagaaatt ttcttaaaaa tatatagcac tagccaattt agcacttctt 14580 tatgagatat attatagact ttattaagcc agatttgtgt attatatgta tttacccggc 14640 gaatcatgga catacattct gaaataggta atattctcta tggtgagaca gcatagataa 14700 cctaggatac aagttaaaag ctagtactgt tttgcagtaa tttttttctt ttttataaga 14760 atgttaccac ctaaataagt tataaagtca atagttaagt ttgatatttg attgtaaaat 14820 accgtaatat atttgcatga tcaaaaggct caatgttgac tagccagcat gtcaaccact 14880 atattgatca ccgatattag gacttccaca ccaactagta atatgacaat aaattcaaga 14940 tattcttcat gagaatggcc cagctcatgt ttgacagctt atcatcgata agctttaatg 15000 cggtagttta tcacagttaa attgctaacg cagtcaggca ccgtgtatga aatctaacaa 15060 tgcgctcatc gtcatcctcg gcaccgtcac cctggatgct gtaggcatag gcttggttat 15120 gccggtactg ccgggcctct tgcgggatat cgtccattcc gacagcatcg ccagtcacta 15180 tggcgtgctg ctagcgctat atgcgttgat gcaatttcta tgcgcacccg ttctcggagc 15240 actgtccgac cgctttggcc gccgcccagt cctgctcgct tcgctacttg gagccactat 15300 cgactacgcg atcatggcga ccacacccgt cctgtggatc aattctttag tataaatttc 15360 actctgaacc atcttggaag gaccggataa ttatttgaaa tctctttttc aattgtatat 15420 gtgttatgta gtatactctt tcttcaacaa ttaaatactc tcggtagcca agttggttta 15480 aggcgcaaga ctttaattta tcactacgga attggcctat taggcctacc cactagtcaa 15540 ttcgggagga tcgaaacggc agatcgcaaa aaacagtaca tacagaagga gacatgaaca 15600 tgaacatcaa aaaaattgta aaacaagcca cagttctgac ttttacgact gcacttctgg 15660 caggaggagc gactcaagcc ttcgcgaaag aaaataacca aaaagcatac aaagaaacgt 15720 acggcgtctc tcatattaca cgccatgata tgctgcagat ccctaaacag cagcaaaacg 15780 aaaaatacca agtgcctcaa ttcgatcaat caacgattaa aaatattgag tctgcaaaag 15840 gacttgatgt gtgggacagc tggccgctgc aaaacgctga cggaacagta gctgaataca 15900 acggctatca cgttgtgttt gctcttgcgg gaagcccgaa agacgctgat gacacatcaa 15960 tctacatgtt ttatcaaaag gtcggcgaca actcaatcga cagctggaaa aacgcgggcc 16020 gtgtctttaa agacagcgat aagttcgacg ccaacgatcc gatcctgaaa gatcagacgc 16080 aagaatggtc cggttctgca acctttacat ctgacggaaa aatccgttta ttctacactg 16140 actattccgg taaacattac ggcaaacaaa gcctgacaac agcgcaggta aatgtgtcaa 16200 aatctgatga cacactcaaa atcaacggag tggaagatca caaaacgatt tttgacggag 16260 acggaaaaac atatcagaac gttcagcagt ttatcgatga aggcaattat acatccggcg 16320 acaaccatac gctgagagac cctcactacg ttgaagacaa aggccataaa taccttgtat 16380 tcgaagccaa cacgggaaca gaaaacggat accaaggcga agaatcttta tttaacaaag 16440 cgtactacgg cggcggcacg aacttcttcc gtaaagaaag ccagaagctt cagcagagcg 16500 ctaaaaaacg cgatgctgag ttagcgaacg gcgccctcgg tatcatagag ttaaataatg 16560 attacacatt gaaaaaagta atgaagccgc tgatcacttc aaacacggta actgatgaaa 16620 tcgagcgcgc gaatgttttc aaaatgaacg gcaaatggta cttgttcact gattcacgcg 16680 gttcaaaaat gacgatcgat ggtattaact caaacgatat ttacatgctt ggttatgtat 16740 caaactcttt aaccggccct tacaagccgc tgaacaaaac agggcttgtg ctgcaaatgg 16800 gtcttgatcc aaacgatgtg acattcactt actctcactt cgcagtgccg caagccaaag 16860 gcaacaatgt ggttatcaca agctacatga caaacagagg cttcttcgag gataaaaagg 16920 caacatttgc gccaagcttc ttaatgaaca tcaaaggcaa taaaacatcc gttgtcaaaa 16980 acagcatcct ggagcaagga cagctgacag tcaactaata acagcaaaaa gaaaatgccg 17040 atacttcatt ggcattttct tttatttctc aacaagatgg tgaattgact agtgggtaga 17100 tccacaggac gggtgtggtc gccatgatcg cgtagtcgat agtggctcca agtagcgaag 17160 cgagcaggac tgggcggcgg ccaaagcggt cggacagtgc tccgagaacg ggtgcgcata 17220 gaaattgcat caacgcatat agcgctagca gcacgccata gtgactggcg atgctgtcgg 17280 aatggacgat atcccgcaag aggcccggca gtaccggcat aaccaagcct atgcctacag 17340 catccagggt gacggtgccg aggatgacga tgagcgcatt gttagatttc atacacggtg 17400 cctgactgcg ttagcaattt aactgtgata aactaccgca ttaaagctta tcgatgataa 17460 gctgtcaaac atgagaattg atccggaacc cttaatataa cttcgtataa tgtatgctat 17520 acgaagttat taggtccctc gactacgtcg ttaaggccgt ttctgacaga gtaaaattct 17580 tgagggaact ttcaccatta tgggaaatgg ttcaagaagg tattgactta aactccatca 17640 aatggtcagg tcattgagtg ttttttattt gttgtatttt ttttttttag agaaaatcct 17700 ccaatatata aattaggaat catagtttca tgattttctg ttacacctaa ctttttgtgt 17760 ggtgccctcc tccttgtcaa tattaatgtt aaagtgcaat tctttttcct tatcacgttg 17820 agccattagt atcaatttgc ttacctgtat tcctttacat cctccttttt ctccttcttg 17880 ataaatgtat gtagattgcg tatatagttt cgtctaccct atgaacatat tccattttgt 17940 aatttcgtgt cgtttctatt atgaatttca tttataaagt ttatgtacaa atatcataaa 18000 aaaagagaat ctttttaagc aaggattttc ttaacttctt cggcgacagc atcaccgact 18060 tcggtggtac tgttggaacc acctaaatca ccagttctga tacctgcatc caaaaccttt 18120 ttaactgcat cttcaatggc cttaccttct tcaggcaagt tcaatgacaa tttcaacatc 18180 attgcagcag acaagatagt ggcgataggg ttgaccttat tctttggcaa atctggagca 18240 gaaccgtggc atggttcgta caaaccaaat gcggtgttct tgtctggcaa agaggccaag 18300 gacgcagatg gcaacaaacc caaggaacct gggataacgg aggcttcatc ggagatgata 18360 tcaccaaaca tgttgctggt gattataata ccatttaggt gggttgggtt cttaactagg 18420 atcatggcgg cagaatcaat caattgatgt tgaaccttca atgtagggaa ttcgttcttg 18480 atggtttcct ccacagtttt tctccataat cttgaagagg ccaaaacatt agctttatcc 18540 aaggaccaaa taggcaatgg tggctcatgt tgtagggcca tgaaagcggc cattcttgtg 18600 attctttgca cttctggaac ggtgtattgt tcactatccc aagcgacacc atcaccatcg 18660 tcttcctttc tcttaccaaa gtaaatacct cccactaatt ctctgacaac aacgaagtca 18720 gtacctttag caaattgtgg cttgattgga gataagtcta aaagagagtc ggatgcaaag 18780 ttacatggtc ttaagttggc gtacaattga agttctttac ggatttttag taaaccttgt 18840 tcaggtctaa cactaccggt accgcgcttg cggaagcatc agcaaataag gccagcacag 18900 ccagcgcagt tgccgctttg gttcctgatt ctgttcttga tgaattaaac aaagcggcac 18960 agtaacaaag gacttcattg ataatttttc ttcaggagga agacatgtca ttcttttcta 19020 cgttaaaaac agctttgtct ttgaaggaga aacttgctgc tactggtgtt cttgttctga 19080 tttgcgcact tgttggtgct gggtttgcat gggaacgtca tcagctaaag caagccatag 19140 agaaaattgg cagtcttgat caggctgtta aggaacgtga taagtcaata atggatctta 19200 accagaccat tgagacgatg aacaaagcag agcaacattt tcacagccag gaagtgaaaa 19260 atgaatcaga acaagccaag tatgctgaca ggcaaatgga acgaaaagct gaagttcaga 19320 aacaactggt tgcggcgggt aatgttcgcc agcgtattcc tgctgacact cagcggttgc 19380 tccgggagtc gatcagcgaa tttaacgccg acgccgacaa aggttaacca ccctgccccc 19440 aaaagtgcat ttatgtgtag gatgccagag tttagcagtg aatattttga tgatctgcca 19500 gcgtatatcc tcgatacaga aacgatgctg atggggatta acaggaagaa tcgcaacgtt 19560 aatgattaca accgagctat tagcggtaac taaaagggat ttttatgtct gataaagtaa 19620 cagtaaagca aactatcaac aaagcgactt caatctacaa aattgagcaa atcactgttg 19680 gcaagccagg atctgaacaa taccgtcgtg ctttcgagct tgccgatcag cttggtttaa 19740 aacacccgga ttgcattgag catgtatttc cgacctatgc tgatgagcaa tgtactcatg 19800 ttcttaccga agaggatttt ttcagcactg aagaacgaga aggcgttgat cgctgcattg 19860 gtgtgatttg ttcttcggta agtgatgagt tattccctaa tgtgcctgaa tatggtggta 19920 ttggatacca attcctgtac gagggcgatg agcttaaatg ctatgaacat ggtcttctca 19980 tcgaaagcgt agaataatac gactcccttc caaccggcta cgttggccgg tttttcactt 20040 atccacatta tccactggat agatccaata atcaggtcca tacagatccc aattagatcc 20100 atatagatcc ctgatcgttg caggccgcgc cacgtctggc ttagaagtgt atcgcgatgt 20160 gtgctggagg gaaaacgatg tgtgctggag ggataaaaat gtgtgctgac gggttgctaa 20220 tgtgtgctgg cgggatatag gatgtgtgtt gacgggaaag cttgggtagt tatcaccact 20280 tataaaaact atccacacaa ttcggaaaaa gtaatatgaa tcaatcattt atctccgata 20340 ttctttacgc agacattgaa agtaaggcaa aagaactaac agttaattca aacaacactg 20400 tgcagcctgt agcgttgatg cgcttggggg tattcgtgcc gaagccatca aagagcaaag 20460 gagaaagtaa agagattgat gccaccaaag cgttttccca gctggagata gctaaagccg 20520 agggttacga tgatattaaa atcaccggtc ctcgactcga tatggatact gatttcaaaa 20580 cgtggatcgg tgtcatctac gcgttcagca aatacggctt gtcctcaaac accatccagt 20640 tatcgtttca ggaattcgct aaagcctgtg gtttcccctc aaaacgtctg gatgcgaaac 20700 tgcgtttaac cattcatgaa tcacttggac gcttgcgtaa caagggtatc gcttttaagc 20760 gcggaaaaga tgctaaaggc ggctatcaga ctggtctgct gaaggtcggg cgttttgatg 20820 ctgaccttga tctgatagag ctggaggctg attcgaagtt gtgggagctg ttccagcttg 20880 attatcgcgt tctgttgcaa caccacgcct tgcgtgccct tccgaagaaa gaagctgcac 20940 aagccattta cactttcatc gaaagccttc cgcagaaccc gttgccgcta tcgttcgcgc 21000 gaatccgtga gcgcctggct ttgcagtcag ctgttggcga gcaaaaccgt atcattaaga 21060 aagcgataga acagcttaaa acaatcggct atctcgactg ttctattgag aagaaaggcc 21120 gggaaagttt tgtaatcgtc cattctcgca atccaaagct gaaactcccc gaataagtgt 21180 gtgctggagg gaaaccgcat taaaaagatg tgtgctgccg ggaaggcttg tccaatttcc 21240 tgtttttgat gtgcgctgga gggggacgcc cctcagtttg cccagacttt ccctccagca 21300 cacatctgtc catccgcttt tccctccagt gcacatgtaa ttctctgcct ttccctccag 21360 cacacatatt tgataccagc gatccctcca cagcacataa ttcaatgcga cttccctcta 21420 tcgcacatct tagactttta ttctccctcc agcacacatc gaagctgccg ggcaagccgt 21480 tctcaccagt tgatagagag tgaagcttgg ctgcccattg aagcaggaaa tcaccaaaat 21540 gattcaggct acaacctgaa cgtagaagaa atccgcgtcc tttatgcgtg gaggatgcca 21600 aagcatgttg tgacacactt ggcaaaggag taagcatgca gagaatgcta tgtacaagca 21660 tctacgcata cattattatt ttatgcagca tttttaatta aattcaaaaa tacagcataa 21720 aggatgactt tcgatgagtg attccagcca gcttcacaag gttgctcaaa gagcaaacag 21780 aatgctcaat gttctgactg aacaagtaca gttgcaaaag gatgagctac acgcgaacga 21840 gttttaccag gtctatgcga aagcggcact ggcaaaattg cctctactga ctcgagcgaa 21900 cgttgactat gccgtaagtg aaatggaaga aaagggttat gttttcgata aacgccctgc 21960 tggctcttca atgaaatatg cgatgtcaat tcagaacatc attgacatat atgaacatcg 22020 cggagtgcca aaataccggg atcgctacag cgaagcgtat gtgattttca tctccaatct 22080 taaaggcggt gtgtcaaaaa ctgtatcgac ggtttctctg gcgcatgcaa tgcgtgctca 22140 ccctcatctt cttatggagg atttaaggat tctggttatt gaccttgatc cgcaatcttc 22200 agcaacgatg tttttaagcc ataaacactc tattggtatc gtaaacgcaa catctgcaca 22260 ggctatgttg cagaatgtaa gccgtgaaga gctgttagag gagtttattg ttccttctgt 22320 tgtacctggg gttgacgtta tgcctgcgtc gattgacgat gcctttattg catccgattg 22380 gagagagctg tgcaatgagc atctaccggg tcagaacatc catgctgtcc tgaaagaaaa 22440 tgtgattgat aagctgaaga gcgattatga ctttatcctc gttgatagtg gtcctcacct 22500 tgacgccttc ctgaaaaatg ctttggcctc ggccaatata ctgtttacac ctctgccgcc 22560 agcaactgtc gatttccact catcgcttaa atacgttgcc cgccttcctg agttggtgaa 22620 actcatttcg gatgaaggct gcgagtgcca gcttgcgact aacattggtt ttatgtccaa 22680 gttgagtaac aaggcagacc ataagtattg ccatagcctg gctaaagaag tgttcggtgg 22740 ggatatgctt gatgtcttcc tccctcgcct tgacggtttt gaacgctgcg gcgagtcttt 22800 tgacactgtt atttcagcta acccggcaac gtatgttggt agtgctgatg cattgaagaa 22860 cgcgcgaatt gccgcggaag attttgctaa agcagttttt gaccgtat 22908 SEQ ID NO. 7 <211> 7870 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 7 gtgcactctc agtacaatct gctctgatgc cgcatagtta agccagcccc gacacccgcc 60 aacacccgct gacgcgccct gacgggcttg tctgctcccg gcatccgctt acagacaagc 120 tgtgaccgtc tccgggagct gcatgtgtca gaggttttca ccgtcatcac cgaaacgcgc 180 gagacgaaag ggcctcgtga tacgcctatt tttataggtt aatgtcatga taataatggt 240 ttcttagacg tcaggtggca cttttcgggg aaatgtgcgc ggaaccccta tttgtttatt 300 tttctaaata cattcaaata tgtatccgct catgagacaa taaccctgat aaatgcttca 360 ataatattga aaaaggaaga gtatgagtat tcaacatttc cgtgtcgccc ttattccctt 420 ttttgcggca ttttgccttc ctgtttttgc tcacccagaa acgctggtga aagtaaaaga 480 tgctgaagat cagttgggtg cacgagtggg ttacatcgaa ctggatctca acagcggtaa 540 gatccttgag agttttcgcc ccgaagaacg ttttccaatg atgagcactt ttaaagttct 600 gctatgtggc gcggtattat cccgtattga cgccgggcaa gagcaactcg gtcgccgcat 660 acactattct cagaatgact tggttgagta ctcaccagtc acagaaaagc atcttacgga 720 tggcatgaca gtaagagaat tatgcagtgc tgccataacc atgagtgata acactgcggc 780 caacttactt ctgacaacga tcggaggacc gaaggagcta accgcttttt tgcacaacat 840 gggggatcat gtaactcgcc ttgatcgttg ggaaccggag ctgaatgaag ccataccaaa 900 cgacgagcgt gacaccacga tgcctgtagc aatggcaaca acgttgcgca aactattaac 960 tggcgaacta cttactctag cttcccggca acaattaata gactggatgg aggcggataa 1020 agttgcagga ccacttctgc gctcggccct tccggctggc tggtttattg ctgataaatc 1080 tggagccggt gagcgtgggt ctcgcggtat cattgcagca ctggggccag atggtaagcc 1140 ctcccgtatc gtagttatct acacgacggg gagtcaggca actatggatg aacgaaatag 1200 acagatcgct gagataggtg cctcactgat taagcattgg taactgtcag accaagttta 1260 ctcatatata ctttagattg atttaaaact tcatttttaa tttaaaagga tctaggtgaa 1320 gatccttttt gataatctca tgaccaaaat cccttaacgt gagttttcgt tccactgagc 1380 gtcagacccc gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat 1440 ctgctgcttg caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga 1500 gctaccaact ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt 1560 tcttctagtg tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata 1620 cctcgctctg ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac 1680 cgggttggac tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg 1740 ttcgtgcaca cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg 1800 tgagctatga gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag 1860 cggcagggtc ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct 1920 ttatagtcct gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc 1980 aggggggcgg agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt 2040 ttgctggcct tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg 2100 tattaccgcc tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga 2160 gtcagtgagc gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg 2220 gccgattcat taatgcagct ggcacgacag gtttcccgac tggaaagcgg gcagtgagcg 2280 caacgcaatt aatgtgagtt agctcactca ttaggcaccc caggctttac actttatgct 2340 tccggctcgt atgttgtgtg gaattgtgag cggataacaa tttcacacag gaaacagcta 2400 tgaccatgat tacgccaagc tcgcggccgc agtactctgc agattttatg caaaattaaa 2460 gtcttgtgac aacagctttc tccttaagtg caaatatcgc ccattctttc ctcttttcgt 2520 atataaatgc tgtaatagta ggatgtcgta cccgtaaagg tacgacattg aatattaata 2580 tactcctaag tttactttcc caatatttat attaggacgt ccccttcggg taaataaatt 2640 ttagtggcag tggtaccgcc actccctatt ttaatactgc gaaggaggca gttggcaggc 2700 aactcgtcgt tcgcagtata taaatatcca ctaatattta tattcccgta aggggacgtc 2760 ccgaagggga aggggaaaga agcagtcgcc tccttgcgaa aaggtttact tgcccgacca 2820 gtgaaaagca tgctgtaaga tataaatcta ccctgaaagg gatgcatttc accataatac 2880 tatacaaatg gtgttaccct ttgaggatca taacggtgct actggaatat atggtctctt 2940 catggataga cgatagccat ttatttaccc attaagggga cattagtggc ctgtcactgc 3000 tccttacgag acgccagtgg acgttcgtcc tagaaaattt atgcgctgcc tagaagcccc 3060 aaaagggaag tttactgact cgttagagcg tgcgctaaca ggtttaaata cttcaatatg 3120 tatattagga cgccggtggc agtggtaccg ccactgccac cgtcggagga cgtcccttac 3180 ggtatattat atactaggat tttaatactc cgaaggaggc agtggcggta ccactgccac 3240 taatatttat attcccgtaa gggacgtcct ccttcggagt atgtaaacat tctaagttta 3300 cttgcccaat atttatatta ggcagttggc aggcaactgc tagctctcct ccttcggagt 3360 atgtaaacat cgcagtatat aaatatccac taatatttat attcccgtaa ggggacgtcc 3420 cgaaggggaa ggggaaggac gtcagtggca gttgcctgcc aactgcctag gcaagtaaac 3480 ttaggagtat ataaatatag gcagtcgcgg taccactgcc actgacgtcc tgccaactgc 3540 ctaggcaagt aaacttaagt ggcactaaaa tgcatttgcc cgaaggggaa ggaggacgcc 3600 agtggcagtg gtaccgccac tgcctccttc ggagtattaa aatcctagta tgtaaatctg 3660 ctagcgcagg aaataaattt tattctattt atatactccg ttaggaggta agtaaacccc 3720 ttccccttcg ggacgtcagt gcagttgcct gccaactgcc taatataaat attagaccac 3780 taaagtttgg caactgccaa ctgttgtcct tcggaggaaa aaaaatggtt aactcgcaag 3840 cagttaacat aactaaagtt tgttacttta ccgaagacgt ttaccctttc tcggttaagg 3900 agacggagac agttgcactg tgactgccta gtatagcaat tttgtttttg tttatatgct 3960 cgacaaaatg actttcataa aaatataaag tagttagcta gttattttat atcactataa 4020 ctagggttct cagaggcacc gaagtcactt gtaaaaatag tactttttaa cttgtttaat 4080 cttcgtgttc ttcaaaagga tcacgtaatt tttttgaagg tggaccaaaa ctaacataaa 4140 ctgaatagcc agttacactt aacagaagaa accataaaaa aaaggtaaag aaaaaagctg 4200 gactttccat agctcattta ataataaaat tattctcttt tcaacatatc tcttagatag 4260 ttcaaaagac ttgacgactg tgtcccacat ttttaaacaa aattaatcta ctcaaaattt 4320 tgccctgaga aagaataact tacttcgttt ttgcagtagc cattcatgtc actttgaaac 4380 tgtccttaca aagttaaaca ttaattaaaa attatttaat ttttatataa caaatattat 4440 attaaataaa aaatgaacaa agaacttcta agatcgtctt tagtgagtaa ttaaagagtt 4500 ttacttacca gacaaggcag ttttttcatt cttttaaagc aggcagttct gaaggggaaa 4560 agggactgcc tactgcggtc ctaggtaaat acatttttat gcaatttatt tcttgtgcta 4620 gtaggtttct atactcacaa gaagcaaccc cttgacgaga gaacgttatc ctcagagtat 4680 ttataatcct gagagggaat gcactgaaga atattttcct tattttttac agaaagtaaa 4740 taaaatagcg ctaataacgc ttaattcatt taatcaatta tggcaacagg aacttctaaa 4800 gctaaaccat caaaagtaaa ttcagacttc caagaacctg gtttagttac accattaggt 4860 actttattac gtccacttaa ctcagaagca ggtaaagtat taccaggctg gggtacaact 4920 gttttaatgg ctgtatttat ccttttattt gcagcattct tattaatcat tttagaaatt 4980 tacaacagtt ctttaatttt agatgacgtt tctatgagtt gggaaacttt agctaaagtt 5040 tcttaatttt atttaacaca aacataaaat ataaaactgt ttgttaaggc tagctgctaa 5100 gtcttctttt cgctaaggta aactaagcaa ctcaaccata tttatattcg gcagtggcac 5160 cgccaactgc cactggcctt ccgttaagat aaacgcgtgg atctcacgtg actagtgata 5220 tctacgtaat cgatgaattc gatcccattt ttataactgg atctcaaaat acctataaac 5280 ccattgttct tctcttttag ctctaagaac aatcaattta taaatatatt tattattatg 5340 ctataatata aatactatat aaatacattt acctttttat aaatacattt accttttttt 5400 taatttgcat gattttaatg cttatgctat cttttttatt tagtccataa aacctttaaa 5460 ggaccttttc ttatgggata tttatatttt cctaacaaag caatcggcgt cataaacttt 5520 agttgcttac gacgcctgtg gacgtccccc ccttcccctt acgggcaagt aaacttaggg 5580 attttaatgc aataaataaa tttgtcctct tcgggcaaat gaattttagt atttaaatat 5640 gacaagggtg aaccattact tttgttaaca agtgatctta ccactcacta tttttgttga 5700 attttaaact tatttaaaat tctcgagaaa gattttaaaa ataaactttt ttaatctttt 5760 atttattttt tcttttttcg tatggctcgt gaagcggtta tcgccgaagt atcaactcaa 5820 ctatcagagg tagttggcgt catcgagcgc catctcgaac cgacgttgct ggccgtacat 5880 ttgtacggct ccgcagtgga tggcggcctg aagccacaca gtgatattga tttgctggtt 5940 acggtgaccg taaggcttga tgaaacaacg cggcgagctt tgatcaacga ccttttggaa 6000 acttcggctt cccctggaga gagcgagatt ctccgcgctg tagaagtcac cattgttgtg 6060 cacgacgaca tcattccgtg gcgttatcca gctaagcgcg aactgcaatt tggagaatgg 6120 cagcgcaatg acattcttgc aggtatcttc gagccagcca cgatcgacat tgatctggct 6180 atcttgctga caaaagcaag agaacatagc gttgccttgg taggtccagc ggcggaggaa 6240 ctctttgatc cggttcctga acaggatcta tttgaggcgc taaatgaaac cttaacgcta 6300 tggaactcgc cgcccgactg ggctggcgat gagcgaaatg tagtgcttac gttgtcccgc 6360 atttggtaca gcgcagtaac cggcaaaatc gcgccgaagg atgtcgctgc cgactgggca 6420 atggagcgcc tgccggccca gtatcagccc gtcatacttg aagctagaca ggcttatctt 6480 ggacaagaag aagatcgctt ggcctcgcgc gcagatcagt tggaagaatt tgtccactac 6540 gtgaaaggcg agatcactaa ggtagttggc aaataattcc aagcattatc taaaatactc 6600 tgcaggcacg ctagcttgta ctcaagctcg taacgaaggt cgtgaccttg ctcgtgaagg 6660 tggcgacgta attcgttcag cttgtaaatg gtctccagaa cttgctgctg catgtgaagt 6720 ttggaaagaa attaaattcg aatttgatac tattgacaaa ctttaatttt tatttttcat 6780 gatgtttatg tgaatagcat aaacatcgtt tttattttta tggtgtttag gttaaatacc 6840 taaacatcat tttacatttt taaaattaag ttctaaagtt atcttttgtt taaatttgcc 6900 tgtctttata aattacgatg tgccagaaaa ataaaatctt agctttttat tatagaattt 6960 atctttatgt attatatttt ataagttata ataaaagaaa tagtaacata ctaaagcgga 7020 tgtagcgcgt ttatcttaac ggaaggaatt cggcgcctac gtacccgggt cgcgaggatc 7080 cacgcgttaa tagctcactt ttctttaaat ttaattttta atttaaaggt gtaagcaaat 7140 tgcctgacga gagatccact taaaggatga cagtggcggg ctactgccta cttccctccg 7200 ggataaaatt tatttgaaaa acgttagtta cttcctaacg gagcattgac atccccatat 7260 ttatattagg acgtcccctt cgggtaaata aattttagtg gacgtcccct tcgggcaaat 7320 aaattttagt ggacaataaa taaatttgtt gcctgccaac tgcctaggca agtaaacttg 7380 ggagtattaa aataggacgt cagtggcagt tgcctgccaa ctgcctatat ttatatactg 7440 cgaagcaggc agtggcggta ccactgccac tggcgtccta atataaatat tgggcaacta 7500 aagtttatag cagtattaac atcctatatt tatatactcc gaaggaactt gttagccgat 7560 aggcgaggca acaaatttat ttattgtccc gtaaaaggat gcctccagca tcgaagggga 7620 aggggacgtc ctaggccata aaactaaagg gaaatccata gtaactgatg ttataaattt 7680 atagactcca aaaaacagct gcgttataaa taacttctgt taaatatggc caaggggaca 7740 ggggcacttt caactaagtg tacattaaaa attgacaatt caattttttt taattataat 7800 atatatttag taaaatataa caaaaagccc ccatcgtcta ggtagaattc cagctggcgg 7860 ccgccctatg 7870 SEQ ID NO. 8 <211> 1353 <212> DNA <213> Saccharomyces cerevisiae <400> 8 tcgcgcgttt cggtgatgac ggtgaaaacc tctgacacat gcagctcccg gagacggtca 60 cagcttgtct gtaagcggat gccgggagca gacaagcccg tcagggagcg cgtcagcggg 120 tgttggcggg tgtcggggct ggcttaacta tgcggcatca gagcagattg tactgagagt 180 gcaccatacc acagcttttc aattcaattc atcatttttt ttttattctt ttttttgatt 240 tcggtttctt tgaaattttt ttgattcggt aatctccgaa cagaaggaag aacgaaggaa 300 ggagcacaga cttagattgg tatatatacg catatgtagt gttgaagaaa catgaaattg 360 cccagtattc ttaacccaac tgcacagaac aaaaacctgc aggaaacgaa gataaatcat 420 gtcgaaagct acatataagg aacgtgctgc tactcatcct agtcctgttg ctgccaagct 480 atttaatatc atgcacgaaa agcaaacaaa cttgtgtgct tcattggatg ttcgtaccac 540 caaggaatta ctggagttag ttgaagcatt aggtcccaaa atttgtttac taaaaacaca 600 tgtggatatc ttgactgatt tttccatgga gggcacagtt aagccgctaa aggcattatc 660 cgccaagtac aattttttac tcttcgaaga cagaaaattt gctgacattg gtaatacagt 720 caaattgcag tactctgcgg gtgtatacag aatagcagaa tgggcagaca ttacgaatgc 780 acacggtgtg gtgggcccag gtattgttag cggtttgaag caggcggcag aagaagtaac 840 aaaggaacct agaggccttt tgatgttagc agaattgtca tgcaagggct ccctatctac 900 tggagaatat actaagggta ctgttgacat tgcgaagagc gacaaagatt ttgttatcgg 960 ctttattgct caaagagaca tgggtggaag agatgaaggt tacgattggt tgattatgac 1020 acccggtgtg ggtttagatg acaagggaga cgcattgggt caacagtata gaaccgtgga 1080 tgatgtggtc tctacaggat ctgacattat tattgttgga agaggactat ttgcaaaggg 1140 aagggatgct aaggtagagg gtgaacgtta cagaaaagca ggctgggaag catatttgag 1200 aagatgcggc cagcaaaact aaaaaactgt attataagta aatgcatgta tactaaactc 1260 acaaattaga gcttcaattt aattatatca gttattaccc tatgcggtgt gaaataccgc 1320 acagatgcgt aaggagaaaa taccgcatca gga 1353 SEQ ID NO. 9 <211> 2474 <212> DNA <213> Saccharomyces cerevisiae <400> 9 tcctgatgcg gtattttctc cttacgcatc tgtgcggtat ttcacaccgc atatcgacgg 60 tcgaggagaa cttctagtat atccacatac ctaatattat tgccttatta aaaatggaat 120 cccaacaatt acatcaaaat ccacattctc ttcaaaatca attgtcctgt acttccttgt 180 tcatgtgtgt tcaaaaacgt tatatttata ggataattat actctatttc tcaacaagta 240 attggttgtt tggccgagcg gtctaaggcg cctgattcaa gaaatatctt gaccgcagtt 300 aactgtggga atactcaggt atcgtaagat gcaagagttc gaatctctta gcaaccatta 360 tttttttcct caacataacg agaacacaca ggggcgctat cgcacagaat caaattcgat 420 gactggaaat tttttgttaa tttcagaggt cgcctgacgc atataccttt ttcaactgaa 480 aaattgggag aaaaaggaaa ggtgagaggc cggaaccggc ttttcatata gaatagagaa 540 gcgttcatga ctaaatgctt gcatcacaat acttgaagtt gacaatatta tttaaggacc 600 tattgttttt tccaataggt ggttagcaat cgtcttactt tctaactttt cttacctttt 660 acatttcagc aatatatata tatatttcaa ggatatacca ttctaatgtc tgcccctatg 720 tctgccccta agaagatcgt cgttttgcca ggtgaccacg ttggtcaaga aatcacagcc 780 gaagccatta aggttcttaa agctatttct gatgttcgtt ccaatgtcaa gttcgatttc 840 gaaaatcatt taattggtgg tgctgctatc gatgctacag gtgtcccact tccagatgag 900 gcgctggaag cctccaagaa ggttgatgcc gttttgttag gtgctgtggg tggtcctaaa 960 tggggtaccg gtagtgttag acctgaacaa ggtttactaa aaatccgtaa agaacttcaa 1020 ttgtacgcca acttaagacc atgtaacttt gcatccgact ctcttttaga cttatctcca 1080 atcaagccac aatttgctaa aggtactgac ttcgttgttg tcagagaatt agtgggaggt 1140 atttactttg gtaagagaaa ggaagacgat ggtgatggtg tcgcttggga tagtgaacaa 1200 tacaccgttc cagaagtgca aagaatcaca agaatggccg ctttcatggc cctacaacat 1260 gagccaccat tgcctatttg gtccttggat aaagctaatg ttttggcctc ttcaagatta 1320 tggagaaaaa ctgtggagga aaccatcaag aacgaattcc ctacattgaa ggttcaacat 1380 caattgattg attctgccgc catgatccta gttaagaacc caacccacct aaatggtatt 1440 ataatcacca gcaacatgtt tggtgatatc atctccgatg aagcctccgt tatcccaggt 1500 tccttgggtt tgttgccatc tgcgtccttg gcctctttgc cagacaagaa caccgcattt 1560 ggtttgtacg aaccatgcca cggttctgct ccagatttgc caaagaataa ggttgaccct 1620 atcgccacta tcttgtctgc tgcaatgatg ttgaaattgt cattgaactt gcctgaagaa 1680 ggtaaggcca ttgaagatgc agttaaaaag gttttggatg caggtatcag aactggtgat 1740 ttaggtggtt ccaacagtac caccgaagtc ggtgatgctg tcgccgaaga agttaagaaa 1800 atccttgctt aaaaagattc tcttttttta tgatatttgt acataaactt tataaatgaa 1860 attcataata gaaacgacac gaaattacaa aatggaatat gttcataggg tagacgaaac 1920 tatatacgca atctacatac atttatcaag aaggagaaaa aggaggatag taaaggaata 1980 caggtaagca aattgatact aatggctcaa cgtgataagg aaaaagaatt gcactttaac 2040 attaatattg acaaggagga gggcaccaca caaaaagtta ggtgtaacag aaaatcatga 2100 aactacgatt cctaatttga tattggagga ttttctctaa aaaaaaaaaa atacaacaaa 2160 taaaaaacac tcaatgacct gaccatttga tggagtttaa gtcaatacct tcttgaacca 2220 tttcccataa tggtgaaagt tccctcaaga attttactct gtcagaaacg gccttacgac 2280 gtagtcgata tggtgcactc tcagtacaat ctgctctgat gccgcatagt taagccagcc 2340 ccgacacccg ccaacacccg ctgacgcgcc ctgacgggct tgtctgctcc cggcatccgc 2400 ttacagacaa gctgtgaccg tctccgggag ctgcatgtgt cagaggtttt caccgtcatc 2460 accgaaacgc gcga 2474 SEQ ID NO. 10 <211> 1177 <212> DNA <213> Saccharomyces cerevisiae <400> 10 aattcccgtt ttaagagctt ggtgagcgct aggagtcact gccaggtatc gtttgaacac 60 ggcattagtc agggaagtca taacacagtc ctttcccgca attttctttt tctattactc 120 ttggcctcct ctagtacact ctatattttt ttatgcctcg gtaatgattt tcattttttt 180 ttttccccta gcggatgact cttttttttt cttagcgatt ggcattatca cataatgaat 240 tatacattat ataaagtaat gtgatttctt cgaagaatat actaaaaaat gagcaggcaa 300 gataaacgaa ggcaaagatg acagagcaga aagccctagt aaagcgtatt acaaatgaaa 360 ccaagattca gattgcgatc tctttaaagg gtggtcccct agcgatagag cactcgatct 420 tcccagaaaa agaggcagaa gcagtagcag aacaggccac acaatcgcaa gtgattaacg 480 tccacacagg tatagggttt ctggaccata tgatacatgc tctggccaag cattccggct 540 ggtcgctaat cgttgagtgc attggtgact tacacataga cgaccatcac accactgaag 600 actgcgggat tgctctcggt caagctttta aagaggccct actggcgcgt ggagtaaaaa 660 ggtttggatc aggatttgcg cctttggatg aggcactttc cagagcggtg gtagatcttt 720 cgaacaggcc gtacgcagtt gtcgaacttg gtttgcaaag ggagaaagta ggagatctct 780 cttgcgagat gatcccgcat tttcttgaaa gctttgcaga ggctagcaga attaccctcc 840 acgttgattg tctgcgaggc aagaatgatc atcaccgtag tgagagtgcg ttcaaggctc 900 ttgcggttgc cataagagaa gccacctcgc ccaatggtac caacgatgtt ccctccacca 960 aaggtgttct tatgtagtga caccgattat ttaaagctgc agcatacgat atatatacat 1020 gtgtatatat gtatacctat gaatgtcagt aagtatgtat acgaacagta tgatactgaa 1080 gatgacaagg taatgcatca ttctatacgt gtcattctga acgaggcgcg ctttcctttt 1140 ttctttttgc tttttctttt tttttctctt gaactcg 1177 SEQ ID NO. 11 <211> 3008 <212> DNA <213> Saccharomyces cerevisiae <400> 11 tgggcaattt catgtttctt caacactaca tatgcgtata tataccaatc taagtctgtg 60 ctccttcctt cgttcttcct tctgttcgga gattaccgaa tcaaaaaaat ttcaaggaaa 120 ccgaaatcaa aaaaaagaat aaaaaaaaaa tgatgaattg aaaccccccc cccccccccc 180 gatgcgccgc gtgcggctgc tggagatggc ggacgcgatg gatatgttct gccaagggtt 240 gggtcgacgc taccttaaga gagacgcgtg cggccgcaag cttgcatgcc tgcaggtcga 300 tcgactctag aaatcgatag atctgaatta attcttgaat aatacataac ttttcttaaa 360 agaatcaaag acagataaaa tttaagagat attaaatatt agtgagaagc cgagaatttt 420 gtaacaccaa cataacactg acatctttaa caacttttaa ttatgataca tttcttacgt 480 catgattgat tattacagct atgctgacaa atgactcttg ttgcatggct acgaaccggg 540 taatactaag tgattgactc ttgctgacct tttattaaga actaaatgga caatattatg 600 gagcatttca tgtataaatt ggtgcgtaaa atcgttggat ctctcttcta agtacatcct 660 actataacaa tcaagaaaaa caagaaaatc ggacaaaaca atcaagtatg gattctagaa 720 cagttggtat attaggaggg ggacaattgg gacgtatgat tgttgaggca gcaaacaggc 780 tcaacattaa gacggtaata ctagatgctg aaaattctcc tgccaaacaa ataagcaact 840 ccaatgacca cgttaatggc tccttttcca atcctcttga tatcgaaaaa ctagctgaaa 900 aatgtgatgt gctaacgatt gagattgagc atgttgatgt tcctacacta aagaatcttc 960 aagtaaaaca tcccaaatta aaaatttacc cttctccaga aacaatcaga ttgatacaag 1020 acaaatatat tcaaaaagag catttaatca aaaatggtat agcagttacc caaagtgttc 1080 ctgtggaaca agccagtgag acgtccctat tgaatgttgg aagagatttg ggttttccat 1140 tcgtcttgaa gtcgaggact ttggcatacg atggaagagg taacttcgtt gtaaagaata 1200 aggaaatgat tccggaagct ttggaagtac tgaaggatcg tcctttgtac gccgaaaaat 1260 gggcaccatt tactaaagaa ttagcagtca tgattgtgag gtctgttaac ggtttagtgt 1320 tttcttaccc aattgtagag actatccaca aggacaatat ttgtgactta tgttatgcgc 1380 ctgctagagt tccggactcc gttcaactta aggcgaagtt gttggcagaa aatgcaatca 1440 aatcttttcc cggttgtggt atatttggtg tggaaatgtt ctatttagaa acaggggaat 1500 tgcttattaa cgaaattgcc ccaaggcctc acaactctgg acattatacc attgatgctt 1560 gcgtcacttc tcaatttgaa gctcatttga gatcaatatt ggatttgcca atgccaaaga 1620 atttcacatc tttctccacc attacaacga acgccattat gctaaatgtt cttggagaca 1680 aacatacaaa agataaagag ctagaaactt gcgaaagagc attggcgact ccaggttcct 1740 cagtgtactt atatggaaaa gagtctagac ctaacagaaa agtaggtcac ataaatatta 1800 ttgcctccag tatggcggaa tgtgaacaaa ggctgaacta cattacaggt agaactgata 1860 ttccaatcaa aatctctgtc gctcaaaagt tggacttgga agcaatggtc aaaccattgg 1920 ttggaatcat catgggatca gactctgact tgccggtaat gtctgccgca tgtgcggttt 1980 taaaagattt tggcgttcca tttgaagtga caatagtctc tgctcataga actccacata 2040 ggatgtcagc atatgctatt tccgcaagca agcgtggaat taaaacaatt atcgctggag 2100 ctggtggggc tgctcacttg ccaggtatgg tggctgcaat gacaccactt cctgtcatcg 2160 gtgtgcccgt aaaaggttct tgtctagatg gagtagattc tttacattca attgtgcaaa 2220 tgcctagagg tgttccagta gctaccgtcg ctattaataa tagtacgaac gctgcgctgt 2280 tggctgtcag actgcttggc gcttatgatt caagttatac aacgaaaatg gaacagtttt 2340 tattaaagca agaagaagaa gttcttgtca aagcacaaaa gttagaaact gtcggttacg 2400 aagcttatct agaaaacaag taatatataa gtttattgat atacttgtac agcaaataat 2460 tataaaatga tatacctatt ttttaggctt tgttatgatt acatcaaatg tggacttcat 2520 acatagaaat caacgcttac aggtgtcctt ttttaagaat ttcatacata agatctctcg 2580 aggatccccg ggtaccgagc tcgaattcgc ggccgcccgc gggttaaccc tagggcatgc 2640 actagtggcc taattggccg acgtcaggtg gcacttttcg gggaaatgtg cgcggaaccc 2700 ctatttgttt atttttctaa atacattcaa atatgtatcc gctcatgaga caataaccct 2760 gataaatgct tcaataatat tgaaaaagga agagtatgag tattcaacat ttccgtgtcg 2820 cccttattcc cttttttgcg gcattttgcc ttcctgtttt tgctcaccca gaaacgctgg 2880 tgaaagtaaa agatgctgaa gatcagttgg gtgcacgagt gggttacatc gaactggatc 2940 tcaacagcgg taagatcctt gagagttttc gccccgaaga acgttttcca atgatgagca 3000 cttttaaa 3008 SEQ ID NO. 12 <211> 4879 <212> DNA <213> Saccharomyces cerevisiae <400> 12 agcagttgct ttctcctatg ggaagagctt tctaagtctg aagaagtaaa cagttctttg 60 ctatttcaca cttcctggtt gatggtcact tgctgcctga aatatatata tatgtatgac 120 atatgtactt gttttctttt ttgtgccttt gttacgtcta tattcattga aactgattat 180 tcgattttct tcttgctgac cgcttctaga ggcatcgcac agttttagcg aggaaaactc 240 ttcaatagtt ttgccagcgg aattccactt gcaattacat aaaaaattcc ggcggttttt 300 cgcgtgtgac tcaatgtcga aatacctgcc taatgaacat gaacatcgcc caaatgtatt 360 tgaagacccg ctgggagaag ttcaagatat ataagtaaca agcagccaat agtataaaaa 420 aaaatctgag tttattacct ttcctggaat ttcagtgaaa aactgctaat tatagagaga 480 tatcacagag ttactcacta atgactaacg aaaaggtctg gatagagaag ttggataatc 540 caactctttc agtgttacca catgactttt tacgcccaca acaagaacct tatacgaaac 600 aagctacata ttcgttacag ctacctcagc tcgatgtgcc tcatgatagt ttttctaaca 660 aatacgctgt cgctttgagt gtatgggctg cattgatata tagagtaacc ggtgacgatg 720 atattgttct ttatattgcg aataacaaaa tcttaagatt caatattcaa ccaacgtggt 780 catttaatga gctgtattct acaattaaca atgagttgaa caagctcaat tctattgagg 840 ccaatttttc ctttgacgag ctagctgaaa aaattcaaag ttgccaagat ctggaaagga 900 cccctcagtt gttccgtttg gcctttttgg aaaaccaaga tttcaaatta gacgagttca 960 agcatcattt agtggacttt gctttgaatt tggataccag taataatgcg catgttttga 1020 acttaattta taacagctta ctgtattcga atgaaagagt aaccattgtt gcggaccaat 1080 ttactcaata tttgactgct gcgctaagcg atccatccaa ttgcataact aaaatctctc 1140 tgatcaccgc atcatccaag gatagtttac ctgatccaac taagaacttg ggctggtgcg 1200 atttcgtggg gtgtattcac gacattttcc aggacaatgc tgaagccttc ccagagagaa 1260 cctgtgttgt ggagactcca acactaaatt ccgacaagtc ccgttctttc acttatcgcg 1320 acatcaaccg cacttctaac atagttgccc attatttgat taaaacaggt atcaaaagag 1380 gtgatgtagt gatgatctat tcttctaggg gtgtggattt gatggtatgt gtgatgggtg 1440 tcttgaaagc cggcgcaacc ttttcagtta tcgaccctgc atatccccca gccagacaaa 1500 ccatttactt aggtgttgct aaaccacgtg ggttgattgt tattagagct gctggacaat 1560 tggatcaact agtagaagat tacatcaatg atgaattgga gattgtttca agaatcaatt 1620 ccatcgctat tcaagaaaat ggtaccattg aaggtggcaa attggacaat ggcgaggatg 1680 ttttggctcc atatgatcac tacaaagaca ccagaacagg tgttgtagtt ggaccagatt 1740 ccaacccaac cctatctttc acatctggtt ccgaaggtat tcctaagggt gttcttggta 1800 gacatttttc cttggcttat tatttcaatt ggatgtccaa aaggttcaac ttaacagaaa 1860 atgataaatt cacaatgctg agcggtattg cacatgatcc aattcaaaga gatatgttta 1920 caccattatt tttaggtgcc caattgtatg tccctactca agatgatatt ggtacaccgg 1980 gccgtttagc ggaatggatg agtaagtatg gttgcacagt tacccattta acacctgcca 2040 tgggtcaatt acttactgcc caagctacta caccattccc taagttacat catgcgttct 2100 ttgtgggtga cattttaaca aaacgtgatt gtctgaggtt acaaaccttg gcagaaaatt 2160 gccgtattgt taatatgtac ggtaccactg aaacacagcg tgcagtttct tatttcgaag 2220 ttaaatcaaa aaatgacgat ccaaactttt tgaaaaaatt gaaagatgtc atgcctgctg 2280 gtaaaggtat gttgaacgtt cagctactag ttgttaacag gaacgatcgt actcaaatat 2340 gtggtattgg cgaaataggt gagatttatg ttcgtgcagg tggtttggcc gaaggttata 2400 gaggattacc agaattgaat aaagaaaaat ttgtgaacaa ctggtttgtt gaaaaagatc 2460 actggaatta tttggataag gataatggtg aaccttggag acaattctgg ttaggtccaa 2520 gagatagatt gtacagaacg ggtgatttag gtcgttatct accaaacggt gactgtgaat 2580 gttgcggtag ggctgatgat caagttaaaa ttcgtgggtt cagaatcgaa ttaggagaaa 2640 tagatacgca catttcccaa catccattgg taagagaaaa cattacttta gttcgcaaaa 2700 atgccgacaa tgagccaaca ttgatcacat ttatggtccc aagatttgac aagccagatg 2760 acttgtctaa gttccaaagt gatgttccaa aggaggttga aactgaccct atagttaagg 2820 gcttaatcgg ttaccatctt ttatccaagg acatcaggac tttcttaaag aaaagattgg 2880 ctagctatgc tatgccttcc ttgattgtgg ttatggataa actaccattg aatccaaatg 2940 gtaaagttga taagcctaaa cttcaattcc caactcccaa gcaattaaat ttggtagctg 3000 aaaatacagt ttctgaaact gacgactctc agtttaccaa tgttgagcgc gaggttagag 3060 acttatggtt aagtatatta cctaccaagc cagcatctgt atcaccagat gattcgtttt 3120 tcgatttagg tggtcattct atcttggcta ccaaaatgat ttttacctta aagaaaaagc 3180 tgcaagttga tttaccattg ggcacaattt tcaagtatcc aacgataaag gcctttgccg 3240 cggaaattga cagaattaaa tcatcgggtg gatcatctca aggtgaggtc gtcgaaaatg 3300 tcactgcaaa ttatgcggaa gacgccaaga aattggttga gacgctacca agttcgtacc 3360 cctctcgaga atattttgtt gaacctaata gtgccgaagg aaaaacaaca attaatgtgt 3420 ttgttaccgg tgtcacagga tttctgggct cctacatcct tgcagatttg ttaggacgtt 3480 ctccaaagaa ctacagtttc aaagtgtttg cccacgtcag ggccaaggat gaagaagctg 3540 catttgcaag attacaaaag gcaggtatca cctatggtac ttggaacgaa aaatttgcct 3600 caaatattaa agttgtatta ggcgatttat ctaaaagcca atttggtctt tcagatgaga 3660 agtggatgga tttggcaaac acagttgata taattatcca taatggtgcg ttagttcact 3720 gggtttatcc atatgccaaa ttgagggatc caaatgttat ttcaactatc aatgttatga 3780 gcttagccgc cgtcggcaag ccaaagttct ttgactttgt ttcctccact tctactcttg 3840 acactgaata ctactttaat ttgtcagata aacttgttag cgaagggaag ccaggcattt 3900 tagaatcaga cgatttaatg aactctgcaa gcgggctcac tggtggatat ggtcagtcca 3960 aatgggctgc tgagtacatc attagacgtg caggtgaaag gggcctacgt gggtgtattg 4020 tcagaccagg ttacgtaaca ggtgcctctg ccaatggttc ttcaaacaca gatgatttct 4080 tattgagatt tttgaaaggt tcagtccaat taggtaagat tccagatatc gaaaattccg 4140 tgaatatggt tccagtagat catgttgctc gtgttgttgt tgctacgtct ttgaatcctc 4200 ccaaagaaaa tgaattggcc gttgctcaag taacgggtca cccaagaata ttattcaaag 4260 actacttgta tactttacac gattatggtt acgatgtcga aatcgaaagc tattctaaat 4320 ggaagaaatc attggaggcg tctgttattg acaggaatga agaaaatgcg ttgtatcctt 4380 tgctacacat ggtcttagac aacttacctg aaagtaccaa agctccggaa ctagacgata 4440 ggaacgccgt ggcatcttta aagaaagaca ccgcatggac aggtgttgat tggtctaatg 4500 gaataggtgt tactccagaa gaggttggta tatatattgc atttttaaac aaggttggat 4560 ttttacctcc accaactcat aatgacaaac ttccactgcc aagtatagaa ctaactcaag 4620 cgcaaataag tctagttgct tcaggtgctg gtgctcgtgg aagctccgca gcagcttaag 4680 gttgagcatt acgtatgata tgtccatgta caataattaa atatgaatta ggagaaagac 4740 ttagcttctt ttcgggtgat gtcacttaaa aactccgaga ataatatata ataagagaat 4800 aaaatattag ttattgaata agaactgtaa atcagctggc gttagtctgc taatggcagc 4860 ttcatcttgg tttattgta 4879 SEQ ID NO. 13 <211> 1475 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 13 ttaggtctag agatctgttt agcttgcctc gtccccgccg ggtcacccgg ccagcgacat 60 ggaggcccag aataccctcc ttgacagtct tgacgtgcgc agctcagggg catgatgtga 120 ctgtcgcccg tacatttagc ccatacatcc ccatgtataa tcatttgcat ccatacattt 180 tgatggccgc acggcgcgaa gcaaaaatta cggctcctcg ctgcagacct gcgagcaggg 240 aaacgctccc ctcacagacg cgttgaattg tccccacgcc gcgcccctgt agagaaatat 300 aaaaggttag gatttgccac tgaggttctt ctttcatata cttcctttta aaatcttgct 360 aggatacagt tctcacatca catccgaaca taaacaacca tgggtaagga aaagactcac 420 gtttcgaggc cgcgattaaa ttccaacatg gatgctgatt tatatgggta taaatgggct 480 cgcgataatg tcgggcaatc aggtgcgaca atctatcgat tgtatgggaa gcccgatgcg 540 ccagagttgt ttctgaaaca tggcaaaggt agcgttgcca atgatgttac agatgagatg 600 gtcagactaa actggctgac ggaatttatg cctcttccga ccatcaagca ttttatccgt 660 actcctgatg atgcatggtt actcaccact gcgatccccg gcaaaacagc attccaggta 720 ttagaagaat atcctgattc aggtgaaaat attgttgatg cgctggcagt gttcctgcgc 780 cggttgcatt cgattcctgt ttgtaattgt ccttttaaca gcgatcgcgt atttcgtctc 840 gctcaggcgc aatcacgaat gaataacggt ttggttgatg cgagtgattt tgatgacgag 900 cgtaatggct ggcctgttga acaagtctgg aaagaaatgc ataagctttt gccattctca 960 ccggattcag tcgtcactca tggtgatttc tcacttgata accttatttt tgacgagggg 1020 aaattaatag gttgtattga tgttggacga gtcggaatcg cagaccgata ccaggatctt 1080 gccatcctat ggaactgcct cggtgagttt tctccttcat tacagaaacg gctttttcaa 1140 aaatatggta ttgataatcc tgatatgaat aaattgcagt ttcatttgat gctcgatgag 1200 tttttctaat cagtactgac aataaaaaga ttcttgtttt caagaacttg tcatttgtat 1260 agttttttta tattgtagtt gttctatttt aatcaaatgt tagcgtgatt tatatttttt 1320 ttcgcctcga catcatctgc ccagatgcga agttaagtgc gcagaaagta atatcatgcg 1380 tcaatcgtat gtgaatgctg gtcgctatac tgctgtcgat tcgatactaa cgccgccatc 1440 cagtgtcgaa aacgagctct cgagaaccct taata 1475 SEQ ID NO. 14 <211> 931 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 14 ttcaaatatg tatccgctca tgagacaata accctgataa atgcttcaat aatattgaaa 60 aaggaagagt atgagtattc aacatttccg tgtcgccctt attccctttt ttgcggcatt 120 ttgccttcct gtttttgctc acccagaaac gctggtgaaa gtaaaagatg ctgaagatca 180 gttgggtgca cgagtgggtt acatcgaact ggatctcaac agcggtaaga tccttgagag 240 ttttcgcccc gaagaacgtt ttccaatgat gagcactttt aaagttctgc tatgtggcgc 300 ggtattatcc cgtattgacg ccgggcaaga gcaactcggt cgccgcatac actattctca 360 gaatgacttg gttgagtact caccagtcac agaaaagcat cttacggatg gcatgacagt 420 aagagaatta tgcagtgctg ccataaccat gagtgataac actgcggcca acttacttct 480 gacaacgatc ggaggaccga aggagctaac cgcttttttg cacaacatgg gggatcatgt 540 aactcgcctt gatcgttggg aaccggagct gaatgaagcc ataccaaacg acgagcgtga 600 caccacgatg cctgcagcaa tggcaacaac gttgcgcaaa ctattaactg gcgaactact 660 tactctagct tcccggcaac aattaataga ctggatggag gcggataaag ttgcaggacc 720 acttctgcgc tcggcccttc cggctggctg gtttattgct gataaatctg gagccggtga 780 gcgtgggtct cgcggtatca ttgcagcact ggggccagat ggtaagccct cccgtatcgt 840 agttatctac acgacgggga gtcaggcaac tatggatgaa cgaaatagac agatcgctga 900 gataggtgcc tcactgatta agcattggta a 931 SEQ ID NO. 15 <211> 1382 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 15 ttctcatgtt tgacagctta tcatcgataa gctttaatgc ggtagtttat cacagttaaa 60 ttgctaacgc agtcaggcac cgtgtatgaa atctaacaat gcgctcatcg tcatcctcgg 120 caccgtcacc ctggatgctg taggcatagg cttggttatg ccggtactgc cgggcctctt 180 gcgggatatc gtccattccg acagcatcgc cagtcactat ggcgtgctgc tagcgctata 240 tgcgttgatg caatttctat gcgcacccgt tctcggagca ctgtccgacc gctttggccg 300 ccgcccagtc ctgctcgctt cgctacttgg agccactatc gactacgcga tcatggcgac 360 cacacccgtc ctgtggatcc tctacgccgg acgcatcgtg gccggcatca ccggcgccac 420 aggtgcggtt gctggcgcct atatcgccga catcaccgat ggggaagatc gggctcgcca 480 cttcgggctc atgagcgctt gtttcggcgt gggtatggtg gcaggccccg tggccggggg 540 actgttgggc gccatctcct tgcatgcacc attccttgcg gcggcggtgc tcaacggcct 600 caacctacta ctgggctgct tcctaatgca ggagtcgcat aagggagagc gtcgaccgat 660 gcccttgaga gccttcaacc cagtcagctc cttccggtgg gcgcggggca tgactatcgt 720 cgccgcactt atgactgtct tctttatcat gcaactcgta ggacaggtgc cggcagcgct 780 ctgggtcatt ttcggcgagg accgctttcg ctggagcgcg acgatgatcg gcctgtcgct 840 tgcggtattc ggaatcttgc acgccctcgc tcaagccttc gtcactggtc ccgccaccaa 900 acgtttcggc gagaagcagg ccattatcgc cggcatggcg gccgacgcgc tgggctacgt 960 cttgctggcg ttcgcgacgc gaggctggat ggccttcccc attatgattc ttctcgcttc 1020 cggcggcatc gggatgcccg cgttgcaggc catgctgtcc aggcaggtag atgacgacca 1080 tcagggacag cttcaaggat cgctcgcggc tcttaccagc ctaacttcga tcattggacc 1140 gctgatcgtc acggcgattt atgccgcctc ggcgagcaca tggaacgggt tggcatggat 1200 tgtaggcgcc gccctatacc ttgtctgcct ccccgcgttg cgtcgcggtg catggagccg 1260 ggccacctcg acctgaatgg aagccggcgg cacctcgcta acggattcac cactccaaga 1320 attggagcca atcaattctt gcggagaact gtgaatgcgc aaaccaaccc ttggcagaac 1380 at 1382 SEQ ID NO. 16 <211> 679 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 16 cccaatggca tcgtaaagaa cattttgagg catttcagtc agttgctcaa tgtacctata 60 accagaccgt tcagctggat attacggcct ttttaaagac cgtaaagaaa aataagcaca 120 agttttatcc ggcctttatt cacattcttg cccgcctgat gaatgctcat ccggaattcc 180 gtatggcaat gaaagacggt gagctggtga tatgggatag tgttcaccct tgttacaccg 240 ttttccatga gcaaactgaa acgttttcat cgctctggag tgaataccac gacgatttcc 300 ggcagtttct acacatatat tcgcaagatg tggcgtgtta cggtgaaaac ctggcctatt 360 tccctaaagg gtttattgag aatatgtttt tcgtctcagc caatccctgg gtgagtttca 420 ccagttttga tttaaacgtg gccaatatgg acaacttctt cgcccccgtt ttcaccatgg 480 gcaaatatta tacgcaaggc gacaaggtgc tgatgccgct ggcgattcag gttcatcatg 540 ccgtttgtga tggcttccat gtcggcagaa tgcttaatga attacaacag tactgcgatg 600 agtggcaggg cggggcgtaa tttttttaag gcagttattg gtgcccttaa acgcctggtt 660 gctacgcctg aataagtga 679 SEQ ID NO. 17 <211> 875 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 17 ttgccgggtg acgcacaccg tggaaacgga tgaaggcacg aacccagttg acataagcct 60 gttcggttcg taaactgtaa tgcaagtagc gtatgcgctc acgcaactgg tccagaacct 120 tgaccgaacg cagcggtggt aacggcgcag tggcggtttt catggcttgt tatgactgtt 180 tttttgtaca gtctatgcct cgggcatcca agcagcaagc gcgttacgcc gtgggtcgat 240 gtttcatgtt atggagcagc aacgatgtta cgcagcagca acgatgttac gcagcagggc 300 agtcgcccta aaacaaagtt aggtggctca agtatgggca tcattcgcac atgtaggctc 360 ggccctgacc aagtcaaatc catgcgggct gctcttgatc ttttcggtag tgagttcgga 420 gacgtagcca cctactccca acatcagccg gactccgatt acctcgggaa cttgctccgt 480 agtaagacat tcatcgcgct tgctgccttc gaccaagaag cggttgttgg cgctctcgcg 540 gcttacgttc tgcccaggtt tgagcagccg cgtagtgaga tctatatcta tgatctcgca 600 gtctccggcg agcaccggag gcagggcatt gccaccgcgc tcatcaatct cctcaagcat 660 gaggccaacg cgcttggtgc ttatgtgatc tacgtgcaag cagattacgg tgacgatccc 720 gcagtggctc tctatacaaa gttgggcata cgggaagaag tgatgcactt tgatatcgac 780 ccaagtaccg ccacctaaca attcgttcaa gccgagatcg gcttcccggc cgcggagttg 840 ttcggtaaat tgtcacaacg ccgcggccat cggca 875 SEQ ID NO. 18 <211> 1582 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 18 actagtatga aattaaatgg atatttggta catttaattc cacaaaaatg tccaatactt 60 aaaatacaaa attaaaagta ttagttgtaa acttgactaa cattttaaat tttaaatttt 120 ttcctaatta tatattttac ttgcaaaatt tataaaaatt ttatgcattt ttatatcata 180 ataataaaac ctttattcat ggtttataat ataataattg tgatgactat gcacaaagca 240 gttctagtcc catatatata actatatata acccgtttaa agatttattt aaaaatatgt 300 gtgtaaaaaa tgcttatttt taattttatt ttatataagt tataatatta aatacacaat 360 gattaaaatt aaataataat aaatttaacg taacgatgag ttgttttttt attttggaga 420 tacacgcata tggtaccagt atctttcaca agtcttttag cagcatctcc accttcacgt 480 gcaagttgcc gtccagctgc tgaagtggaa tcagttgcag tagaaaaacg tcaaacaatt 540 caaccaggta caggttacaa taacggttac ttttattctt actggaatga tggacacggt 600 ggtgttacat atactaatgg acctggtggt caatttagtg taaattggag taactcaggc 660 aattttgttg gaggaaaagg ttggcaacct ggtacaaaga ataaggtaat caatttctct 720 ggtagttaca accctaatgg taattcttat ttaagtgtat acggttggag ccgtaaccca 780 ttaattgaat attatattgt agagaacttt ggtacataca acccttcaac aggtgctact 840 aaattaggtg aagttacttc agatggatca gtttatgata tttatcgtac tcaacgcgta 900 aatcaaccat ctataattgg aactgccact ttctaccaat actggagtgt aagacgtaat 960 catcgttcaa gtggtagtgt taatacagca aaccacttta atgcatgggc tcaacaaggt 1020 ttaacattag gtacaatgga ctatcaaatt gtagctgttg aaggttattt ttcatcaggt 1080 agtgcttcta tcactgttag cggtaccggt gaaaacttat actttcaagg ctcaggtggc 1140 ggtggaagtg attacaaaga tgatgatgat aaaggaaccg gttaatctag acttagcttc 1200 aactaactct agctcaaaca actaattttt ttttaaacta aaataaatct ggttaaccat 1260 acctggttta ttttagttta gtttatacac acttttcata tatatatact taatagctac 1320 cataggcagt tggcaggacg tccccttacg ggacaaatgt atttattgtt gcctgccaac 1380 tgcctaatat aaatattagt ggacgtcccc ttccccttac gggcaagtaa acttagggat 1440 tttaatgctc cgttaggagg caaataaatt ttagtggcag ttgcctcgcc tatcggctaa 1500 caagttcctt cggagtatat aaatatcctg ccaactgccg atatttatat actaggcagt 1560 ggcggtacca ctcgacacta gt 1582 SEQ ID NO. 19 <211> 2017 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 19 actagtatga aattaaatgg atatttggta catttaattc cacaaaaatg tccaatactt 60 aaaatacaaa attaaaagta ttagttgtaa acttgactaa cattttaaat tttaaatttt 120 ttcctaatta tatattttac ttgcaaaatt tataaaaatt ttatgcattt ttatatcata 180 ataataaaac ctttattcat ggtttataat ataataattg tgatgactat gcacaaagca 240 gttctagtcc catatatata actatatata acccgtttaa agatttattt aaaaatatgt 300 gtgtaaaaaa tgcttatttt taattttatt ttatataagt tataatatta aatacacaat 360 gattaaaatt aaataataat aaatttaacg taacgatgag ttgttttttt attttggaga 420 tacacgcata tggtaccaca caagttcaca ggtgttaacg ctaaattcca gcaaccagca 480 ttaagaaatt tatctccagt ggtagttgag cgcgaacgtg aggaatttgt aggattcttt 540 ccacaaattg ttcgtgactt aactgaagat ggtattggtc atccagaagt aggtgacgct 600 gtagctcgtc ttaaagaagt attacaatac aacgcacctg gtggtaaatg caatagaggt 660 ttaacagttg ttgcagctta ccgtgaactt tctggaccag gtcaaaaaga cgctgaaagt 720 cttcgttgtg ctttagcagt aggatggtgt attgaattat tccaagcctt tttcttagtt 780 gctgacgata taatggacca gtcattaact agacgtggtc aattatgttg gtacaagaaa 840 gaaggtgttg gtttagatgc aataaatgat tcttttcttt tagaaagctc tgtgtatcgc 900 gttcttaaaa agtattgccg tcaacgtcca tattatgtac atttattaga gctttttctt 960 caaacagctt accaaacaga attaggacaa atgttagatt taatcactgc tcctgtatct 1020 aaggtagatt taagccattt ctcagaagaa cgttacaaag ctattgttaa gtataaaact 1080 gctttctatt cattctattt accagttgca gcagctatgt atatggttgg tatagattct 1140 aaagaagaac atgaaaacgc aaaagctatt ttacttgaga tgggtgaata cttccaaatt 1200 caagatgatt atttagattg ttttggcgat cctgctttaa caggtaaagt aggtactgat 1260 attcaagata acaaatgttc atggttagtt gtgcaatgct tacaaagagt aacaccagaa 1320 caacgtcaac ttttagaaga taattacggt cgtaaagaac cagaaaaagt tgctaaagtt 1380 aaagaattat atgaggctgt aggtatgaga gccgcctttc aacaatacga agaaagtagt 1440 taccgtcgtc ttcaagagtt aattgagaaa cattctaatc gtttaccaaa agaaattttc 1500 ttaggtttag ctcagaaaat atacaaacgt caaaaaggta ccggtgaaaa cttatacttt 1560 caaggctcag gtggcggtgg aagtgattac aaagatgatg atgataaagg aaccggttaa 1620 tctagactta gcttcaacta actctagctc aaacaactaa ttttttttta aactaaaata 1680 aatctggtta accatacctg gtttatttta gtttagttta tacacacttt tcatatatat 1740 atacttaata gctaccatag gcagttggca ggacgtcccc ttacgggaca aatgtattta 1800 ttgttgcctg ccaactgcct aatataaata ttagtggacg tccccttccc cttacgggca 1860 agtaaactta gggattttaa tgctccgtta ggaggcaaat aaattttagt ggcagttgcc 1920 tcgcctatcg gctaacaagt tccttcggag tatataaata tcctgccaac tgccgatatt 1980 tatatactag gcagtggcgg taccactcga cactagt 2017 SEQ ID NO. 20 <211> 6521 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 20 tcgtgtagat aactacgata cgggagggct taccatctgg ccccagtgct gcaatgatac 60 cgcgagaccc acgctcaccg gctccagatt tatcagcaat aaaccagcca gccggaaggg 120 ccgagcgcag aagtggtcct gcaactttat ccgcctccat ccagtctatt aattgttgcc 180 gggaagctag agtaagtagt tcgccagtta atagtttgcg caacgttgtt gccattgcta 240 caggcatcgt ggtgtcacgc tcgtcgtttg gtatggcttc attcagctcc ggttcccaac 300 gatcaaggcg agttacatga tcccccatgt tgtgcaaaaa agcggttagc tccttcggtc 360 ctccgatcgt tgtcagaagt aagttggccg cagtgttatc actcatggtt atggcagcac 420 tgcataattc tcttactgtc atgccatccg taagatgctt ttctgtgact ggtgagtact 480 caaccaagtc attctgagaa tagtgtatgc ggcgaccgag ttgctcttgc ccggcgtcaa 540 tacgggataa taccgcgcca catagcagaa ctttaaaagt gctcatcatt ggaaaacgtt 600 cttcggggcg aaaactctca aggatcttac cgctgttgag atccagttcg atgtaaccca 660 ctcgtgcacc caactgatct tcagcatctt ttactttcac cagcgtttct gggtgagcaa 720 aaacaggaag gcaaaatgcc gcaaaaaagg gaataagggc gacacggaaa tgttgaatac 780 tcatactctt cctttttcaa tattattgaa gcatttatca gggttattgt ctcatgagcg 840 gatacatatt tgaatgtatt tagaaaaata aacaaatagg ggttccgcgc acatttcccc 900 gaaaagtgcc acctgacgtc taagaaacca ttattatcat gacattaacc tataaaaata 960 ggcgtatcac gaggcccttt cgtctcgcgc gtttcggtga tgacggtgaa aacctctgac 1020 acatgcagct cccggagacg gtcacagctt gtctgtaagc ggatgccggg agcagacaag 1080 cccgtcaggg cgcgtcagcg ggtgttggcg ggtgtcgggg ctggcttaac tatgcggcat 1140 cagagcagat tgtactgaga gtgcaccata ggcggccgcg gcgcgccgtt ccggatctgc 1200 atcctgcgat gcagatccgg aacataatgg tgcagggcgc tgacttccgc gtttccagac 1260 tttacgaaac acggaaaccg aagaccattc atgttgttgc tcaggtcgca gacgttttgc 1320 agcagcagtc gcttcacgtt cgctcgcgta tcggtgattc attctgctaa ccagtaaggc 1380 aaccccgcca gcctagccgg gtcctcaacg acaggagcac gatcatgcgc acccgtggcc 1440 aggacccaac gctgcccgag atgcgccgcg tgcggctgct ggagatggcg gacgcgatgg 1500 atatgttctg ccaagggttg gtttgcgcat tcacagttct ccgcaagaat tgattggctc 1560 caattcttgg agtggtgaat ccgttagcga ggtgccgccg gcttccattc aggtcgaggt 1620 ggcccggctc catgcaccgc gacgcaacgc ggggaggcag acaaggtata gggcggcgcc 1680 tacaatccat gccaacccgt tccatgtgct cgccgaggcg gcataaatcg ccgtgacgat 1740 cagcggtcca atgatcgaag ttaggctggt aagagccgcg agcgatcctt gaagctgtcc 1800 ctgatggtcg tcatctacct gcctggacag catggcctgc aacgcgggca tcccgatgcc 1860 gccggaagcg agaagaatca taatggggaa ggccatccag cctcgcgtcg cgaacgccag 1920 caagacgtag cccagcgcgt cggccgccat gccggcgata atggcctgct tctcgccgaa 1980 acgtttggtg gcgggaccag tgacgaaggc ttgagcgagg gcgtgcaaga ttccgaatac 2040 cgcaagcgac aggccgatca tcgtcgcgct ccagcgaaag cggtcctcgc cgaaaatgac 2100 ccagagcgct gccggcacct gtcctacgag ttgcatgata aagaagacag tcataagtgc 2160 ggcgacgata gtcatgcccc gcgcccaccg gaaggagctg actgggttga aggctctcaa 2220 gggcatcggt cgagcttgac attgtaggac gtttaaacat taccctgtta tccctaggat 2280 cctacgtata catactccga aggaggacaa atttatttat tgtggtacaa taaataagtg 2340 gtacaataaa taaattgtat gtaaacccct tccccttcgg gacgtcccct tacgggaata 2400 taaatattag tggcagttgc ctgccaacaa atttatttat tgtattaaca taggcagtgg 2460 cggtaccact gccactggcg tcctaatata aatattgggc aactaaagtt tatcgcagta 2520 ttaacatagg cagtggcggt accactgcca ctggcgtcct ccttcggagt atgtaaacct 2580 gctaccgcag caaataaatt ttattctatt ttaatactac aatatttaga ttcccgttag 2640 gggataggcc aggcaattgt cactggcgtc atagtatatc aatattgtaa cagattgaca 2700 ccctttaagt aaacattttt tttaggattc atatgaaatt aaatggatat ttggtacatt 2760 taattccaca aaaatgtcca atacttaaaa tacaaaatta aaagtattag ttgtaaactt 2820 gactaacatt ttaaatttta aattttttcc taattatata ttttacttgc aaaatttata 2880 aaaattttat gcatttttat atcataataa taaaaccttt attcatggtt tataatataa 2940 taattgtgat gactatgcac aaagcagttc tagtcccata tatataacta tatataaccc 3000 gtttaaagat ttatttaaaa atatgtgtgt aaaaaatgct tatttttaat tttattttat 3060 ataagttata atattaaata cacaatgatt aaaattaaat aataataaat ttaacgtaac 3120 gatgagttgt ttttttattt tggagataca cgcaatgaca attgcgatcg gtacatatca 3180 agagaaacgc acatggttcg atgacgctga tgactggctt cgtcaagacc gtttcgtatt 3240 cgtaggttgg tcaggtttat tactattccc ttgtgcttac tttgcaactc cggtccggcg 3300 gccgcctcga gacgcttacc agacaaggca gttttttcat tcttttaaag caggcagttc 3360 tgaaggggaa aagggactgc ctactgcggt cctaggtaaa tacattttta tgcaatttat 3420 ttcttgtgct agtaggtttc tatactcaca agaagcaacc ccttgacgag agaacgttat 3480 cctcagagta tttataatcc tgagagggaa tgcactgaag aatattttcc ttatttttta 3540 cagaaagtaa ataaaatagc gctaataacg cttaattcat ttaatcaatt atggcaacag 3600 gaacttctaa agctaaacca tcaaaagtaa attcagactt ccaagaacct ggtttagtta 3660 caccattagg tactttatta cgtccactta actcagaagc aggtaaagta ttaccaggct 3720 ggggtacaac tgttttaatg gctgtattta tccttttatt tgcagcattc ttattaatca 3780 ttttagaaat ttacaacagt tctttaattt tagatgacgt ttctatgagt tgggaaactt 3840 tagctaaagt ttcttaattt tatttaacac aaacataaaa tataaaactg tttgttaagg 3900 ctagctgcta agtcttcttt tcgctaaggt aaactaagca actcaaccat atttatattc 3960 ggcagtggca ccgccactgc cactggcctt ccgttaagat aaacgcgtta atagctcact 4020 tttctttaaa tttaattttt aatttaaagg tgtaagcaaa ttgcctgacg agagatccac 4080 ttaaaggatg acagtggcgg gctactgcct acttccctcc gggataaaat ttatttgaaa 4140 aacgttagtt acttcctaac ggagcattga catccccata tttatattag gacgtcccct 4200 tcgtcgacat taccctgtta tccctaggcc ggcctaagaa accattatta tcatgacatt 4260 aacctataaa aataggcgta tcacgaggcc ctttcgtctt caagaaattc ggtcgaaaaa 4320 agaaaaggag agggccaaga gggagggcat tggtgactat tgagcacgtg agtatacgtg 4380 attaagcaca caaaggcagc ttggagtatg tctgttatta atttcacagg tagttctggt 4440 ccattggtga aagtttgcgg cttgcagagc acagaggccg cagaatgtgc tctagattcc 4500 gatgctgact tgctgggtat tatatgtgtg cccaatagaa agagaacaat tgacccggtt 4560 attgcaagga aaatttcaag tcttgtaaaa gcatataaaa atagttcagg cactccgaaa 4620 tacttggttg gcgtgtttcg taatcaacct aaggaggatg ttttggctct ggtcaatgat 4680 tacggcattg atatcgtcca actgcatgga gatgagtcgt ggcaagaata ccaagagttc 4740 ctcggtttgc cagttattaa aagactcgta tttccaaaag actgcaacat actactcagt 4800 gcagcttcac agaaacctca ttcgtttatt cccttgtttg attcagaagc aggtgggaca 4860 ggtgaacttt tggattggaa ctcgatttct gactgggttg gaaggcaaga gagccccgaa 4920 agcttacatt ttatgttagc tggtggactg acgccagaaa atgttggtga tgcgcttaga 4980 ttaaatggcg ttattggtgt tgatgtaagc ggaggtgtgg agacaaatgg tgtaaaagac 5040 tctaacaaaa tagcaaattt cgtcaaaaat gctaagaaat aggttattac tgagtagtat 5100 ttatttaagt attgtttgtg cacttgcctg caggcctttt gaaaagcaag cataaaagat 5160 ctaaacataa aatctgtaaa ataacaagat gtaaagataa tgctaaatca tttggctttt 5220 tgattgattg tacaggaaaa tatacatcgt taattaagcg gccgcgagct tggcgtaatc 5280 atggtcatag ctgtttcctg tgtgaaattg ttatccgctc acaattccac acaacatacg 5340 agccggaagc ataaagtgta aagcctgggg tgcctaatga gtgagctaac tcacattaat 5400 tgcgttgcgc tcactgcccg ctttccagtc gggaaacctg tcgtgccagc tgcattaatg 5460 aatcggccaa cgcgcgggga gaggcggttt gcgtattggg cgctcttccg cttcctcgct 5520 cactgactcg ctgcgctcgg tcgttcggct gcggcgagcg gtatcagctc actcaaaggc 5580 ggtaatacgg ttatccacag aatcagggga taacgcagga aagaacatgt gagcaaaagg 5640 ccagcaaaag gccaggaacc gtaaaaaggc cgcgttgctg gcgtttttcc ataggctccg 5700 cccccctgac gagcatcaca aaaatcgacg ctcaagtcag aggtggcgaa acccgacagg 5760 actataaaga taccaggcgt ttccccctgg aagctccctc gtgcgctctc ctgttccgac 5820 cctgccgctt accggatacc tgtccgcctt tctcccttcg ggaagcgtgg cgctttctca 5880 tagctcacgc tgtaggtatc tcagttcggt gtaggtcgtt cgctccaagc tgggctgtgt 5940 gcacgaaccc cccgttcagc ccgaccgctg cgccttatcc ggtaactatc gtcttgagtc 6000 caacccggta agacacgact tatcgccact ggcagcagcc actggtaaca ggattagcag 6060 agcgaggtat gtaggcggtg ctacagagtt cttgaagtgg tggcctaact acggctacac 6120 tagaagaaca gtatttggta tctgcgctct gctgaagcca gttaccttcg gaaaaagagt 6180 tggtagctct tgatccggca aacaaaccac cgctggtagc ggtggttttt ttgtttgcaa 6240 gcagcagatt acgcgcagaa aaaaaggatc tcaagaagat cctttgatct tttctacggg 6300 gtctgacgct cagtggaacg aaaactcacg ttaagggatt ttggtcatga gattatcaaa 6360 aaggatcttc acctagatcc ttttaaatta aaaatgaagt tttaaatcaa tctaaagtat 6420 atatgagtaa acttggtctg acagttacca atgcttaatc agtgaggcac ctatctcagc 6480 gatctgtcta tttcgttcat ccatagttgc ctgactcccc g 6521 SEQ ID NO. 21 <211> 46 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 21 ttggttgcgg ccgcttaatt aacgatgtat attttcctgt acaatc 46 SEQ ID NO. 22 <211> 58 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 22 gtttaaacat taccctgtta tccctaggcc ggcctaagaa accattatta tcatgaca 58 SEQ ID NO. 23 <211> 58 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 23 ggccggccta gggataacag ggtaatgttt aaacgtccta caatgtcaag ctcgaccg 58 SEQ ID NO. 24 <211> 46 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 24 ttggttgcgg ccgcggcgcg ccgttccgga tctgcatcgc aggatg 46 SEQ ID NO. 25 <211> 54 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 25 ttggtttagg gataacaggg taatgtcgac aacatgctaa gtttacttgc ccga 54 SEQ ID NO. 26 <211> 52 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 26 actccggtcc ggcggccgcc tcgagacgac ttgtccgctt catcagacac gg 52 SEQ ID NO. 27 <211> 52 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 27 cgtctcgagg cggccgccgg accggagttg caaagtaagc acaagggaat ag 52 SEQ ID NO. 28 <211> 59 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 28 tggttattac cctgttatcc ctaggatcct acgtatacat actccgaagg aggacaaat 59 SEQ ID NO. 29 <211> 48 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 29 cgtctcgagg cggccgccgg accggagtca tccgccccat ctaataaa 48 SEQ ID NO. 30 <211> 56 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 30 ttggttatta ccctgttatc cctaggatcc tacgtacagt ggcggtacca caataa 56 SEQ ID NO. 31 <211> 53 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 31 ttggtttagg gataacaggg taatgtcgac gtatgtaaac cccttcgggc aac 53 SEQ ID NO. 32 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 32 actccggtcc ggcggccgcc tcgagacgcc gtaaacagat aggaatgacg 50 SEQ ID NO. 33 <211> 48 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 33 cgtctcgagg cggccgccgg accggagtga atccaggcat cttgggta 48 SEQ ID NO. 34 <211> 56 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 34 ttggttatta ccctgttatc cctaggatcc tacgtaggga aaggtgcaac tacctg 56 SEQ ID NO. 35 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 35 ttggtttagg gataacaggg taatgtcgac aacatgcttg gcactggttt 50 SEQ ID NO. 36 <211> 54 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 36 actccggtcc ggcggccgcc tcgagacgtg gtaatttatt tggtaatttg gtca 54 SEQ ID NO. 37 <211> 48 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 37 cgtctcgagg cggccgccgg accggagtaa ccaaccattg tgtgacca 48 SEQ ID NO. 38 <211> 56 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 38 ttggttatta ccctgttatc cctaggatcc tacgtaagag tacgggatgt gggatg 56 SEQ ID NO. 39 <211> 53 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 39 ttggtttagg gataacaggg taatgtcgac ccataagtaa actccctttt gga 53 SEQ ID NO. 40 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 40 actccggtcc ggcggccgcc tcgagacgta aaattgtttg tgtggtctgg 50 SEQ ID NO. 41 <211> 52 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 41 cgtctcgagg cggccgccgg accggagtaa atgtaacttt tgttgtcgat cc 52 SEQ ID NO. 42 <211> 60 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 42 ttggttatta ccctgttatc cctaggatcc tacgtagggt aaataaattt tagtggacgt 60 SEQ ID NO. 43 <211> 54 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 43 ttggtttagg gataacaggg taatgtcgac gaaggggacg tcctaatata aata 54 SEQ ID NO. 44 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 44 actccggtcc ggcggccgcc tcgagacgct taccagacaa ggcagttttt 50 SEQ ID NO. 45 <211> 48 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 45 cgtctcgagg cggccgccgg accggagtgc tgctggttat gcagttga 48 SEQ ID NO. 46 <211> 56 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 46 ttggttatta ccctgttatc cctaggatcc tacgtagagg accaaatcct gcgtta 56 SEQ ID NO. 47 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 47 ttggtttagg gataacaggg taatgtcgac tttgcttgcc tacaagagca 50 SEQ ID NO. 48 <211> 48 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 48 actccggtcc ggcggccgcc tcgagacgtt gcattaaaat ccggaagg 48 SEQ ID NO. 49 <211> 36 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 49 ttggttcccg ggtcgcgcgt ttcggtgatg acggtg 36 SEQ ID NO. 50 <211> 42 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 50 ttggttgtcg acccgcggtg atgcggtatt ttctccttac gc 42 SEQ ID NO. 51 <211> 36 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 51 ttggttcccg ggtcctgatg cggtattttc tcctta 36 SEQ ID NO. 52 <211> 36 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 52 ttggttcccg ggtcgcgcgt ttcggtgatg acggtg 36 SEQ ID NO. 53 <211> 36 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 53 ttggttcccg ggaagcttgc atgcctgcag gtcgat 36 SEQ ID NO. 54 <211> 36 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 54 ttggttcccg ggagcagttg ctttctccta tgggaa 36 SEQ ID NO. 55 <211> 36 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 55 ttggttcccg ggttaggtct agagatctgt ttagct 36 SEQ ID NO. 56 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 56 ttggttgtcg acggccggcc actagttcgc gcgtttcggt gatgacggtg 50 SEQ ID NO. 57 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 57 ttggttgtcg acggccggcc actagttgat gcggtatttt ctccttacgc 50 SEQ ID NO. 58 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 58 ttggttgtcg acggccggcc actagtgatc ctcgagagat cttatgtatg 50 SEQ ID NO. 59 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 59 ttggttgtcg acggccggcc actagttaca ataaaccaag atgaagctgc 50 SEQ ID NO. 60 <211> 50 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 60 ttggttgtcg acggccggcc actagttatt aagggttctc gagagctcgt 50 SEQ ID NO. 61 <211> 39 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 61 ttggttcccg gggatatcaa tacattcaaa tatgtatcc 39 SEQ ID NO. 62 <211> 41 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 62 ttggttcccg gggatatcat ccttttaaat taaaaatgaa g 41 SEQ ID NO. 63 <211> 42 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 63 ttggttcccg gggatatctt ctcatgtttg acagcttatc at 42 SEQ ID NO. 64 <211> 42 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 64 aaccaacccg gggatatcat gttctgccaa gggttggttt gc 42 SEQ ID NO. 65 <211> 42 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 65 ttggttcccg gggatatccc caatccaggt cctgaccgtt ct 42 SEQ ID NO. 66 <211> 42 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 66 aaccaacccg gggatatctc acttattcag gcgtagcaac ca 42 SEQ ID NO. 67 <211> 42 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 67 ttggttcccg gggatatctt gccgggtgac gcacaccgtg ga 42 SEQ ID NO. 68 <211> 42 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 68 aaccaacccg gggatatctg ccgatggccg cggcgttgtg ac 42 SEQ ID NO. 69 <211> 23 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 69 catactactc agtgcagctt cac 23 SEQ ID NO. 70 <211> 25 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 70 gtgaaggagc atgttcggca cacag 25 SEQ ID NO. 71 <211> 25 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 71 ctgtgtgccg aacatgctcc ttcac 25 SEQ ID NO. 72 <211> 24 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 72 ttgtcatatt actagttggt gtgg 24 SEQ ID NO. 73 <211> 24 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 73 ggtcggcgac aactcaatcg acag 24 SEQ ID NO. 74 <211> 23 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 74 caacggatgt tttattgcct ttg 23 SEQ ID NO. 75 <211> 24 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 75 gcaaggattt tcttaacttc ttcg 24 SEQ ID NO. 76 <211> 25 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 76 atgaagtcct ttgttactgt gccgc 25 SEQ ID NO. 77 <211> 23 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 77 caggaattcg ctaaagcctg tgg 23 SEQ ID NO. 78 <211> 24 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 78 gagaataaaa gtctaagatg tgcg 24 SEQ ID NO. 79 <211> 24 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 79 gacatatatg aacatcgcgg agtg 24 SEQ ID NO. 80 <211> 24 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 80 cttcaatgca tcagcactac caac 24 SEQ ID NO. 81 <211> 23 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 81 ggtcagattg ccctgtcgtt ctc 23 SEQ ID NO. 82 <211> 24 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 82 cagtttcatt tgatgctcga tgag 24 SEQ ID NO. 83 <211> 25 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 83 ggtagaattg tccgttagtt gttta 25 SEQ ID NO. 84 <211> 25 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 84 aacagacgta gtaagaacca ccagc 25 SEQ ID NO. 85 <211> 25 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 85 ctccagaagc gttaatgtct ggctt 25 SEQ ID NO. 86 <211> 24 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 86 cgaccatcag ggacagcttc aagg 24 SEQ ID NO. 87 <211> 20 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 87 ggtctccaga acttgctgct 20 SEQ ID NO. 88 <211> 20 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 88 cctatcccct aacgggaatc 20 SEQ ID NO. 89 <211> 22 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 89 agattttgtg taatgccgaa gt 22 SEQ ID NO. 90 <211> 20 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 90 tgccgtaatc attgaccaga 20 SEQ ID NO. 91 <211> 20 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 9].
ggtgcgtaaa atcgttggat 20 SEQ ID NO. 92 <211> 20 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 92 tttttcggcg tacaaaggac 20 SEQ ID NO. 93 <211> 20 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 93 ctcgcctatc ggctaacaag 20 SEQ ID NO. 94 <211> 20 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 94 cacaagaagc aaccccttga 20 SEQ ID NO. 95 <211> 23 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 95 aaatttaacg taacgatgag ttg 23 SEQ ID NO. 96 <211> 23 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 96 gcactacctg atgaaaaata acc 23 SEQ ID NO. 97 <211> 23 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 97 ggaaggggac gtaggtacat aaa 23 SEQ ID NO. 98 <211> 23 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 98 ttagaacgtg ttttgttccc aat 23 SEQ ID NO. 99 <211> 22 <212> DNA <213> Artificial Sequence <223> Description of Artificial Sequence: Synthetic primer <400> 99 cgttcttctg agaaatggct ta 22
RELEVANT PARAGRAPHS
1. An isolated vector comprising: (a) a yeast element; (h) a bacterial origin of replication; and (c) at least 20 kb genomic DNA from a photosynthetic organism.
2. The vector of paragraph 1, wherein said yeast element is a yeast centromere, a yeast autonomous replicating sequence, or a combination thereof 3. The vector of paragraph 1 or paragraph 2, wherein said organism is a non-vascular photosynthetic organism.
4. The vector of any preceding paragraph, wherein said organism is selected from the group consisting of: macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sal/na, S. quadricanda or H pluva/is.
5. The vector of any preceding paragraph, wherein said genomic DNA is modified.
6. The vector of paragraph 5, wherein said modification is insertion of a heterologous or homologous potynucteotide, deletion of one or more nucleic acid bases, mutation of one or more nucleic acid bases, rearrangement of one or more potynucleotides, or a combination thereof 7. The vector of paragraph 5 or paragraph 6, wherein said modification is synthetic.
8. The vector of paragraph 5, wherein expression of said vector in a host cell produces a product not naturally produced by said host cell.
9. The vector of paragraph 8, wherein said product is a biomass-degrading enzyme, a fatty acid, a terpene or a terpenoid.
10. The vector of paragraph 5, wherein expression of said vector results in an increase production of a product naturally produced by said host cell.
11. The vector of paragraph 10, wherein said product is a biomass-degrading enzyme, a terpene or a terpenoid.
12. The vector of any preceding paragraph, thither comprising one or more selection markers.
13. The vector of paragraph 12, wherein said selection marker is selected from tile group consisting of a yeast auxotrophic marker, a yeast antibiotic resistance marker, a bacterial auxotrophic marker, a bacterial antibiotic resistance marker, an algae auxotrophic marker, an algae antibiotic resistance marker or a combination thereof.
14. The vector of any preceding paragraph, wherein said genomic DNA is chloroplast genomic DNA, optionally comprising 10-200 genes.
15. The vector of any preceding paragraph, wherein said chioroplast genomic DNA comprises all essential chioroplast genes.
16. The vector of any preceding paragraph, wherein said chloroplast genomic DNA comprises 30-400 kb.
17. A host cell compri sing a vector of paragraph 1.
18. The host cell of paragraph 17, wherein said host cell is naturally non-photosynthetic.
19. The host cell of paragraph 17, wherein said host cell is naturally photosynthetic.
20. The host cell of paragraph 17, wherein said cell is from an organism selected from the group consisting of: Saccharomyces cerevisiae, Eselierichia coli, macroalgae, microatgae, Ch. vulgaris, C. rein Jiardtii, D. salina, S. quadricana'a or H. pluvalis.
21. A method for producing a vector comprising: (a) inserting a polynucleotide comprising targeting DNA into a vector, wherein said vector comprises a yeast centromere, a yeast autonomous replicating sequence, and a bacterial origin of replication; (b) transforming an organism with said vector; and (c) capturing a portion of a chloroplast genome, thereby producing a vector with said portion of a chioroplast genome.
22. The method ofparagraph 21, wherein said targeting DNA is chloroplast genomic DNA.
23. The method ofparagraph 21 or paragraph 22, wherein said portion is 10-400 kb in length 24. The method ofparagraphs 21 to 23, wherein said capturing step occurs by recombination.
25. The method of paragraph 24, wherein said portion of a chloroplast genome is co-transformed into said organism with said vector.
26. The method of paragraph 24, wherein said recombination occurs in vivo.
27. The method of any ofparagraphs 21 to 26, wherein said organism is eukaryotic.
28. The method of any ofparagraphs 21 to 27, wherein said organism is a photosynthetic organism.
29. The method of any ofparagraphs 21 to 28, wherein said organism is a non-vascular photosynthetic organism.
30. The method ofparagraph 29, wherein said organism is selected from the group consisting of: macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sauna, S. quadricanda or H pluva/is.
31. The method of any ofparagraphs 21 to 27, wherein said organism is non-photosynthetic.
32. The method ofparagraph 31, wherein said organism is yeast.
33. The method ofparagraph 32, wherein said yeast comprises exogenous chloroplast DNA.
34. The method of any ofparagraphs 21 to 33, ffirther comprising modifying said portion of a chloroplast genome 35. The method ofparagraph 34, wherein said modifIcation step comprises homologous recombination.
36. The method of paragraph 34, wherein said recombination occurs in an organism.
37. The method of paragraph 36, wherein said organism is eukaryotic.
38. The method ofparagraph 37, wherein said organism is a photosynthetic organism.
39. The method of paragraph 38, wherein said organism is a non-vascular photosynthetic organism.
40. The vector of paragraph 39, wherein said organism is selected from the group consisting of macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sauna, S. quadricanda or H. pluva/is.
41. The method ofparagraph 36, wherein said organism is non-photosynthetic.
42. The method ofparagraph 41, wherein said organism is yeast.
43. The method of any ofparagraphs 34 to 42, wherein said modifying step comprises addition of a polynucleotide, deletion of one or more nucleic acid bases, mutation of one or more nucleic acid bases, rearrangement or a polynucleotide, or combination thereof.
44. An isolated vector comprising: essential chlorop last genes, a selectable marker and a manipulation in one or more nucleic acids in said vector.
45. The vector of paragraph 44, wherein said essential chloroplast genes are cloned from a non-vascular phiotoshynthetic organism.
46. The vector of paragraph 45, wherein said organism is selected from the group consisting of: macroalgae, microalgae, Cli. vulgaris, C. reinhardtü, D. sauna, S. quadricanda or H. pluvalis.
47. The vector of paragraph 44, wherein said essential chloroplast genes are synthetic.
48. The vector of any of paragraphs 44 to 47, further comprising an expression cassette.
49. The vector of paragraph 48, wherein said expression cassette ffirther comprises a region for integration into target DNA.
50. The vector of paragraph 49, wherein said target DNA is organelle DNA.
51. The vector of paragraph 44, further comprising one or more selection markers.
52. The vector of paragraph 51, wherein said selection marker is selected from the group consisting of an auxotrophic marker, an antibiotic resistance marker, a chloroplast marker, or combinations thereof.
53. The vector of any of paragraphs 44 to 52, wherein said essential chloroplast genes are those required for cliloroplast ffinction, photosynthesis, carbon fixation, production of one or more hydrocarbons, or a combination thereof 54. The vector of any of paragraphs 44 to 53, wherein said essential chloroplast genes comprise up to 200 genes.
55. The vector of any of paragraphs 44 to 54, wherein said essential chloroplast genes consist of up to 400 kh.
56. The vector of any of paragraphs 44 to 55, wherein said manipulation comprises an addition, deletion, mutation, or rearrangement.
57. The vector of any of paragraphs 44 to 56, wherein expression of said vector in a host cell produces a product not naturally produced by said host cell.
58. The vector of any of paragraphs 44 to 57, wherein expression of said vector results in an increase production of a product naturally produced by said host cell.
59. The vector of paragraph 57 or 58, wherein said product is a biomass degrading enzyme, fatty acid, terpene or terpenoid.
60. An isolated chlorop last comprising a vector of any ofparagraphs 44 to 59.
61. A host cell comprising a vector of any of paragraphs 44 to 59.
62. The host cell of paragraph 61, wherein said host cell is naturally non-photosynthetic.
63. The host cell of paragraph 61, wherein said host cell is naturally photosynthetic.
64. The host cell of paragraph 61, wherein said cell is from an organism selected from the group consisting of: Saccharornvces cerevisiae, Escherichia co/i, macroalgae, microalgae, Ch. vulgaris, C. reinhardtii, D. sauna, S. quadricanda or H. p/ma/is.
65. A method for transforming a cell or organism comprising inserting into said cell or organism a vector comprising all essential chloroplast genes and optionally one or more genes not naturally occurring in said cell or organism.
66. The method ofparagraph 65, further comprising the step of eliminating substantially all chloroplast genomes in said cell or organism.
67. The method ofparagraph 65 or 66, wherein said cell or organism is naturally non-photosthetic.
68. The method ofparagraph 65 or 66, wherein said cell or organism is naturally phiotosmthetic.
69. The method ofparagraph 65, wherein said cell or organism is eukaryotic.
70. The method of paragraph 65, wherein said organism is non-vascular.
71. The method of any of paragraphs 65 to 70, wherein said vector further comprises an expression cassette.
72. The method of paragraph 71, wherein said expression cassette integrates into non-nuclear DNA.
73. The method of any ofparagraphs 65 to 72, wherein said one or more genes not naturally occuning in said cell or organism is a gene in the isoprenoid pathway, MVA pathway, or MEP pathway.
74. The method of any o fp aragraphs 65 to 73, wherein said essential chioroplast genes are those that are required for chioroplast function, photosynthesis, carbon fixation, production of one or more hydrocarbons, or a combination thereof 75. A method for modifying an organism comprising: transforming said organism with a vector comprising one or more polynucleotides sufficient to perform chioroplast ftinction.
76. The method ofparagraph 75, wherein said vector fUrther comprises sequence for production or secretion of a compound from said organism.
77. The method ofparagraph 76, wherein said compound is an isoprenoid.
78. The method of paragraph 75 or 76, wherein said vector comprises all essential chioroplast genes.
79. The method of paragraph 78, wherein said essential chioroplast genes are rearranged or mutated.
80. The method of any of paragraphs 75 to 79, wherein organism comprises essentially no chioroplast genome prior to said transformation.
81. A method for making a product from an organism comprising: transforming said organism with a vector comprising at least 20 kb of genomic DNA and one or more of the following: (i) a gene not naturally occurring in said organism; (ii) a deletion in a gene naturally occurring in said organism; (iii) a rearrangement of genes naturally occurring in said organism; and (iv) a mutation in a gene naturally occurring in said organism.
82. The method ofparagraph 81, wherein said organism is naturally photosynthetic.
83. The method ofparagraph 81 or 82, wherein said additional genes is in the isoprenoid pathway, MYA pathway, or MEP pathway.
84. A method for transforming a cell or organism comprising inserting into said ccii or organism a ehloroplast and a vector comprising all essential chioroplast genes.
85. A method of producing an artificial chloroplast genome comprising the steps oL (a) providing a vector comprising one or more essential chloroplast genes; (h) adding to said vector a DNA fragment; (c) transforming a cell or organism with the vector produced by step (b); and (d) determining whether chloroplast flinction exists with said added DNA fragment.
86. The method ofparagraph 85, wherein said added DNA fragments comprises one or more coding regions for an enzyme in the isoprenoid, MVA or MEP pathway.
87. A shuttle vector comprising a chloroplast genome 88. The shuttle vector of paragraph 87, wherein said chloroplast genome is modified.
89. A vector comprising an isolated, functional cliloroplast genome.
90. The vector of paragraph 89, wherein said chloroplast genome is modified.
91. A method of producing an artificial chloroplast genome comprising the steps oL (a) providing a vector comprising all essential chloroplast genes; and (b) removing, adding, mutating, or rearranging DNA from said chloroplast genome.
92. The method of paragraph 91, further comprising the steps of: (c) transforming redacted genome into a host organism; and (d) determining chioroplast function in said host organism.
93. The method ofparagraph 92, wherein steps (b), (e), and (d) are repeated.
94. The method ofparagraph 91, wherein said chioroplast genome is from an organism selected from the group consisting of: macroalgae, microalgae, Ch. vu/garis, C. reinhardui, D. sauna, S. quadricanda or H. pluva/is.
95. The method ofparagraph 92, wherein said host organism is selected from the group consisting of: macroalgae, microalgae, Ch. vu/garis, C. reinhardtii, D. sauna, S. quadricanda or H pluva/is.
96. The method of any ofparagraphs 91 to 94, thrther comprising the step ofremoving redundant DNA from said chioroplast genorne.
97. The method of any ofparagraphs 91 to 96, wherein said vector comprises all or substantially alt of a chloroplast genome.
98. The method of any of paragraphs 91 to 97, wherein said chloroplast genome was cloned from a photosynthetic organism.
99. The method of any ofparagraphs 91 to 97, wherein said chioroplast genome is a synthetic chioroplast genome.
100.The method of any ofparagraphs 91 to 99, wherein said vector ifirther comprises a gene not naturally occurring in said host organism.
101.The method ofparagraph 100 wherein said gene is a gene from the isoprenoid pathway, MYA pathway, or MEP pathway.
102.A method of producing an artificial chloroplast genome comprising the steps of: (a) providing a vector comprising an entire chloroplast genome; (b) deleting a portion of said entire chloroplast genome; and (c) determining whether chloroplast ftrnction exists without said deleted portion.
103.A composition comprising an isolated and functional chloroplast genome.
104.The composition ofparagraph 103, further comprising a modification to said chioroptast genorne.
105.An cx vivo vector comprising: (a) a nucleic acid comprising at least about 10% of a chtoroplast genome; and (b) a manipulation in one or more nucleic acids in said vector.
1 06.The vector of paragraph 105, wherein said nucleic acid is cloned from a non-vascular photosynthetic organism.
1 07.The vector of paragraph 106, wherein said organism is selected from the group consisting of: macroalgae, microalgae, Ch. vu/garis, C. reinhardili, D. sauna, S. quadricanda or H pluva/is.
108.The vector of paragraph 105, wherein said nucleic acid is synthetic.
1 09.The vector of paragraph 105, ifirther comprising an expression cassette.
1 10.The vector of paragraph 109, wherein said expression cassette fijrther comprises a region for integration into target DNA.
111.The vector of paragraph 110, wherein said target DNA is organetle DNA.
112.The vector of any of paragraphs 105 to 111, further comprising one or more selection markers.
113. The vector of paragraph 112, wherein said selection marker is selected from the group consisting of an auxotrophic marker, an antibiotic resistance marker, a chloroplast marker, or combinations thereof.
114. The vector of any of paragraphs 105 to 113, wherein said manipulation comprises an addition, deletion, mutation, or rearrangement.
11 5.The vector of any of paragraphs 105 to 114, wherein expression of said vector results in production of a product not naturally produced by a host cell.
1 16.The vector of any of paragraphs 105 to 114, wherein expression of said vector results in an increase production of a product naturally produced by a host cell.
11 7.The vector of paragraph 115 or 116, wherein said product is a terpene, terpenoid, fatty acid, or biomass degrading enzyme.
1 18.An cx vivo vector comprising: (a) a nucleic acid comprising at least about 20 kitobases of a chioroplast genome; and (b) a manipulation in one or more nucleic acids in said vector.
1 19.The vector of paragraph 118, wherein said nucleic acid is cloned from a non-vascular photosmthetic organism.
1 20.The vector of paragraph 119, wherein said organism is selected from the group consisting of: macroalgae, microalgae, Ch. vu/garis, C. reinhardtü, D. sauna, S. quac/ricanda or H. pluva/is.
121.The vector of paragraph 118, wherein said nucleic acid is synthetic.
1 22.The vector of any of paragraphs 118 to 121, further comprising an expression cassette.
123.The vector of paragraph 122, wherein said expression cassette further comprises a region for integration into target DNA.
1 24.The vector of paragraph 123, wherein said target DNA is organelle DNA.
125.The vector of any of paragraphs 118 to 124, further comprising one or more selection markers.
126. The vector of paragraph 125, wherein said selection marker is selected from the group consisting of an auxotrophic marker, an antibiotic resistance marker, a chloroplast marker, or combinations thereof 1 27.The vector of any of paragraphs 118 to 126, wherein said manipulation comprises an addition, deletion, mutation, or rearrangement.
1 28.The vector of any of paragraphs 118 to 126, wherein expression of said vector results in production of a product not naturally produced by a 110 St cell.
1 29.The vector of any of paragraphs 118 to 126, wherein expression of said vector results in an increase production of a product naturally produced by a host cell.
1 30.The vector of paragraph 128 or 129, wherein said product is a terpene, terpenoid, fatty acid or biomass degrading enzyme.
131.A method of producing a vector containing a reconstructed genome, comprising: (a) introducing two or more vectors into a host cell, wherein said vectors comprise fragments of a genome; (b) recombining said vectors into a single vector comprising at least about 90% of a genorne, thereby producing a vector containing a reconstructed genome.
132.The method ofparagraph 131, wherein said host cell is eukaryotic.
133.The method ofparagraph 131 or 132, wherein said host cell is S. cerevisiae.
134.The method of any ofparagraphs 131 to 133, wherein said genome is an organelle genome.
1 35.The method of paragraph 134, wherein said organelle is a chloroplast.
1 36.The method of paragraph 135, wherein said cliloroplast is an alga chloroplast.
137.The method of paragraph 136, wherein said alga is a microalga.
138.The method ofparagraph 137, wherein said microalga is Ch. vulgaris, C. reinhara'tii, D. sal/na, S. quadricanda or H. p/ma/is.
139.The method of any ofparagraphs 131 to 137, wherein at least one of said vectors comprises a selectable marker.
140.The method of any ofparagraphs 131 to 137, wherein at least one of said fragments is synthetic.
141.The method of any ofparagraphs 131 to 137, ifirther comprising modiflying a portion of said genome.
142.The method ofparagraph 141, wherein said modification comprises an addition, deletion, mutation, or rearrangement.
143.The method ofparagraph 141, wherein said modification is the addition of an exogenous nucleic acid which results in the production or increased production of a terpeue, terpeuoid, fatty acid or biomass degrading enzyme.
Claims (22)
- CLAIMS1. A method for producing a product of interest in a photosynthetic organism comprising: obtaining a plurality of vectors collectively comprising all chloroplast genes necessary for photosynthesis; wherein at least one of said vectors comprises at least one heterologous polynucleotide encoding said product of interest, wherein each vector of said plurality of vectors comprises two regions of homologous recombination with one or two other vectors in said plurality of vectors, wherein at least one vector of said plurality of vectors comprises a yeast DNA replication element and at least on vector of said plurality of vectors comprise a bacterial DNA replication element, wherein at least one vector of said plurality of vectors comprise a yeast stability element comprising at least one yeast selection marker, and said at least one vector comprising a yeast stability element does not contain a yeast DNA replication element; introducing said plurality of vectors into yeast to assemble said plurality of vectors by homologous recombination to produce an assembled chloroplast genome; selecting for complete assembly of said chloroplast genome by selecting for the presence of said at least one yeast stability element; introducing said assembled chloroplast genome into said photosynthetic organism; and expressing said at least one heterologous polynucleotide to produce said product of interest.
- 2. The method of claim 1, wherein said plurality of vectors comprises two vectors and each of said vectors comprise two areas for recombination with the other vector.
- 3. The method of claim 1 or 2, wherein said yeast DNA replication element is a yeast centromere, a yeast autonomous replicating sequence, or both.
- 4. The method of claim 1 or 2, wherein said bacterial DNA replication element is a P1 replication sequence or an F factor replication sequence.
- 5. The method of any one of claims 1-4, wherein in said assembled chloroplast genome comprises a single yeast element.
- 6. The method of any one of claims 1-5, wherein said yeast DNA replication element and said bacterial DNA replication element are contained in the same vector.
- 7. The method of any one of claims 1-6, where at least one of said vectors comprises chemically synthesized DNA.
- 8. The method of any one of claims 1-6, wherein at least one of said vectors comprises genomic chloroplast DNA.
- 9. The method of any one of claims 1-8, wherein said yeast stability element comprises a pair of yeast selection markers.
- 10. The method of claim 9, wherein said pair of selection markers is a URA3 gene and an additional yeast selection marker.
- 11. The method of claim 10, wherein said additional marker is ADE, LEU, HIS, LYS or G418.
- 12. The method of claim 11, wherein for each vector comprising a yeast stability element, said yeast stability element comprises a different pair of yeast selection markers.
- 13. The method of any one of claims 1-12, wherein said photosynthetic organism is a eukaryote.
- 14. The method of claim 13, wherein said eukaryote is an alga.
- 15. The method of claim 14, wherein said alga is microalgae.
- 16. The method of claim 15, wherein said microalgae is a Chiamydomanas sp., Chiorella sp., Dunaliella sp., Haematococcus sp. or Scenedesmus sp.
- 17. The method of any one of claims 1-12, wherein said photosynthetic organism is a prokaryote.
- 18. The method of claim 17, wherein said prokaryote is a cyanobacterium.
- 19. The method of any one of claims 1-18, wherein said product of interest is a terpene or a terpenoid.
- 20. The method of any one of claims 1-18, wherein said product of interest is a fatty acid.
- 21. The method of any one of claims 1-18, wherein said product of interest is a biomass degrading enzyme.
- 22. The method of any one of claims 1-21, wherein said product of interest is not naturally produced by said photosynthetic organism.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97802407P | 2007-10-05 | 2007-10-05 | |
GB0913302A GB2460351B (en) | 2007-10-05 | 2008-10-06 | System for capturing and modifying large pieces of genomic DNA and constructing organisms with synthetic chloroplasts |
Publications (3)
Publication Number | Publication Date |
---|---|
GB201100928D0 GB201100928D0 (en) | 2011-03-02 |
GB2475435A true GB2475435A (en) | 2011-05-18 |
GB2475435B GB2475435B (en) | 2012-03-28 |
Family
ID=43903975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1100928.9A Expired - Fee Related GB2475435B (en) | 2007-10-05 | 2008-10-06 | System for capturing and modifying large pieces of genomic DNA and constructing organisms with synthetic chloroplasts |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2475435B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016008885A1 (en) * | 2014-07-14 | 2016-01-21 | Photanol B.V. | Biosynthesis of sesquiterpenes in cyanobacteria |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111440733A (en) * | 2020-02-07 | 2020-07-24 | 天津大学 | Recombinant saccharomyces cerevisiae for producing terpineol, construction method and application |
CN111484142B (en) * | 2020-03-24 | 2022-04-12 | 浙江省海洋水产养殖研究所 | Bioremediation technology of eutrophic water body |
CN115807021A (en) * | 2022-08-01 | 2023-03-17 | 深圳大学 | Method for synthesizing, assembling and testing functions of artificial chloroplast genome of chlamydomonas reinhardtii |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000075299A1 (en) * | 1999-06-07 | 2000-12-14 | Cell Genesys, Inc. | Hybrid yeast-bacteria cloning system and uses thereof |
US20050003511A1 (en) * | 1995-12-06 | 2005-01-06 | Bradshaw M. Suzanne | New yeast-bacteria shuttle vector |
-
2008
- 2008-10-06 GB GB1100928.9A patent/GB2475435B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050003511A1 (en) * | 1995-12-06 | 2005-01-06 | Bradshaw M. Suzanne | New yeast-bacteria shuttle vector |
WO2000075299A1 (en) * | 1999-06-07 | 2000-12-14 | Cell Genesys, Inc. | Hybrid yeast-bacteria cloning system and uses thereof |
Non-Patent Citations (3)
Title |
---|
Nature Methods, Vol. 5, 2008, Itaya et al, 'Bottom-up genome assembly using the Bacillus subtilis genome vector', pp. 41-43 * |
Plant Molecular Biology, Vol. 17, 1991, Gupta and Hoo, 'Entire maize chloroplast genome is stably maintained in a yeast artificial chromosome', pp. 361-369 * |
Plant Physiology, Vol. 145, 2007, Verma and Daniell, 'Chloroplast vector systems for biotechnology Applications', pp. 1129-1143 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016008885A1 (en) * | 2014-07-14 | 2016-01-21 | Photanol B.V. | Biosynthesis of sesquiterpenes in cyanobacteria |
Also Published As
Publication number | Publication date |
---|---|
GB201100928D0 (en) | 2011-03-02 |
GB2475435B (en) | 2012-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2460351A (en) | Vectors comprising essential chloroplast genes | |
CN101939434B (en) | Dgat genes from yarrowia lipolytica for increased seed storage lipid production and altered fatty acid profiles in soybean | |
KR102274445B1 (en) | Methods for genomic integration | |
KR101794298B1 (en) | Compositions and methods for the assembly of polynuceleotides | |
KR20210149060A (en) | RNA-induced DNA integration using TN7-like transposons | |
CA2834053C (en) | Yeast strains engineered to produce ethanol from glycerol | |
CN110684806A (en) | FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks | |
CN101815432A (en) | Plants with altered root architecture, related constructs and methods involving genes encoding nucleoside diphosphatase kinase (NDK) polypeptides and homologs thereof | |
CN101827938A (en) | Plants with altered root architecture, involving the RT1 gene, related constructs and methods | |
KR20140113997A (en) | Genetic switches for butanol production | |
IL236992A (en) | Genetically modified cyanobacteria producing ethanol | |
CA2730126C (en) | Plant regulatory sequence | |
KR20100037031A (en) | Gene knockout mesophilic and thermophilic organisms, and methods of use thereof | |
BRPI0806354A2 (en) | transgender oilseeds, seeds, oils, food or food analogues, medicinal food products or medicinal food analogues, pharmaceuticals, beverage formulas for babies, nutritional supplements, pet food, aquaculture feed, animal feed, whole seed products , mixed oil products, partially processed products, by-products and by-products | |
KR20140099224A (en) | Keto-isovalerate decarboxylase enzymes and methods of use thereof | |
CN112204147A (en) | Cpf 1-based plant transcription regulatory system | |
KR20130032897A (en) | Production of alcohol esters and in situ product removal during alcohol fermentation | |
BRPI0620552A2 (en) | isolated polynucleotide, delta-9 elongase polypeptide, recombinant construct, plant cell, method for transforming a cell, method for producing a transgenic plant, transgenic seed, method for making long chain polyunsaturated fatty acids, oils, method for producing at least one polyunsaturated fatty acid, oilseed plants, seeds, food, isolated nucleic acid fragment and plant progenies | |
CN113621642A (en) | Genetic intelligent breeding system for crop cross breeding seed production and application thereof | |
AU2024205703A1 (en) | Wheat stem rust resistance genes and methods of use | |
CN115997023A (en) | Novel resistance genes associated with disease resistance in soybean | |
CN101918560B (en) | Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding LNT2 polypeptides and homologs thereof | |
CN101868545B (en) | Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (LLRK) polypeptides and homologs thereof | |
GB2475435A (en) | Producing a product using shuttle vectors containing essential chloroplast genes | |
CN114085858B (en) | L-serine producing strain and construction method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20181006 |